<?xml version="1.0" encoding="ISO-8859-1"?><COCHRANE_REVIEW DESCRIPTION="For publication" DOI="10.1002/14651858.CD001117" GROUP_ID="AIRWAYS" ID="148499081019290831" MERGED_FROM="" MODIFIED="2009-03-30 13:57:54 +0200" MODIFIED_BY="Paolo Rosati" NOTES="&lt;p&gt;Exported from Review Manager 4.2.1&lt;br&gt;Technical Editing by CJC 12/7/2002&lt;/p&gt;&lt;p&gt;Authors and contributions: fine, also the What's new section is very helpful.  Have the conclusions changed at all?&lt;/p&gt;&lt;p&gt;References: fine (wow, this is a huge list)&lt;/p&gt;&lt;p&gt;Table of included studies:  very comprehensive&lt;/p&gt;&lt;p&gt;Metaview Labels: Good. There is however a very interesting effect on the weights in #1~4 ER visits in which Kotses steals all the weight due to low event rates and low SDs. This looks wrong to me and perhaps SMD should be used with such a large variation in event rate in the control group. Intuitively I would want the weight where there is more data (such as Ghosh). The same argument applies to #1~8. Posthoc this brings the continuous and dichotomous results into line as well.  I will discuss this with Paul. I have switched off the total in #1~12 as this is a single study conclusion.&lt;/p&gt;&lt;p&gt;SYNOPSIS: Last sentence could stand alone as summary. Then strip out methods and just report results? (too long at present)&lt;/p&gt;&lt;p&gt;ABSTRACT: I have removed the following from the results (?left by mistake?) &amp;quot;Self-management programmes that involved a written action plan showed a greater reduction in hospitalisation than those that did not (relative risk 0.58, 95% confidence interval 0.43 to 0.77). &amp;quot;&lt;/p&gt;&lt;p&gt;&lt;br&gt;METHODS: Fine&lt;/p&gt;&lt;p&gt;RESULTS:&lt;br&gt;Hospitalisations: &amp;quot;Optimal self-management involving provision of a written action plan led to a significant reduction in hospitalisations for asthma (RR 0.58, 0.43-0.77), whereas less intensive interventions did not.&amp;quot;&lt;br&gt;&amp;gt;&amp;gt;&amp;gt;THIS MAY WELL BE  A TYPE 2 ERROR AND SHOULD BE REWORDED. THERE IS NO STATISTICAL SIGNIFICANCE BETWEEN THE RESULTS IN THE SUBGROUPS, AS THE TOTAL CHI SCORE MINUS THE SUM OF THE SUBGROUP SCORES IS 8.10 MINUS 6.86 = 1.24 WHICH IS NOT SIGNIFICANT WITH DF 2.  PERHAPS YOU SHOULD SAY THAT YOU DO NOT HAVE THE POWER TO COMPARE SUBGROUPS, OR THAT NO SIG DIFFERENCE WAS FOUND BETWEEN APPROACHES?&amp;lt;&amp;lt;&amp;lt;&amp;lt;&lt;/p&gt;&lt;p&gt;&amp;gt;&amp;gt;&amp;gt;ER visits: &amp;quot;Mean ER visits were examined in 8 studies suitable for meta-analysis, finding no significant difference and significant heterogeneity.&amp;quot; Please consider re-analysing this using SMD as this is significant even with a random model..... See metaview comments above.&amp;lt;&amp;lt;&amp;lt;&lt;br&gt;I WOULD SUGGEST USING SMD THROUGHOUT THE REVIEW!&lt;/p&gt;&lt;p&gt;DISCUSSION&lt;br&gt;&amp;quot;There was also a gradation of effect. Those interventions which included a written action plan, consistently showed an effect, whereas less intense interventions were not always of obvious benefit. &amp;quot; &lt;br&gt;&amp;gt;&amp;gt;&amp;gt;SEE COMMENT  ABOVE ABOUT TYPE 2 ERROR - YOU CANNOT JUSTIFY THIS GRADATION ON THE DATA SHOWN AND THE LESS INTENSE INTERVENTIONS MAY MERELY BE UNDERPOWERED SO PLEASE CONSIDER REWORDING THIS&amp;lt;&amp;lt;&amp;lt;&amp;lt;&lt;/p&gt;&lt;p&gt;&lt;br&gt;This is a very useful and well presented review but could you have a look at my concerns above and respond to them.&lt;br&gt;Chris Cates&lt;br&gt;Back to Authors 12/7/2002&lt;/p&gt;&lt;p&gt;&lt;/p&gt;&lt;p&gt;RESPONSE TO EDITOR 14/8/02&lt;/p&gt;&lt;p&gt;Thankyou for your comments and suggestions. We have made the following changes according to your suggestions:&lt;/p&gt;&lt;p&gt;WHAT'S NEW: This update does not change the conclusions of the earlier review. I HAVE ADDED THIS TO THE WHAT'S NEW BOX&lt;/p&gt;&lt;p&gt;METAVIEWS: We agree with your concern regarding the variation in the control event rates and  have re-analysed the continuous outcomes using SMD as suggested. The text has been adjusted accordingly. THANKS - I HAVE CHECKED THE RESULTS AGAINST METAVIEW AND THEY ALL MATCH UP. i HAVE PUT A COMMA BETWEEN THE HIGHER AND LOWER CONFIDENCE INTERVALS AND TAKEN OUT THE DASHES AS THESE CAN BE MISINTERPRETED AS MINUS SIGNS.&lt;/p&gt;&lt;p&gt;SYNOPSIS: We have abbreviated the Synopsis THANKS&lt;/p&gt;&lt;p&gt;RESULTS: Agree. We have reworded  the text.&lt;/p&gt;&lt;p&gt;DISCUSSION: This sentence has been removed THANKS&lt;/p&gt;&lt;p&gt;&lt;br&gt;Many thanks&lt;br&gt;Heather Powell&lt;/p&gt;&lt;p&gt;SIGNED OFF BY CJC ON 23/8/2002.  Passed to Toby for Paul.  &lt;br&gt;[Paul you may wish to look at the reporting of the Quality of Life results in relation to results that do not reach statistical significance].&lt;/p&gt;" NOTES_MODIFIED="2009-03-30 13:57:54 +0200" NOTES_MODIFIED_BY="Paolo Rosati" REVIEW_NO="EDU-AST" REVMAN_SUB_VERSION="5.0.18" REVMAN_VERSION="5" SPLIT_FROM="" STAGE="R" STATUS="A" TYPE="INTERVENTION" VERSION_NO="7.0">
<COVER_SHEET MODIFIED="2009-03-30 13:57:54 +0200" MODIFIED_BY="Paolo Rosati">
<TITLE>Self-management education and regular practitioner review for adults with asthma</TITLE>
<CONTACT>
<PERSON ID="4647" ROLE="AUTHOR">
<PREFIX>Prof</PREFIX>
<FIRST_NAME>Peter</FIRST_NAME>
<MIDDLE_INITIALS>G</MIDDLE_INITIALS>
<LAST_NAME>Gibson</LAST_NAME>
<SUFFIX/>
<POSITION/>
<EMAIL_1>Peter.Gibson@hnehealth.nsw.gov.au</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Department of Respiratory and Sleep Medicine</DEPARTMENT>
<ORGANISATION>John Hunter Hospital</ORGANISATION>
<ADDRESS_1/>
<ADDRESS_2>Locked Bag 1</ADDRESS_2>
<CITY>Hunter Mail Centre</CITY>
<ZIP>2310</ZIP>
<REGION>NSW</REGION>
<COUNTRY CODE="AU">Australia</COUNTRY>
<PHONE_1>+61 2 498555766</PHONE_1>
<PHONE_2/>
<FAX_1>+ 61 2 49855850</FAX_1>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
</CONTACT>
<CREATORS MODIFIED="2009-03-30 13:57:54 +0200" MODIFIED_BY="Paolo Rosati">
<PERSON ID="4647" ROLE="AUTHOR">
<PREFIX>Prof</PREFIX>
<FIRST_NAME>Peter</FIRST_NAME>
<MIDDLE_INITIALS>G</MIDDLE_INITIALS>
<LAST_NAME>Gibson</LAST_NAME>
<SUFFIX/>
<POSITION/>
<EMAIL_1>Peter.Gibson@hnehealth.nsw.gov.au</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Department of Respiratory and Sleep Medicine</DEPARTMENT>
<ORGANISATION>John Hunter Hospital</ORGANISATION>
<ADDRESS_1/>
<ADDRESS_2>Locked Bag 1</ADDRESS_2>
<CITY>Hunter Mail Centre</CITY>
<ZIP>2310</ZIP>
<REGION>NSW</REGION>
<COUNTRY CODE="AU">Australia</COUNTRY>
<PHONE_1>+61 2 498555766</PHONE_1>
<PHONE_2/>
<FAX_1>+ 61 2 49855850</FAX_1>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="12480" ROLE="AUTHOR">
<PREFIX/>
<FIRST_NAME>Heather</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Powell</LAST_NAME>
<SUFFIX/>
<POSITION>Research Data Manager</POSITION>
<EMAIL_1>Heather.Powell@hnehealth.nsw.gov.au</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Department of Respiratory &amp; Sleep Medicine</DEPARTMENT>
<ORGANISATION>John Hunter Hospital</ORGANISATION>
<ADDRESS_1/>
<ADDRESS_2>Locked Bag 1</ADDRESS_2>
<CITY>Hunter Region Mail Centre</CITY>
<ZIP>2310</ZIP>
<REGION>NSW</REGION>
<COUNTRY CODE="AU">Australia</COUNTRY>
<PHONE_1>02 49213446</PHONE_1>
<PHONE_2/>
<FAX_1/>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="5095" ROLE="AUTHOR">
<PREFIX>Ms</PREFIX>
<FIRST_NAME>Amanda</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Wilson</LAST_NAME>
<SUFFIX/>
<POSITION/>
<EMAIL_1>amanda.wilson@newcastle.edu.au</EMAIL_1>
<EMAIL_2>kirkwood.wilson@hotkey.net.au</EMAIL_2>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT/>
<ORGANISATION>Unviersity of Newcastle</ORGANISATION>
<ADDRESS_1/>
<ADDRESS_2/>
<CITY>Newcastle</CITY>
<ZIP/>
<REGION>New South Wales</REGION>
<COUNTRY CODE="AU">Australia</COUNTRY>
<PHONE_1/>
<PHONE_2/>
<FAX_1/>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="4417" ROLE="AUTHOR">
<PREFIX>A/Prof</PREFIX>
<FIRST_NAME>Michael</FIRST_NAME>
<MIDDLE_INITIALS>J</MIDDLE_INITIALS>
<LAST_NAME>Abramson</LAST_NAME>
<SUFFIX/>
<POSITION>Deputy Head</POSITION>
<EMAIL_1>Michael.Abramson@med.monash.edu.au</EMAIL_1>
<EMAIL_2>michael.abramson@med.monash.edu.au</EMAIL_2>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Epidemiology &amp; Preventive Medicine</DEPARTMENT>
<ORGANISATION>Monash University</ORGANISATION>
<ADDRESS_1>Central &amp; Eastern Clinical School</ADDRESS_1>
<ADDRESS_2>The Alfred</ADDRESS_2>
<CITY>Melbourne</CITY>
<ZIP>3004</ZIP>
<REGION>Victoria</REGION>
<COUNTRY CODE="AU">Australia</COUNTRY>
<PHONE_1>+61 3 9903 0573</PHONE_1>
<PHONE_2>+61 3 9903 0555</PHONE_2>
<FAX_1>+61 3 9903 0556</FAX_1>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="19408" ROLE="AUTHOR">
<PREFIX>Dr</PREFIX>
<FIRST_NAME>P</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Haywood</LAST_NAME>
<SUFFIX/>
<POSITION/>
<EMAIL_1>phaywood@bigpond.com</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT/>
<ORGANISATION/>
<ADDRESS_1>54 Lawson Street</ADDRESS_1>
<ADDRESS_2>St Hamilton</ADDRESS_2>
<CITY>NSW</CITY>
<ZIP>2303</ZIP>
<REGION/>
<COUNTRY CODE="AU">Australia</COUNTRY>
<PHONE_1>+61 2 4961-1565</PHONE_1>
<PHONE_2/>
<FAX_1/>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="4455" ROLE="AUTHOR">
<PREFIX>Dr</PREFIX>
<FIRST_NAME>Adrian</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Bauman</LAST_NAME>
<SUFFIX/>
<POSITION/>
<EMAIL_1/>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Epidemiology Unit Level 4</DEPARTMENT>
<ORGANISATION>Health Services Building</ORGANISATION>
<ADDRESS_1>Campbell and Goulbourn Streets</ADDRESS_1>
<ADDRESS_2/>
<CITY>Liverpool</CITY>
<ZIP>NSW 2170</ZIP>
<REGION/>
<COUNTRY CODE="AU">Australia</COUNTRY>
<PHONE_1>61 2 828 4936</PHONE_1>
<PHONE_2/>
<FAX_1>61 2 828 4910</FAX_1>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="4693" ROLE="AUTHOR">
<PREFIX>Prof</PREFIX>
<FIRST_NAME>Michael</FIRST_NAME>
<MIDDLE_INITIALS>J</MIDDLE_INITIALS>
<LAST_NAME>Hensley</LAST_NAME>
<SUFFIX/>
<POSITION>Professor of Medicine</POSITION>
<EMAIL_1>michael.hensley@newcastle.edu.au</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Discipline of Medicine</DEPARTMENT>
<ORGANISATION>The University of Newcastle</ORGANISATION>
<ADDRESS_1>Division of Medicine</ADDRESS_1>
<ADDRESS_2>John Hunter Hospital</ADDRESS_2>
<CITY>Locked Bag 1</CITY>
<ZIP>2310</ZIP>
<REGION>Hunter Region Mail Centre</REGION>
<COUNTRY CODE="AU">Australia</COUNTRY>
<PHONE_1>61 2 4921 3542</PHONE_1>
<PHONE_2>61 2 4921 3549</PHONE_2>
<FAX_1>61 2 4921 3537</FAX_1>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="DA990F8082E26AA2005DA36437887272" ROLE="AUTHOR">
<PREFIX>Prof</PREFIX>
<FIRST_NAME>E. Haydn</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Walters</LAST_NAME>
<SUFFIX/>
<POSITION>Professor and clinical chief of Medicine</POSITION>
<EMAIL_1>Haydn.Walters@utas.edu.au</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Discipline of Medicine</DEPARTMENT>
<ORGANISATION>University of Tasmania Medical School</ORGANISATION>
<ADDRESS_1>43, Collins Street</ADDRESS_1>
<ADDRESS_2>PO BOX 252-34</ADDRESS_2>
<CITY>Hobart</CITY>
<ZIP>7001</ZIP>
<REGION>Tasmania</REGION>
<COUNTRY CODE="AU">Australia</COUNTRY>
<PHONE_1>+61 3 6226 4870</PHONE_1>
<PHONE_2/>
<FAX_1>+61 3 6226 4894</FAX_1>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="12401" ROLE="AUTHOR">
<PREFIX>Mrs</PREFIX>
<FIRST_NAME>Jennifer</FIRST_NAME>
<MIDDLE_INITIALS>JL</MIDDLE_INITIALS>
<LAST_NAME>Roberts</LAST_NAME>
<SUFFIX/>
<POSITION/>
<EMAIL_1>Jennifer.Roberts@newcastle.edu.au</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT/>
<ORGANISATION/>
<ADDRESS_1>66 Moorhouse Street</ADDRESS_1>
<ADDRESS_2>O'Connor</ADDRESS_2>
<CITY>ACT</CITY>
<ZIP>2602</ZIP>
<REGION/>
<COUNTRY CODE="AU">Australia</COUNTRY>
<PHONE_1>61 21 49213542</PHONE_1>
<PHONE_2/>
<FAX_1>61 2 4921 3537</FAX_1>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
</CREATORS>
<DATES MODIFIED="2008-08-22 11:47:15 +0200" MODIFIED_BY="Toby Lasserson" NOTES="&lt;p&gt;Minor update: 30/01/03&lt;/p&gt;&lt;p&gt;New studies found and included or excluded: 12/03/02&lt;/p&gt;&lt;p&gt;Conclusions changed: 12/03/02&lt;/p&gt;" NOTES_MODIFIED="2008-08-22 11:47:15 +0200" NOTES_MODIFIED_BY="Toby Lasserson">
<UP_TO_DATE>
<DATE DAY="12" MONTH="3" YEAR="2002"/>
</UP_TO_DATE>
<LAST_SEARCH>
<DATE DAY="12" MONTH="3" YEAR="2002"/>
</LAST_SEARCH>
<NEXT_STAGE>
<DATE DAY="" MONTH="" YEAR=""/>
</NEXT_STAGE>
<PROTOCOL_PUBLISHED ISSUE="1" YEAR="1998"/>
<REVIEW_PUBLISHED ISSUE="1" YEAR="1999"/>
<LAST_CITATION_ISSUE ISSUE="4" YEAR="1998"/>
</DATES>
<WHATS_NEW NOTES="&lt;p&gt;This review is an update of the existing &amp;quot;Self-management education and regular practitioner review for adults with asthma&amp;quot;. Thirty six trials comparing asthma self-management education with a usual care control group have been included.  Thirteen new trials have been added with this update. We have removed three trials from the original review that did not have a control group and compared two options for self-management education.  These have been included in a third review &amp;quot;Options for self-management education for adults with asthma&amp;quot;.  Two new outcomes, quality of life and costs, have also been evaluated.&lt;br&gt;&lt;br&gt;The conclusions of the review are unchanged.&lt;/p&gt;">
<WHATS_NEW_ENTRY EVENT="AMENDMENT">
<DATE DAY="20" MONTH="8" YEAR="2008"/>
<DESCRIPTION>
<P>Converted to new review format.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</WHATS_NEW>
<HISTORY>
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_NEW_CONCLUSIONS">
<DATE DAY="12" MONTH="3" YEAR="2002"/>
<DESCRIPTION>
<P>Substantive amendment</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</HISTORY>
<SOURCES_OF_SUPPORT>
<INTERNAL_SOURCES>
<SOURCE>
<NAME>Hunter Area Health Service</NAME>
<COUNTRY CODE="NONE">Not specified</COUNTRY>
<DESCRIPTION/>
</SOURCE>
</INTERNAL_SOURCES>
<EXTERNAL_SOURCES>
<SOURCE>
<NAME>Cooperative Research Centre for Asthma</NAME>
<COUNTRY CODE="AU">Australia</COUNTRY>
<DESCRIPTION/>
</SOURCE>
</EXTERNAL_SOURCES>
</SOURCES_OF_SUPPORT>
<MESH_TERMS VERIFIED="NO"/>
<KEYWORDS/>
</COVER_SHEET>
<MAIN_TEXT MODIFIED="2008-08-20 18:55:23 +0200" MODIFIED_BY="Toby J Lasserson">
<SUMMARY MODIFIED="2008-08-20 18:08:39 +0200" MODIFIED_BY="Toby J Lasserson">
<TITLE MODIFIED="2008-08-20 18:08:39 +0200" MODIFIED_BY="Toby J Lasserson">Self-management education and regular practitioner review for adults with asthma</TITLE>
<SUMMARY_BODY>
<P>Guidelines for the treatment of asthma recommend that patients be educated about their condition, obtain regular medical review, monitor their condition at home with either peak flow or symptoms and use a written action plan. The results of trials comparing asthma self-management education to usual care were combined. These results showed that asthma sufferers who were educated about their asthma, visited the doctor regularly and who used a written action plan had fewer visits to the emergency room; less hospital admissions; better lung function; improvement in peak expiratory flow; fewer symptoms; and used less rescue medication. </P>
</SUMMARY_BODY>
</SUMMARY>
<ABSTRACT>
<ABS_BACKGROUND>
<P>A key component of many asthma management guidelines is the recommendation for patient education and regular medical review. A number of controlled trials have been conducted to measure the effectiveness of asthma education programmes. These programmes improve patient knowledge, but their impact on health outcomes is less well established. This review was conducted to examine the strength of evidence supporting Step 6 of the Australian Asthma Management Plan: "Educate and Review Regularly"; to test whether health outcomes are influenced by education and self-management programmes. </P>
</ABS_BACKGROUND>
<ABS_OBJECTIVES>
<P>The objective of this review was to assess the effects of asthma self-management programmes, when coupled with regular health practitioner review, on health outcomes in adults with asthma.</P>
</ABS_OBJECTIVES>
<ABS_SEARCH_STRATEGY>
<P>We searched the Cochrane Airways Group trials register and reference lists of articles.</P>
</ABS_SEARCH_STRATEGY>
<ABS_SELECTION_CRITERIA>
<P>Randomised trials of self-management education in adults over 16 years of age with asthma.</P>
</ABS_SELECTION_CRITERIA>
<ABS_DATA_COLLECTION>
<P>Two reviewers assessed trial quality and extracted data independently. We contacted study authors for confirmation.</P>
</ABS_DATA_COLLECTION>
<ABS_RESULTS>
<P>We included thirty six trials, which compared self-management education with usual care. Self-management education reduced hospitalisations (relative risk (RR) 0.64, 95% confidence interval (CI) 0.50 to 0.82); emergency room visits (RR 0.82, 95% CI 0.73 to 0.94); unscheduled visits to the doctor (RR 0.68, 95% CI 0.56 to 0.81); days off work or school (RR 0.79, 95% CI 0.67 to 0.93); nocturnal asthma (RR 0.67, 95% CI 0.0.56 to 0.79); and quality of life (standard mean difference 0.29,CI 0.11 to 0.47). Measures of lung function were little changed. </P>
</ABS_RESULTS>
<ABS_CONCLUSIONS>
<P>Education in asthma self-management which involves self-monitoring by either peak expiratory flow or symptoms, coupled with regular medical review and a written action plan improves health outcomes for adults with asthma. Training programmes that enable people to adjust their medication using a written action plan appear to be more effective than other forms of asthma self-management. </P>
</ABS_CONCLUSIONS>
</ABSTRACT>
<BODY MODIFIED="2008-08-20 18:55:23 +0200" MODIFIED_BY="Toby J Lasserson">
<BACKGROUND MODIFIED="2008-08-20 18:08:41 +0200" MODIFIED_BY="Toby J Lasserson">
<P>The burden of illness from asthma is high and increasing (<LINK REF="REF-Peat-1994" TYPE="REFERENCE">Peat 1994</LINK>). There are problems with the delivery of care, which include under-treatment with corticosteroids, limited knowledge, and poor asthma management skills amongst patients with severe asthma ( <LINK REF="REF-Gibson-1993a" TYPE="REFERENCE">Gibson 1993a</LINK>). Asthma management guidelines have been developed in many countries to assist in the application of standardised, high-quality medical care (<LINK REF="REF-Woolcock-1989" TYPE="REFERENCE">Woolcock 1989</LINK>). These guidelines rely on expert opinion with variable reporting of their evidence base (<LINK REF="REF-Gibson-1993b" TYPE="REFERENCE">Gibson 1993b</LINK>).<BR/>
<BR/>A key component of many asthma management guidelines, including Part 1 of the Six-Part Asthma Management Program proposed by the International Consensus Report on diagnosis and Treatment of Asthma (<LINK REF="REF-Anonymous-1992" TYPE="REFERENCE">Anonymous 1992</LINK>), is the recommendation for patient education and regular medical review. Education is considered to be necessary "to help patients gain the motivation, skills and confidence to control their asthma" (<LINK REF="REF-Anonymous-1996" TYPE="REFERENCE">Anonymous 1996</LINK>). A narrative review of asthma education has emphasised the need for asthma education and suggested successful strategies (<LINK REF="REF-Clark-1993" TYPE="REFERENCE">Clark 1993</LINK>). A number of controlled trials have been conducted to identify the effectiveness of asthma education and self-management programmes. Whilst there is general agreement that these programmes improve patient knowledge, the impact that this may have on health outcomes is less well acknowledged. For example, a review of paediatric education programmes failed to identify a positive benefit on asthma admissions, doctor visits, or school absenteeism (<LINK REF="REF-Bernard_x002d_Bonnin-1995" TYPE="REFERENCE">Bernard-Bonnin 1995</LINK>). The influence of programme characteristics on health outcomes has not been examined in adults. This review was conducted to address these issues. Specifically, it examined the strength of evidence supporting Step 6 of the Australian Asthma Management Plan, "Educate and Review Regularly" in order to identify whether health outcomes are influenced by asthma education and self-management programmes.</P>
<P>A companion review has dealt with trials of limited (information only) education interventions (<LINK REF="REF-Gibson-1998" TYPE="REFERENCE">Gibson 1998</LINK>) and concluded that education did not have a significant effect when administered without an action plan, self-monitoring or regular review.</P>
</BACKGROUND>
<OBJECTIVES MODIFIED="2008-08-20 18:08:55 +0200" MODIFIED_BY="Toby J Lasserson">
<P>This study aimed to evaluate the literature supporting Step 6 of the Australian Asthma Management Plan (AAMP), "Educate and Review Regularly." The specific questions addressed are:</P>
<OL>
<LI>Do asthma self-management education and regular review (by doctor or nurse practitioner) lead to improved health outcomes in asthma?</LI>
<LI>What are the characteristics of those programmes which lead to measurable changes in health outcomes?</LI>
</OL>
</OBJECTIVES>
<METHODS MODIFIED="2008-08-20 18:47:53 +0200" MODIFIED_BY="Toby J Lasserson">
<SELECTION_CRITERIA MODIFIED="2008-08-20 18:09:26 +0200" MODIFIED_BY="Toby J Lasserson">
<CRIT_STUDIES>
<P>Studies were included if they were randomised controlled trials (RCTs) or quasi-randomised controlled trials (CCTs) which studied the effects of asthma education and self-management on health outcomes in adults with asthma.</P>
</CRIT_STUDIES>
<CRIT_PARTICIPANTS>
<P>Predominantly adults (&gt; 16 years old) with asthma (defined by doctor's diagnosis or objective criteria or according to American Thoracic Society guidelines).</P>
</CRIT_PARTICIPANTS>
<CRIT_INTERVENTIONS MODIFIED="2008-08-20 18:09:26 +0200" MODIFIED_BY="Toby J Lasserson">
<P>We categorised the interventions according to whether or not they involved asthma education, self-monitoring of peak expiratory flow or symptoms, regular medical review and a written action plan.</P>
<SUBSECTION>
<HEADING LEVEL="6">Intervention characteristics</HEADING>
<P>Patient Asthma Education: a programme which transfers information about asthma in any of these forms: written, verbal, visual or audio. It may be interactive or non-interactive, structured or unstructured. Minimal education is characterised by the provision of written material alone or the conduct of a short unstructured verbal interaction between a health provider and a patient where the primary goal is to improve patient knowledge and understanding of asthma. Maximal education is considered to be structured with the use of both interactive and non-interactive modes of information transfer. The content of the education must be related to asthma and its management.</P>
<P>Self-monitoring: consists of the regular measurement of either peak expiratory flow or symptoms. It is further characterised by the recording (or not) of those measurements in a diary.</P>
<P>Regular Review: consists of regular consultation with a doctor during the intervention period for the purpose of reviewing the patients' asthma status and medications. This may occur either as a formal part of the intervention or the patients may be advised to see their own doctor on a regular basis. Interventions are classified as having "regular review" either inside the programme (if the patients were seen as a part of the programme) or outside the programme (if the patients were merely advised to seek regular medical review).</P>
<P>Written Action Plan: an individualised written plan produced for the purpose of patient self-management of asthma exacerbations. The action plan is characterised by being individualised to the patient's underlying asthma severity and treatment. It is also a written plan which informs participants about:<BR/>
</P>
<UL>
<LI>when and how to modify medications in response to worsening asthma; and</LI>
<LI>how to access the medical system in response to worsening asthma.</LI>
</UL>
</SUBSECTION>
</CRIT_INTERVENTIONS>
<CRIT_OUTCOMES>
<P>Any of the following outcomes: asthma admissions, emergency room visits, doctor visits, days lost from work or school, lung function (FEV1), peak expiratory flow (PEF), use of rescue beta-agonists, courses of oral corticosteroids, symptom scores, quality of life scores, costs.</P>
</CRIT_OUTCOMES>
</SELECTION_CRITERIA>
<SEARCH_METHODS MODIFIED="2008-08-20 18:13:52 +0200" MODIFIED_BY="Toby J Lasserson">
<P>We identified studies from the following sources:</P>
<P>Cochrane Airways Group trial register derived from MEDLINE, EMBASE, CINAHL, handsearched respiratory journals and meeting abstracts. We searched the register using the following terms: (Asthma OR wheez*) AND (education* OR self management OR self-management).</P>
<P>We obtained the articles, and handsearched their bibliographic lists for additional articles.</P>
</SEARCH_METHODS>
<DATA_COLLECTION MODIFIED="2008-08-20 18:47:53 +0200" MODIFIED_BY="Toby J Lasserson">
<P>
<BR/>
</P>
<STUDY_SELECTION MODIFIED="2008-08-20 18:17:04 +0200" MODIFIED_BY="Toby J Lasserson">
<P>Two reviewers independently coded studies from the above sources into three categories based upon the abstract/key word/title:</P>
<OL>
<LI>Include: as RCT, adult, asthma, education</LI>
<LI>Possible RCT but cannot determine from abstract</LI>
<LI>Exclude: non-RCT or CCT, paediatric age range, doctor education.</LI>
</OL>
<P>We examined full text versions of the articles or studies in category (2) in order to define if the study met the inclusion criteria.</P>
<P>To investigators independently categorised study eligibility, study quality and intervention type. Agreement was examined and disagreement resolved by consensus.</P>
<P>We included articles if they were: randomised or quasi-randomised controlled trials; of asthma education delivered to adults (&gt; 16 years) with asthma. We reported relevant health outcomes: hospitalisations, visits to medical practitioner, visits to emergency room, use of beta-agonists, lung functions, quality of life, symptoms score, symptoms or peak expiratory flow diary.</P>
</STUDY_SELECTION>
<DATA_EXTRACTION MODIFIED="2008-08-20 18:47:53 +0200" MODIFIED_BY="Toby J Lasserson">
<P>Two review authors extracted data on the following variables, and entered the data into Review Manager:<BR/>
</P>
<OL>
<LI>Hospital admissions</LI>
<LI>Emergency room visits</LI>
<LI>Unscheduled doctor visits</LI>
<LI>Days lost from work or school</LI>
<LI>Forced Expiratory Volume in 1 second (FEV1)</LI>
<LI>Peak Expiratory Flow (PEF)</LI>
<LI>Use of 'rescue' (or reliever) medications</LI>
<LI>Quality of life, symptoms scores, symptom/peak flow diary</LI>
<LI>Economic data, cost, days lost from college/work.</LI>
</OL>
<P>The data extraction process also included collecting information on</P>
<OL>
<LI>Demographics: age, gender, ethnicity, socio-economic level,</LI>
<LI>Type of control: several different types of control intervention were used. These included an "intervention" of low efficacy (eg. written material only), usual medical care and (waiting list control. It is likely that a true placebo has not been used in any study.</LI>
<LI>Setting of intervention: primary care vs hospital based. The severity of asthma differs in these settings and this may influence the ability to detect a change in outcome measures. For example: in a hospital based setting, the greater number of events (e.g. re-admission) could make it easier to detect differences than in primary care.</LI>
<LI>Duration of intervention: number of sessions, hours of teaching.</LI>
<LI>Sample size</LI>
<LI>Asthma severity</LI>
<LI>Intermediate outcomes: asthma knowledge, skills.</LI>
</OL>
</DATA_EXTRACTION>
<QUALITY_ASSESSMENT MODIFIED="2008-08-20 18:47:48 +0200" MODIFIED_BY="Toby J Lasserson">
<P>Two reviewers independently assessed the quality of the full text versions of all included papers using the Cochrane system. Study quality was assessed according to the following criteria:</P>
<P>Two authors assessed whether the process of concealment of allocation was adequate. This was deemed to be adequate if there was a central randomisation scheme, randomisation i.e. external person or use of coded containers/ envelopes. This was determined to be unclear if information was not available. This was deemed to be inadequate if there was alternate allocation, reference to case record number, date of birth, day of the week, or an open list of random numbers.</P>
<P>Additional quality variables recorded were:</P>
<OL>
<LI>Blinding of interventions</LI>
<LI>Withdrawals/ dropouts</LI>
<LI>Blinding of outcome assessment.</LI>
</OL>
</QUALITY_ASSESSMENT>
<MISSING_DATA MODIFIED="2008-08-20 18:26:56 +0200" MODIFIED_BY="Toby J Lasserson">
<P>We made an attempt to contact all authors for verification of methodological quality, classification of the intervention(s) and of outcomes data. Replies were received from thirteen authors who are listed in the acknowledgements section. Two were returned to sender (<LINK REF="STD-Snyder-1987" TYPE="STUDY">Snyder 1987</LINK>; <LINK REF="STD-Huss-1992" TYPE="STUDY">Huss 1992</LINK>). We attempted to contact the second author if we were unsuccessful in contacting the first author.</P>
</MISSING_DATA>
<DATA_SYNTHESIS MODIFIED="2008-08-20 18:26:18 +0200" MODIFIED_BY="Toby J Lasserson">
<P>We analysed outcomes as continuous and/or dichotomous variables, using standard statistical techniques.</P>
<OL>
<LI>For continuous outcomes, the weighted mean difference (WMD) or standardised mean difference (SMD) with 95% confidence intervals (CI) were calculated as appropriate.</LI>
<LI>For dichotomous outcomes, the relative risk (RR) was calculated with 95% CI.</LI>
</OL>
<P>We examined heterogeneity using a Chi-squared test and explored reasons for heterogeneity if appropriate.</P>
<P>Where appropriate, we entered data as negative values to eliminate differences in scoring scales for quality of life.</P>
<P>The primary comparison, based on the treatment of the intervention and control groups used was:</P>
<P>Self Management versus usual care.</P>
<P>Another review comparing different options for optimal self-management has been published (Gibson 2002).</P>
</DATA_SYNTHESIS>
<SUBGROUP_ANALYSIS MODIFIED="2008-08-20 18:14:38 +0200" MODIFIED_BY="Toby J Lasserson">
<P>We further divided study groups by the intensity of their intervention into one of the following categories:</P>
<OL>
<LI>Optimal Self-Management which involved a written action plan for self-management of medications for exacerbations, together with self-monitoring and regular medical review;</LI>
<LI>Self Monitoring and Regular Review without a written action plan;</LI>
<LI>Self Monitoring Only,</LI>
<LI>Regular Review Only, and</LI>
<LI>Written Action Plan but not Optimal Self-Management: These interventions included a written action plan but did not include both self-monitoring and regular review</LI>
</OL>
</SUBGROUP_ANALYSIS>
</DATA_COLLECTION>
</METHODS>
<RESULTS MODIFIED="2008-08-20 18:55:06 +0200" MODIFIED_BY="Toby J Lasserson">
<STUDY_DESCRIPTION MODIFIED="2008-08-20 18:30:03 +0200" MODIFIED_BY="Toby J Lasserson">
<SEARCH_RESULTS MODIFIED="2008-08-20 18:26:42 +0200" MODIFIED_BY="Toby J Lasserson">
<P>We identified 101 papers describing 87 potentially relevant studies of asthma education in adults. We obtained full text versions of these papers, and two reviewers independently assessed them. We agreed to include 45 papers describing 36 randomised controlled trials in this review.</P>
</SEARCH_RESULTS>
<INCLUDED_STUDIES_DESCR MODIFIED="2008-08-20 18:30:03 +0200" MODIFIED_BY="Toby J Lasserson">
<SUBSECTION>
<HEADING LEVEL="4">PARTICIPANTS &amp; SETTING</HEADING>
<P>6090 participants were randomised into 36 trials. Thirty four studies reported that 4593 participants completed the trial. The reported drop out rates ranged from 0% to 54%.</P>
<P>Participants were recruited from a variety of settings:<BR/>
</P>
<UL>
<LI>Hospital (n = 6)</LI>
<LI>Emergency Room (n = 3)</LI>
<LI>Hospital and Emergency Room (n = 1)</LI>
<LI>Outpatient Clinic (n = 12)</LI>
<LI>General Practice (n = 5)</LI>
<LI>Community Setting (n = 6)</LI>
<LI>Hospital and Clinic (n = 1)</LI>
<LI>Outpatients and General Practice (n = 1)</LI>
<LI>HMO (n = 1)</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">INTERVENTIONS</HEADING>
<P>The content of the asthma self-management interventions described in the 36 studies included:<BR/>
</P>
<UL>
<LI>education (n = 36, 100%)</LI>
<LI>self-monitoring of symptoms and/or peak expiratory flow (n = 33, 92%)</LI>
<LI>regular review of treatment and asthma severity by a medical practitioner (n = 24, 67%)</LI>
<LI>written action plan (n = 18, 50%).</LI>
</UL>
<P>Some degree of patient education was provided in all of the 36 trials included in this comparison. As education has been shown not to have a significant impact on objective health outcomes when administered without an action plan, self monitoring or regular review (<LINK REF="REF-Gibson-1998" TYPE="REFERENCE">Gibson 1998</LINK>), education was not reflected in sub-group analysis.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">COMPARISONS</HEADING>
<P>Self-management was compared with a usual care control in all 36 studies.The participants in the control groups received 'usual care' which may have included a variety of interventions. The descriptions of 'usual care' included no intervention, education, self monitoring, or regular medical review. No control group received a written action plan. In some cases, the nature of 'usual care' was not specified. The nature of the control intervention did not exclude a study from this review. Control groups received education about asthma in 12 (33%) studies. Self monitoring was performed intermittently for outcome assessment in seven (22%) studies, continuously in four (11%) and provision of a peak flow meter and encouragement of its use occurred in one (3%). Eleven (31%) of the control groups were advised to seek medical review, generally outside the programme.</P>
<P>These studies fell into five subgroups according to the type of self-management intervention:<BR/>(1a) Optimal self management (n = 15),<BR/>(1b) Self monitoring and regular review (n = 7),<BR/>(1c) Self monitoring only (n = 10),<BR/>(1d) Regular Review only (n = 2) and<BR/>(1e) Written action plan but not optimal self management (n = 2)</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">OUTCOMES: SELF MANAGEMENT VERSUS USUAL CARE</HEADING>
<P>The list below describes the measurement and reporting of outcomes from the included studies.<BR/>Measured and Reported (measured but not reported)</P>
<UL>
<LI>Hospitalisations 18 (6)</LI>
<LI>ER visits 20 (3)</LI>
<LI>Unscheduled Dr visits 12 (6)</LI>
<LI>Days off work or school 16 (4)</LI>
<LI>Nocturnal Asthma 7 (4)</LI>
<LI>Disrupted days 2 (6)</LI>
<LI>FEV1 8 (2)</LI>
<LI>PEFR 14 (2)</LI>
<LI>Oral corticosteroids 3 (1)</LI>
<LI>Quality of life 7(3)</LI>
<LI>Cost 4</LI>
</UL>
</SUBSECTION>
</INCLUDED_STUDIES_DESCR>
<EXCLUDED_STUDIES_DESCR MODIFIED="2008-08-20 18:26:37 +0200" MODIFIED_BY="Toby J Lasserson">
<P>Forty seven studies were excluded for the following reasons: the participants had smoking-related chronic obstructive airway disease and not asthma (two); the methodological criteria were not met (11); background data only reported (two); the intervention did not include education (7); or was assessing inhaler technique only (3); the outcome measured was not appropriate (two); the interventions were not patient education (two); two interventions were compared without a control group (9) or the interventions were information-only education; and did not include elements of self-management or behavioural change (ten). The information-only trials were reported in a previous review and the comparisons of two interventions form the basis of a third review. Two studies are ongoing and one is waiting assessment. The results of this review are thus derived from thirty-six RCTs of patient education and self-management in adults with asthma.</P>
</EXCLUDED_STUDIES_DESCR>
</STUDY_DESCRIPTION>
<STUDY_QUALITY MODIFIED="2008-08-20 18:51:43 +0200" MODIFIED_BY="Toby J Lasserson">
<P>An overview of our judgements of concealment of allocation is given in <LINK REF="FIG-01" TYPE="FIGURE">Figure 1</LINK>. The information we have used to as a basis for these judgements is given in <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK>. Eight studies had adequately concealed allocation, and eight studies had inadequately concealed allocation. In the remaining studies we could not determine whether procedures to conceal allocation were adequate or inadequate due to a lack of available information.</P>
</STUDY_QUALITY>
<INTERVENTION_EFFECTS MODIFIED="2008-08-20 18:55:06 +0200" MODIFIED_BY="Toby J Lasserson">
<SUBSECTION>
<HEADING LEVEL="4">HOSPITALISATIONS</HEADING>
<P>Asthma self-management education led to a significant reduction in the proportion of participants who were hospitalised for asthma. Eighteen studies provided data of which 12 could be included in a meta analysis. Approximately 11.4% of participants in the control groups required hospitalisation for asthma exacerbations during the study periods. This was reduced to 7.1% by asthma self-management education (RR 0.64; 95% CI 0.50 to 0.82, <LINK REF="FIG-02" TYPE="FIGURE">Figure 2</LINK>). We performed a sub-group analysis to examine the effects of different types of self-management education on hospitalisation for asthma. Optimal self-management involving provision of a written action plan led to a significant reduction in hospitalisations for asthma (RR 0.58; 95% CI 0.43 to 0.77), however there was insufficient power to compare the subgroups with less intensive interventions. There was no significant difference in mean hospitalisations reported in five studies and no significant difference from baseline was reported in one but data not given (<LINK REF="STD-Blixen-2001" TYPE="STUDY">Blixen 2001</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">EMERGENCY HOSPITAL VISITS</HEADING>
<P>There were 20 studies that examined the effect of self-management education on emergency room (ER) visits for asthma, thirteen providing dichotomous data, nine the mean number of visits, three reporting both and one as the number of visits. The proportion of participants who required ER visits was 24.5% in the usual care group. Overall, there was a significant effect for self-management education to reduce the proportion of asthmatics needing ER visits (RR 0.82; 95% CI 0.73 to 0.94, <LINK REF="FIG-03" TYPE="FIGURE">Figure 3</LINK>). Optimal self-management education led to a significant reduction in ER visits (RR 0.78; 95% CI 0.67 to 0.91), as did the two interventions which included regular review of medications (RR 0.37; 0.14, 0.99). Mean ER visits were examined in eight studies suitable for meta-analysis. There was a significant effect favouring self-management (SMD -0.36; 95% CI -0.5 to -0.21), however significant heterogeneity was present (Chi Sq 8.66, p &lt; 0.05).</P>
<P>Two further studies measured this outcome but did not report the results and one study reported no significant difference in ER visits from baseline (<LINK REF="STD-Blixen-2001" TYPE="STUDY">Blixen 2001</LINK>)</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">UNSCHEDULED DOCTOR VISITS</HEADING>
<P>Eleven studies reported results for the effects of self management education on unscheduled doctors visits suitable for meta-analysis; seven as the proportion of participants requiring one or more visits, and seven as the mean number of visits, with three studies reporting both. When reported as the number of participants there was a significant reduction in unscheduled visits (RR 0.68; 95% CI 0.56 to 0.81, <LINK REF="CMP-001.06" TYPE="ANALYSIS">Analysis 1.6</LINK>). However there was significant heterogeneity in this group (Chi Sq 24.85, p &lt; 0.05). In the seven studies which reported the mean number of visits, there was no significant effect and significant heterogeneity (Chi Sq 30.72, p &lt; 0.05) which is discussed below.</P>
<P>Six further studies reported this outcome either narratively or using data not suitable for meta-analysis. Five of these studies reported no significant effect of self-management education between groups (<LINK REF="STD-Hilton-1986" TYPE="STUDY">Hilton 1986</LINK>; <LINK REF="STD-Allen-1995" TYPE="STUDY">Allen 1995</LINK>; <LINK REF="STD-Cote-1997" TYPE="STUDY">Cote 1997</LINK>; <LINK REF="STD-Levy-2000" TYPE="STUDY">Levy 2000</LINK>; <LINK REF="STD-Blixen-2001" TYPE="STUDY">Blixen 2001</LINK>). One study reported a significant decrease in number of consults for both the self-management and control groups (<LINK REF="STD-Hayward-1996" TYPE="STUDY">Hayward 1996</LINK>). Another study did not report their results (<LINK REF="STD-Snyder-1987" TYPE="STUDY">Snyder 1987</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">DAYS OFF WORK</HEADING>
<P>Sixteen studies reported the effects of self-management education on days off work; seven as the number of participants who had one or more days off work or school, and thirteen as the mean number of days or absences, with five studies reporting both. Asthma self-management education led to a significant reduction in the rest of losing days off work or school due to asthma (RR 0.79; 95% CI 0.67 to 0.93, <LINK REF="CMP-001.07" TYPE="ANALYSIS">Analysis 1.7</LINK>). In the thirteen studies that reported the mean number of days off work or school or mean number of absences, there was a significant effect favouring self-management (SMD -0.18; 95% CI -0.28 to -0.09, <LINK REF="CMP-001.08" TYPE="ANALYSIS">Analysis 1.8</LINK>). Significant heterogeneity was present (Chi Sq 26.85, p &lt; 0.05).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">NOCTURNAL ASTHMA</HEADING>
<P>Nocturnal asthma was examined as an outcome in seven studies, with data from five studies contributing to a meta-analysis. Self-management education reduced the proportion of participants reporting nocturnal asthma (RR 0.67; 95% CI 0.56 to 0.79, <LINK REF="CMP-001.09" TYPE="ANALYSIS">Analysis 1.9</LINK>). However there was significant heterogeneity within this group (Chi Sq 107.02, p &lt; 0.05). In the four other studies which mentioned this outcome, but did not provide numerical data, an improvement was noted in three studies and no significant change in another.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">LUNG FUNCTION</HEADING>
<P>Airway function was assessed as either clinic forced expiratory volume in 1 second (FEV1) (10 studies) or peak expiratory flow (PEF) (16 studies). Of the seven studies that reported data on FEV1 and were used for meta-analysis, six were optimal self-management interventions. No significant effect of education on this variable was found. PEF was measured in 16 studies and data from 10 studies contributed to a meta-analysis. All of these data were available in absolute units (l/min), with one exception (<LINK REF="STD-Jones-1995" TYPE="STUDY">Jones 1995</LINK>), in which the results were presented as % predicted normal. The data tables include this trial, so the analyses used the SMD to permit aggregation. There was an overall positive effect of asthma self-management education which led to an improvement in PEF, that achieved statistical significance at p &lt; 0.05 (<LINK REF="CMP-001.11" TYPE="ANALYSIS">Analysis 1.11</LINK>). When this study was removed and the analysis repeated using the WMD (since all the outcomes were in the same units of measurement), the overall effect remained statistically significant. The absolute improvement in PEF was small (14.5 l/min). Significant heterogeneity was present for both the SMD analysis (Chi Sq 30.13, p &lt; 0.05) and the WMD analysis (Chi Sq 28.77, p &lt; 0.05).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">ORAL CORTICOSTEROIDS</HEADING>
<P>Four studies assessed the use of oral corticosteroids. <LINK REF="STD-Grampian-1994" TYPE="STUDY">Grampian 1994</LINK> measured the number of courses of oral corticosteroids, reporting no between group differences. <LINK REF="STD-Jones-1995" TYPE="STUDY">Jones 1995</LINK> reported that 47% in the treatment group and 38% in the control group used oral corticosteroids. <LINK REF="STD-Mayo-1990" TYPE="STUDY">Mayo 1990</LINK>, who measured the percentage of participants using chronic daily prednisone recorded a drop from 25% to 9% in the treatment group but did not record the results of the control group. <LINK REF="STD-de-Oliveira-1999" TYPE="STUDY">de Oliveira 1999</LINK> reported no significant difference in the percentage of participants who used oral corticosteroids continuously before and after the programme for both the self-management and control groups.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">QUALITY OF LIFE</HEADING>
<P>Quality of life was assessed in ten studies, six of which provided mean total scores. Overall there was a significant improvement in total quality of life score for those receiving the self-management intervention (SMD 0.29;95% CI 0.11 to 0.47). Significant heterogeneity was also present (Chi Sq 26.0; p &lt; 0.05). <LINK REF="STD-Cote-1997" TYPE="STUDY">Cote 1997</LINK> reported a significant improvement for all groups but only a clinically significant improvement (&gt; 0.5 change in score) for the intervention group that received an action plan based on symptoms. No significant inter-group difference was reported by <LINK REF="STD-Jones-1995" TYPE="STUDY">Jones 1995</LINK> but a significant within group improvement in all scores was reported for the self-management group. <LINK REF="STD-Knoell-1998" TYPE="STUDY">Knoell 1998</LINK> reported an improvement in both groups for most domains and no significant difference between the groups. <LINK REF="STD-Moudgil-2000" TYPE="STUDY">Moudgil 2000</LINK> reported an improvement in score for those who received self-management education and a decrease in score for those in the control group. These differences were significant between the two groups.</P>
<P>Self-management intervention improved the impact domain of quality of life as reported in two studies (SMD 0.23; 95% CI -0.02 to 0.47, <LINK REF="CMP-001.14" TYPE="ANALYSIS">Analysis 1.14</LINK>). However this was not statistically significant and heterogeneity was present (Chi Sq 12.54, p &lt; 0.05). Four studies reported mean activity score, three that could be included in a meta-analysis resulting in a non-significant improvement in activity score. Mean symptom score for quality of life favoured the usual care group in three studies but this was not significant. Heterogeneity was present (Chi Sq 10.25, p &lt; 0.05).</P>
<P>We conducted sensitivity analyses to explore reasons for heterogeneity in the quality of life total score meta-analysis.<BR/>
</P>
<UL>
<LI>Asthma Severity: two studies (<LINK REF="STD-Lahdensuo-1996" TYPE="STUDY">Lahdensuo 1996</LINK>; <LINK REF="STD-Gallefoss-1999" TYPE="STUDY">Gallefoss 1999</LINK>) included participants with mild to moderate asthma whereas four studies included moderate to severe asthma. Removal of the mild to moderate asthma severity studies from the meta-analysis did not eliminate heterogeneity (Chi Sq 14.8, p = 0.002).</LI>
<LI>Ethnic Minority: two studies (<LINK REF="STD-de-Oliveira-1999" TYPE="STUDY">de Oliveira 1999</LINK>; <LINK REF="STD-Blixen-2001" TYPE="STUDY">Blixen 2001</LINK>) studied ethnic minority groups. Removal of these studies from the meta-analysis did not eliminate heterogeneity (Chi-Sq 15.9, p = 0.001).</LI>
<LI>Questionnaire: two studies (<LINK REF="STD-Gallefoss-1999" TYPE="STUDY">Gallefoss 1999</LINK>; <LINK REF="STD-Levy-2000" TYPE="STUDY">Levy 2000</LINK>) used the St Georges Respiratory Questionnaire to measure quality of life. Removal of these studies from the meta-analysis reduced but did not eliminate heterogeneity (Ch Sq 10.8, p = 0.013).</LI>
<LI>Intervention Type: a written action plan was part of the intervention in three studies (<LINK REF="STD-Lahdensuo-1996" TYPE="STUDY">Lahdensuo 1996</LINK>; <LINK REF="STD-Gallefoss-1999" TYPE="STUDY">Gallefoss 1999</LINK>; <LINK REF="STD-Levy-2000" TYPE="STUDY">Levy 2000</LINK>). Heterogeneity remained in a meta-analysis that included these studies only (Ch Sq 14.91, p = 0.006)</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">COSTS</HEADING>
<P>Costs were assessed in four studies. <LINK REF="STD-Ghosh-1998" TYPE="STUDY">Ghosh 1998</LINK> recruited participants from a hospital asthma and allergy clinic who had a greater than 15% reversal of FEV1 post bronchodilator and at least one ER visit or hospitalisation in the past 12 months. Participants were randomised to an optimal self-management programme, including a written action plan, or to usual care. The intervention included four, two hour sessions, with a social scientist, commencing during the first month following the baseline interview. Economic outcomes were measured four, eight and twelve months after baseline. Direct costs were measured in Indian Rupees and included daily medication costs, hospitalisation and ER visit costs. The costs of physician visits were excluded as these were not reported consistently. Estimates of transportation, intervention and lost production costs were also provided (<LINK REF="STD-Ghosh-1998" TYPE="STUDY">Ghosh 1998</LINK>).</P>
<P>In a trial conducted by <LINK REF="STD-Lahdensuo-1996" TYPE="STUDY">Lahdensuo 1996</LINK>, mild to moderate asthmatics were recruited from outpatients and randomised to an optimal self-management training intervention that included a written action plan or to a usual care control group that included regular medical review. Both groups were followed up every four months for one year. Direct costs, measured in Finnish marks, included counselling (instruction in self-management for the intervention group and general information in the control group), peak flow meter, drugs, doctor visits that were not related to the study and hospital admissions. Indirect costs included absence from work (<LINK REF="STD-Lahdensuo-1996" TYPE="STUDY">Lahdensuo 1996</LINK>).</P>
<P>
<LINK REF="STD-Gallefoss-1999" TYPE="STUDY">Gallefoss 1999</LINK> recruited mild to moderate asthmatics from an outpatient chest clinic and randomised them to either a self-management intervention, which included self monitoring and a written action plan, or to a usual care control group. The intervention comprised two group sessions, each two hours long and one individual session, which was one to two hours with a physiotherapist and a nurse. All participants in the intervention group also received a booklet summarising the information received during the sessions. Participants were followed for 12 months. Costs were based on utilisation of care and unit costs (Norwegian Krone) and included patient co-payments and reimbursement costs from the National Health Insurance fee. Direct costs were defined as costs incurred by the healthcare system, community and family. Indirect costs included productivity loss, time costs for the individual, family, society and employer. Cost-effectiveness ratios were also estimated (<LINK REF="STD-Gallefoss-1999" TYPE="STUDY">Gallefoss 1999</LINK>).</P>
<P>In an economic analysis of asthma education programmes, <LINK REF="STD-Neri-1996" TYPE="STUDY">Neri 1996</LINK> randomised asthmatics to two different education programmes, a reduced education programme or a complete "asthma school" which involved more intense education. Both groups performed self-monitoring and were followed for one year. Direct costs included intervention costs (personnel related costs, videotape and cost of room), "per diem" costs for hospital admissions, drug costs and medical examination costs. Indirect costs were counted as the salary per day of work lost. Cost-effectiveness ratios were calculated by dividing the difference in the programme costs by the difference in reducing the outcome variables for the two programmes.</P>
<P>
<LINK REF="STD-Ghosh-1998" TYPE="STUDY">Ghosh 1998</LINK> reported a non-significant reduction in direct costs and a significant reduction in indirect costs for the self-management group when compared to the control group. <LINK REF="STD-Lahdensuo-1996" TYPE="STUDY">Lahdensuo 1996</LINK> observed that direct costs were significantly lower for the control group, and that indirect costs were significantly lower for the self-management group. Overall, there was a significant reduction in total costs for the self-management group. <LINK REF="STD-Gallefoss-1999" TYPE="STUDY">Gallefoss 1999</LINK> reported non-significant trends for lower direct costs and higher indirect costs for the control group. Total costs were lower for the intervention group but this was not significant when compared to the control group. <LINK REF="STD-Neri-1996" TYPE="STUDY">Neri 1996</LINK> reported a better outcome for the intensive education programme when calculating the cost-effectiveness ratio for asthma attacks, urgent doctor visits and days off work.</P>
<P>Three studies provided data on mean total, direct and indirect costs. These studies were critically appraised by a health economist (PH). The study by <LINK REF="STD-Ghosh-1998" TYPE="STUDY">Ghosh 1998</LINK> excluded the costs of physician visits and was therefore not included in a meta analysis. The remaining two studies contributed to a meta analysis. As these were reported in different currencies, a standardised mean difference was used for analysis. Self-management intervention led to a significant reduction in indirect costs (SMD -0.40; 95% CI -0.69 to -0.11) but increased direct costs (SMD 0.39; 95% CI 0.10 to 0.68). Overall there was a reduction in total costs (SMD -0.26; 95% CI -0.55 to 0.03) which did not quite reach significance.</P>
</SUBSECTION>
</INTERVENTION_EFFECTS>
</RESULTS>
<DISCUSSION>
<P>This review systematically evaluated 36 RCTs of self-management education for adults with asthma and found that this type of intervention leads to improved health outcomes. The studies showed that with self-management education, there was a reduction in the proportion of participants reporting hospitalisations and ER visits for asthma, unscheduled doctors visits for asthma, days lost from work due to asthma, episodes of nocturnal asthma, indirect costs and an improvement in total quality of life. The effects were large enough to be of both clinical and statistical significance. The review also identified a number of limitations to the current published literature which need to be considered. The interventions were described in varying detail, and included several differing factors. The system used to categorise the interventions in this review was based upon recommendations in current asthma management guidelines. Specifically, they were evaluated as to whether they included peak expiratory flow monitoring, regular medical review, and a written action plan. These are important aspects of asthma management which could be reliably evaluated from the papers. It could be useful in future work to extend this by looking in detail at the concordance of interventions with educational theory. This would require access to the precise details of interventions, which is generally not provided in publications because of space limitations.</P>
<P>There was variable contamination of the control groups with some aspects of self-management education. For example, peak expiratory flow monitoring was used as an outcome measure in some control groups. The effect of this would be to reduce the effect size of self-management education and hence bias against seeing an effect. Despite this, clinically meaningful effects were seen in most outcomes.</P>
<P>Not all papers reported outcomes in a way that could contribute to meta-analysis. We attempted to overcome this by contacting authors, but had variable success. This limits the generalisability of the results. </P>
<P>In some cases, outcomes were reported as continuous measures showing no treatment effect. This is probably due to the inappropriate use of continuous measures for outcomes which are not normally distributed such as hospitalisations, ER visits, doctor visits and days off work or school. Heterogeneity was found in the latter two variables. Possible explanations may be differing definitions of what constitutes an unscheduled doctor visit or a day off work or the combination of groups of differing asthma severity. It is noted that in one study (<LINK REF="STD-Ignacio_x002d_Garcia-1995" TYPE="STUDY">Ignacio-Garcia 1995</LINK>) the control group was instructed to visit the emergency or doctor as a part of their management. This may have also contributed to the heterogeneity.</P>
</DISCUSSION>
<CONCLUSIONS MODIFIED="2008-08-20 18:55:23 +0200" MODIFIED_BY="Toby J Lasserson">
<IMPLICATIONS_PRACTICE>
<P>Self-management education of adults with asthma results in clinically important improvements in asthma health outcomes. This is most apparent with interventions involving a written action plan, self-monitoring and regular medical review. These interventions result in a reduction in the proportions of participants who use health care services and who are bothered by nocturnal asthma and loss of work.</P>
<P>Self-management education that involves a written action plan, self-monitoring and regular medical review should be offered to adults with asthma.</P>
<P>Less intensive interventions, particularly those without a written action plan are less efficacious.</P>
</IMPLICATIONS_PRACTICE>
<IMPLICATIONS_RESEARCH MODIFIED="2008-08-20 18:55:23 +0200" MODIFIED_BY="Toby J Lasserson">
<P>Optimisation of management plan: what are the core 'actions'?</P>
<OL>
<LI>How much PEF/Symptom monitoring is optimal?</LI>
<LI>What is the duration of effect?</LI>
<LI>Is maintenance required?</LI>
<LI>What forms should it take?</LI>
<LI>How do the interventions conform to psycho-educational theory?</LI>
<LI>What is the best form for a written action plan?</LI>
</OL>
</IMPLICATIONS_RESEARCH>
</CONCLUSIONS>
</BODY>
<ACKNOWLEDGEMENTS>
<P>We would like to thank the Cochrane Airways Group who helped with database searches, obtaining studies and translations (Steve Milan, Toby Lasserson, Anna Bara, Karen Blackhall). Thanks also to Kirsty Olsen who copy edited this review.</P>
<P>We would like to thank the following authors for providing information about their trials:<BR/>Dr M Abramson re Abdulwadad<BR/>Dr R Allen,<BR/>Dr I Charlton,<BR/>Dr J Cote,<BR/>Dr JM Ignacio-Garcia<BR/>Dr D Knoell<BR/>Dr A Lahdensuo<BR/>Dr K Lutteral re Yoon, <BR/>Dr J Mercer re Garrett,<BR/>Mr M Mullee re Jones<BR/>Dr M. Neri,<BR/>Dr M Sommaruga,<BR/>Dr L Tougaard,<BR/>Dr RS Zeiger,</P>
<P>We would also like to acknowledge:<BR/>NSW Health Cooperative Research Centre for Asthma, Australia for financial and administrative support.</P>
</ACKNOWLEDGEMENTS>
<CONFLICT_OF_INTEREST>
<P>None<BR/>
</P>
</CONFLICT_OF_INTEREST>
<CONTRIBUTIONS MODIFIED="2008-08-20 18:36:53 +0200" MODIFIED_BY="Toby J Lasserson">
<P>Gibson PG - instigator of the review and conceptual direction - inclusion/exclusion, quality assessment, data extraction, analysis and interpretation, writing and editing.<BR/>Powell H - responsible for review update, inclusion/exclusion, quality assessment, data extraction, analysis, interpretation and writing.<BR/>Roberts JL - inclusion/exclusion, quality assessment, data extraction, analysis, interpretation and writing.<BR/>Wilson A - inclusion/exclusion, quality assessment, data extraction and writing.<BR/>Hensley MJ - text of review and intellectual direction and input.<BR/>Bauman A - input of some guiding concepts particularly in regards to educational principles.<BR/>Abramson MJ - inclusion/exclusion, review of text and concepts.<BR/>Walters EH - academic input.</P>
</CONTRIBUTIONS>
<PRO_REV_DIFF/>
<PUBLIC_NOTES/>
</MAIN_TEXT>
<STUDIES_AND_REFERENCES MODIFIED="2008-08-20 18:56:48 +0200" MODIFIED_BY="Toby J Lasserson">
<STUDIES MODIFIED="2008-08-20 18:56:31 +0200" MODIFIED_BY="Toby J Lasserson">
<INCLUDED_STUDIES MODIFIED="2008-08-20 18:55:40 +0200" MODIFIED_BY="Toby J Lasserson">
<STUDY DATA_SOURCE="PUB" ID="STD-Abdulwadud-1999" NAME="Abdulwadud 1999" YEAR="1999">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Abdulwadud O, Abramson M, Forbes A, James A, Walters EH</AU>
<TI>Evaluation of a randomised controlled trial of adult asthma education in a hospital setting</TI>
<SO>Thorax</SO>
<YR>1999</YR>
<VL>54</VL>
<PG>493-500</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Allen-1995" NAME="Allen 1995" YEAR="1995">
<REFERENCE NOTES="&lt;p&gt;Allen Rm, Jones MP, Oldenburg. Randomised trial of an asthma self-management programme for adults.  Thorax 1995;50:731-38.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Allen RM, Jones MP, Oldenburg</AU>
<TI>Randomised trial of an asthma self-management programme for adults</TI>
<SO>Thorax</SO>
<YR>1995</YR>
<VL>50</VL>
<PG>731-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bailey-1990" NAME="Bailey 1990" YEAR="1990">
<REFERENCE NOTES="&lt;p&gt;Bailey WC, Richards JM, Brooks CM, Soong S, Windsor RA et al.  A randomised trial to improve self-managment practice of adults with asthma. Arch Intern Med 1990;150:1664-68.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bailey WC, Richards JM, Brooks CM, Soong S, Windsor RA et al</AU>
<TI>A randomised trial to improve self-management practice of adults with asthma</TI>
<SO>Archives of Internal Medicine</SO>
<YR>1990</YR>
<VL>150</VL>
<PG>1664-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE NOTES="&lt;p&gt;Bailey WC, Richards JM, Manzella BA, Windsor RA, Brooks CM, Soong SJ. Promoting self management in adults with asthma: an overview of the UAB program. Health Educ Quarterly 1987;14:345-55.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bailey WC, Richards JM, Manzella BA, Windsor RA, Brooks CM, Soong SJ</AU>
<TI>Promoting self management in adults with asthma: an overview of the UAB program</TI>
<SO>Health Education Quarterly</SO>
<YR>1987</YR>
<VL>14</VL>
<PG>345-55</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE NOTES="&lt;p&gt;Windsor RA, Bailey WC, Richards JM et al.   Evaluation of the efficacy and cost effectiveness of health edcuation methods to increase medication adherence among adults with asthma.  AJPH 1990;80:1519-21.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Windsor RA, Bailey WC, Richards JM et al</AU>
<TI>Evaluation of the efficacy and cost effectiveness of health education methods to increase medication adherence among adults with asthma</TI>
<SO>American Journal of Public Health</SO>
<YR>1990</YR>
<VL>80</VL>
<PG>1519-21</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bailey-1999" NAME="Bailey 1999" YEAR="1999">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bailey WC, Kohler CL, Richards JM, Windsor RA, Brooks M, Gerald LB,</AU>
<TI>Asthma self-management: do patient education programs always have an impact?</TI>
<SO>Archives of Internal Medicine</SO>
<YR>1999</YR>
<VL>159</VL>
<PG>2422-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Berg-1997" NAME="Berg 1997" YEAR="1997">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Berg J, Dunbar-Jacob J, Sereika SM</AU>
<TI>An evaluation of a self-management program for adults with asthma</TI>
<SO>Clinical Nursing Research</SO>
<YR>1997</YR>
<VL>6</VL>
<NO>3</NO>
<PG>225-38</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Blixen-2001" NAME="Blixen 2001" YEAR="2001">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Blixen CE, Hammel JP, Murphy D, Ault V</AU>
<TI>Feasibility of a nurse-run asthma education program for urban African-Americans: a pilot study</TI>
<SO>Journal of Asthma</SO>
<YR>2001</YR>
<VL>38</VL>
<NO>1</NO>
<PG>23-32</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Brewin-1995" NAME="Brewin 1995" YEAR="1995">
<REFERENCE NOTES="&lt;p&gt;Brewin AM, Hughes JA.  Effect of patient education on asthma management.  Br J  of  Nursing 1995;4:81-101.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Brewin AM, Hughes JA</AU>
<TI>Effect of patient education on asthma management</TI>
<SO>British Journal of Nursing</SO>
<YR>1995</YR>
<VL>4</VL>
<PG>81-101</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Cote-1997" NAME="Cote 1997" YEAR="1997">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Cote J, Cartier A, Robichaud P, Boutin H, Malo JI</AU>
<TI>Influence of asthma education on asthma severity, quality of life and environmental control</TI>
<SO>Canadian Respiratory Journal</SO>
<YR>2000</YR>
<VL>7</VL>
<NO>5</NO>
<PG>395-400</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE NOTES="&lt;p&gt;Cote J, Cartier A, Robichaud P, Poutin H, Malo J, Rouleau M, Fillion A, Lavellee M, Krusky. Influence on Asthma Morbidity of asthma education programs based on self management plans following treatment optimization. Am J Respir Crit Care Med 1997; 155:1509-14.&lt;/p&gt;" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Cote J, Cartier A, Robichaud P, Poutin H, Malo J, Rouleau M et al</AU>
<TI>Influence on Asthma Morbidity of asthma education programs based on self management plans following treatment optimization</TI>
<SO>American Journal of Respiratory &amp; Critical Care Medicine</SO>
<YR>1997</YR>
<VL>155</VL>
<PG>1509-14</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Cowie-1997" NAME="Cowie 1997" YEAR="1997">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Cowie RL, Revitt SG, Underwood MF, Field SK</AU>
<TI>The effect of a peak flow-based action plan in the prevention of exacerbations of asthma</TI>
<SO>Chest</SO>
<YR>1997</YR>
<VL>112</VL>
<PG>1134-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-de-Oliveira-1999" NAME="de Oliveira 1999" YEAR="1999">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>de Oliveira MA, Faresin SM, Bruno VF, de Bittencourt AR, Fernandes ALG</AU>
<TI>Evaluation of an educational programme for socially deprived asthma patients</TI>
<SO>European Respiratory Journal</SO>
<YR>1999</YR>
<VL>14</VL>
<NO>4</NO>
<PG>908-14</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gallefoss-1999" MODIFIED="2008-08-20 18:44:38 +0200" MODIFIED_BY="Toby J Lasserson" NAME="Gallefoss 1999" YEAR="1999">
<REFERENCE MODIFIED="2008-08-20 18:44:38 +0200" MODIFIED_BY="Toby J Lasserson" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Gallefoss F, Bakke PS, Kjaersgaard P</AU>
<TI>Quality of life assessment after patient education in a randomized controlled study on asthma and chronic obstructive pulmonary disease</TI>
<SO>American Journal of Respiratory &amp; Critical Care Medicine</SO>
<YR>1999</YR>
<VL>159</VL>
<PG>812-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gallefoss F, Bakke PS</AU>
<TI>Cost-effectiveness of self-management in asthmatics: a 1yr follow-up randomized, controlled trial</TI>
<SO>European Respiratory Journal</SO>
<YR>2001</YR>
<VL>17</VL>
<PG>206-213</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gallefoss F, Bakke PS</AU>
<TI>How does patient education and self-management among asthmatics and patients with chronic obstructive pulmonary disease affect medication</TI>
<SO>American Journal of Respiratory &amp; Critical Care Medicine</SO>
<YR>1999</YR>
<VL>160</VL>
<PG>2000-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gallefoss F, Bakke PS</AU>
<TI>Impact of patient education and self-management on morbidity in asthmatics and patients with chronic obstructive pulmonary disease</TI>
<SO>Respiratory Medicine</SO>
<YR>2000</YR>
<VL>94</VL>
<PG>279-87</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gallefoss F, Bakke PS</AU>
<TI>Patient satisfaction with health care in asthmatics and patients with COPD before and after patient education</TI>
<SO>Respiratory Medicine</SO>
<YR>2000</YR>
<VL>94</VL>
<PG>1057-1064</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Garret-1994" NAME="Garret 1994" YEAR="1994">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Garrett J, Fenwick JM, Taylor G, Mitchell E, Stewart J, Rea H</AU>
<TI>Prospective controlled evaluation of the effect of a community based asthma education centre in a multiracial working class neighbourhood</TI>
<SO>Thorax</SO>
<YR>1994</YR>
<VL>49</VL>
<PG>976-83</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-George-1999" NAME="George 1999" YEAR="1999">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>George MR, O'Dowd LC, Martin I, Lindell KO, Whitney F, Jones M et al</AU>
<TI>A comprehensive educational progamme improves clinical outcome measures in inner-city patients with asthma</TI>
<SO>Archives of Internal Medicine</SO>
<YR>1999</YR>
<VL>159</VL>
<PG>1710-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ghosh-1998" NAME="Ghosh 1998" YEAR="1998">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ghosh CS, Ravindran P, Joshi M, Stearns SC</AU>
<TI>Reductions in hospital use from self management training for chronic asthmatics</TI>
<SO>Social Science &amp; Medicine</SO>
<YR>1998</YR>
<VL>46</VL>
<NO>8</NO>
<PG>1087-93</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Grampian-1994" NAME="Grampian 1994" YEAR="1994">
<REFERENCE NOTES="&lt;p&gt;Grampian Asthma Study of Integrated Care (GRASSIC)  Effectiveness of routine self monitoring of peak flow in patients with asthma.  BMJ  1994;308:564-7.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Grampian Asthma Study of Integrated Care (GRASSIC) Effectiveness of routine self monitoring of peak flow in patients with asthma</AU>
<SO>Britich Medical Journal</SO>
<YR>1994</YR>
<VL>308</VL>
<PG>564-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hayward-1996" NAME="Hayward 1996" YEAR="1996">
<REFERENCE NOTES="&lt;p&gt;awaiting assessment&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hayward SA, Jordan M, Golden G, Levy M</AU>
<TI>A randomised controlled evaluation of asthma self management in general practice</TI>
<SO>Asthma in General practice</SO>
<YR>1996</YR>
<VL>4</VL>
<PG>11-3</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Heard-1999" NAME="Heard 1999" YEAR="1999">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Heard AR, Richards IJ, Alpers JH, Pilotto LS, Smith BJ, Black JA</AU>
<TI>Randomised controlled trial of general practice based asthma clinics</TI>
<SO>Medical Journal of Australia</SO>
<YR>1999</YR>
<VL>171</VL>
<PG>68-71</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hilton-1986" NAME="Hilton 1986" YEAR="1986">
<REFERENCE NOTES="&lt;p&gt;Hilton S, Sibbald B, Anderson HR, Freeling P.  Controlled evaluation of the effects of patient education on asthma morbidity in genral practice.  The Lancet 1986;1:26-29.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hilton S, Sibbald B, Anderson HR, Freeling P</AU>
<TI>Controlled evaluation of the effects of patient education on asthma morbidity in general practice</TI>
<SO>The Lancet</SO>
<YR>1986</YR>
<VL>1</VL>
<PG>26-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ignacio_x002d_Garcia-1995" NAME="Ignacio-Garcia 1995" YEAR="1995">
<REFERENCE NOTES="&lt;p&gt;Ignacio-Garcia JM, Gonzalez-Santos P.  Asthma self-management education program by home monitoring of peak expiratory flow.  Am J Respir &amp;amp; Crit Care Med 1995;151:353-9.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ignacio-Garcia JM, Gonzalez-Santos P</AU>
<TI>Asthma self-management education program by home monitoring of peak expiratory flow</TI>
<SO>American Journal of Respiratory &amp; Critical Care Medicine</SO>
<YR>1995</YR>
<VL>151</VL>
<PG>353-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Jones-1995" NAME="Jones 1995" YEAR="1995">
<REFERENCE NOTES="&lt;p&gt;Jones KP, Mullee MA, Middleton M et al'  Peak flow based asthma self management: a randomised controlled study in general practice.  Thorax 1995;50:851-57.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Jones KP, Mullee MA, Middleton M, Chapman E, Holgate ST; British Society Research Committee</AU>
<TI>Peak flow based asthma self management: a randomised controlled study in general practice</TI>
<SO>Thorax</SO>
<YR>1995</YR>
<VL>50</VL>
<PG>851-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Knoell-1998" NAME="Knoell 1998" YEAR="1998">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Knoell DL, Pierson JF, Marsh CB, Allen JN, Pathak DS</AU>
<TI>Measurement of outcomes in adults receiving pharmaceutical care in a comprehensive asthma outpatient clinic</TI>
<SO>Pharmacotherapy</SO>
<YR>1998</YR>
<VL>18</VL>
<NO>6</NO>
<PG>1365-74</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kotses-1995" NAME="Kotses 1995" YEAR="1995">
<REFERENCE NOTES="&lt;p&gt;Kotses H, Bernstein IL, Bernstien DI et al.  A self-management program for adult asthma.  Part 1: development and evaluation. J Allergy Clin Immunol 1995;95:529-40.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kotses H, Bernstein IL, Bernstien DI et al</AU>
<TI>A self-management program for adult asthma. Part 1: development and evaluation</TI>
<SO>Journal of Allergy &amp; Clinical Immunology</SO>
<YR>1995</YR>
<VL>95</VL>
<PG>529-40</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kotses-1996" MODIFIED="2008-08-20 18:55:40 +0200" MODIFIED_BY="Toby J Lasserson" NAME="Kotses 1996" YEAR="1996">
<REFERENCE MODIFIED="2008-08-20 18:55:40 +0200" MODIFIED_BY="Toby J Lasserson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kotses H, Stout C, Mcconnaughty K, Winder JA, Creer TL</AU>
<TI>Evaluation of individualized asthma self-management programmes</TI>
<SO>Journal of Asthma</SO>
<YR>1996</YR>
<VL>33</VL>
<PG>113-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lahdensuo-1996" NAME="Lahdensuo 1996" YEAR="1996">
<REFERENCE NOTES="&lt;p&gt;Lahdensuo A, Haahtela T, Herrala J, et al . Randomised  comparison of guided self-management. Br Med J 1996;312:748-52&lt;/p&gt;" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Lahdensuo A, Haahtela T, Herrala J et al</AU>
<TI>Randomised comparison of guided self-management</TI>
<SO>British Medical Journal</SO>
<YR>1996</YR>
<VL>312</VL>
<PG>748-52</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lahdensuo A, Haahtela T, Herrala J, Kava T, Kiviranta K, Kuusisto P, et al</AU>
<TI>Randomised comparison of cost effectiveness of guided self management and traditional treatment of asthma in Finland</TI>
<SO>British Medical Journal</SO>
<YR>1998</YR>
<VL>316</VL>
<PG>1138-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Levy-2000" NAME="Levy 2000" YEAR="2000">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Levy ML, Robb M, Allen J, Doherty C, Bland JM, Winter RJD</AU>
<TI>A randomized controlled evaluation of specialist nurse education following accident and emergency attendance for acute asthma</TI>
<SO>Respiratory Medicine</SO>
<YR>2000</YR>
<VL>94</VL>
<PG>900-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mayo-1990" NAME="Mayo 1990" YEAR="1990">
<REFERENCE NOTES="&lt;p&gt;Mayo PH, Richman J, Harris  HW. Results of a program to reduce admissions for adult asthma. Ann Int Med 1990;112:864-71.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mayo PH, Richman J, Harris HW</AU>
<TI>Results of a program to reduce admissions for adult asthma</TI>
<SO>Annals of Internal Medicine</SO>
<YR>1990</YR>
<VL>112</VL>
<PG>864-71</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Moudgil-2000" MODIFIED="2008-08-20 18:55:34 +0200" MODIFIED_BY="Toby J Lasserson" NAME="Moudgil 2000" YEAR="2000">
<REFERENCE MODIFIED="2008-08-20 18:55:34 +0200" MODIFIED_BY="Toby J Lasserson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Moudgil H, Marshall T, Honeybourne D</AU>
<TI>Asthma education and quality of life in the community: a randomised controlled study to evaluate the impact on white European and Indian subcontinent ethnic groups from socio-economically deprived areas in Birmingham, UK</TI>
<SO>Thorax</SO>
<YR>2000</YR>
<VL>55</VL>
<PG>177-83</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mulloy-1996" NAME="Mulloy 1996" YEAR="1996">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mulloy E, Donaghy D, Quigley C, McNicholas WT</AU>
<TI>A one-year prospective audit of an asthma education programme in an out-patient setting</TI>
<SO>Irish Medical Journal</SO>
<YR>1996</YR>
<VL>89</VL>
<PG>226-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Neri-1996" NAME="Neri 1996" YEAR="1996">
<REFERENCE NOTES="&lt;p&gt;Neri M, Migliori GB, Spanevello A, Berra D, Nicolin E, Landoni CV, Ballardini L, Sommaruga M, Zanon P.  Economic analysis of two structured treatment and teaching programs on asthma. Allergy 1996;51:313-9.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Neri M, Migliori GB, Spanevello A, Berra D, Nicolin E, Landoni CV, et al</AU>
<TI>Economic analysis of two structured treatment and teaching programs on asthma</TI>
<SO>Allergy</SO>
<YR>1996</YR>
<VL>51</VL>
<PG>313-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Schott_x002d_Baer-1999" NAME="Schott-Baer 1999" YEAR="1999">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Schott-Baer D, Christensen M</AU>
<TI>Research for practice. A pilot programme to increase self-care of adult asthma patients</TI>
<SO>Medsurg Nursing</SO>
<YR>1999</YR>
<VL>8</VL>
<PG>178-83</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Shields-1986" NAME="Shields 1986" YEAR="1986">
<REFERENCE NOTES="&lt;p&gt;Shields MC, Reinhard JD, Szidon JP, White PB. Effectiveness of a patient eduction program for adult asthmatics in reducing emergency room use. Clinical Research 1986;34 (2):[abstract].&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Shields MC, Reinhard JD, Szidon JP, White PB</AU>
<TI>Effectiveness of a patient eduction program for adult asthmatics in reducing emergency room use</TI>
<SO>Clinical Research</SO>
<YR>1986</YR>
<VL>34</VL>
<NO>2</NO>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Shields MC, Vail MJ, Reinhard JD, Szidon JP, White PB</AU>
<TI>Counseling is better accepted than classes in patient education of adult inner city asthmatics. New Health Care Systems: HMOs &amp; Beyond</TI>
<YR>1986</YR>
<VL>June</VL>
<PG>289-98</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Snyder-1987" NAME="Snyder 1987" YEAR="1987">
<REFERENCE NOTES="&lt;p&gt;Snyder Se, Winder JA, Creer TL.  Development and evaluation of an adult asthma self-managment program: Wheezers Anonymous. J Asthma 1987;11:39-43.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Snyder Se, Winder JA, Creer TL</AU>
<TI>Development and evaluation of an adult asthma self-managment program: Wheezers Anonymous</TI>
<SO>Journal of Asthma</SO>
<YR>1987</YR>
<VL>11</VL>
<PG>39-43</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sommaruga-1995" NAME="Sommaruga 1995" YEAR="1995">
<REFERENCE NOTES="&lt;p&gt;Sommaruga M, Spanevello A, Migliori GB, Neri M, Callegari S, Manjani G.  The effects of a cognitive behavioural intervention in asthmatic patients.  Monaldi Arch Chest Disease 1995;50:398-402.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sommaruga M, Spanevello A, Migliori GB, Neri M, Callegari S, Manjani G</AU>
<TI>The effects of a cognitive behavioural intervention in asthmatic patients</TI>
<SO>Monaldi Archives for Chest Disease</SO>
<YR>1995</YR>
<VL>50</VL>
<PG>398-402</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wilson-1993" NAME="Wilson 1993" YEAR="1993">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Nguyen BP, Wilson SR, German DF</AU>
<TI>Patients' perceptions compared with objective ratings of asthma severity</TI>
<SO>Annals of Allergy Asthma &amp; Immunology</SO>
<YR>1996</YR>
<VL>77</VL>
<PG>209-15</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE NOTES="&lt;p&gt;Wilson SR, Scamagas P, German DF, Hughes GW, Lulla S et al.  A controlled trial of two forms of self-managment education for adults with asthma.  Am J Med 1993;94:564-76.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wilson SR, Scamagas P, German DF, Hughes GW, Lulla S et al</AU>
<TI>A controlled trial of two forms of self-managment education for adults with asthma</TI>
<SO>American Journal of Medicine</SO>
<YR>1993</YR>
<VL>94</VL>
<PG>564-76</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE NOTES="&lt;p&gt;Wilson-Pessano ST, et al.  An evaluation of approaches to asthma self management education for adults.  The  AIR/Kaiser Permanente study.  Health Educ Quar 1987;14:333-43.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wilson-Pessano ST et al</AU>
<TI>An evaluation of approaches to asthma self management education for adults. The AIR/Kaiser Permanente study</TI>
<SO>Health Education Quarterly</SO>
<YR>1987</YR>
<VL>14</VL>
<PG>333-43</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Yoon-1993" NAME="Yoon 1993" YEAR="1993">
<REFERENCE NOTES="&lt;p&gt;Yoon R, McKenzie DK, Bauman A, Miles DA.  Controlled trial evaluation of an asthma education program for adults.  Thorax 1993;48:1110-1116.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Yoon R, McKenzie DK, Bauman A, Miles DA</AU>
<TI>Controlled trial evaluation of an asthma education program for adults</TI>
<SO>Thorax</SO>
<YR>1993</YR>
<VL>48</VL>
<PG>1110-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Zeiger-1991" NAME="Zeiger 1991" YEAR="1991">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Zeiger RS, Heller S, Mellon MH, Wald J</AU>
<TI>Falkoff R, Schatz M. Facilitated referral to asthma specialist reduces relapses in asthma emergency room visits</TI>
<SO>Journal of Allergy and Clinical Immunology</SO>
<YR>1991</YR>
<VL>87</VL>
<PG>1160-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</INCLUDED_STUDIES>
<EXCLUDED_STUDIES MODIFIED="2008-08-20 18:56:31 +0200" MODIFIED_BY="Toby J Lasserson">
<STUDY DATA_SOURCE="PUB" ID="STD-Abdulwadud-1997" MODIFIED="2008-08-20 18:55:49 +0200" MODIFIED_BY="Toby J Lasserson" NAME="Abdulwadud 1997" YEAR="1997">
<REFERENCE MODIFIED="2008-08-20 18:55:49 +0200" MODIFIED_BY="Toby J Lasserson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Abdulwadud O, Abramson M, Forbes A, James A, Light L, Thien F, Walters EH</AU>
<TI>Attendance at an asthma educational intervention: characteristics of participants and non-participants</TI>
<SO>Respiratory Medicine</SO>
<YR>1997</YR>
<VL>91</VL>
<PG>524-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Adams-2001" NAME="Adams 2001" YEAR="2001">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Adams RJ, Boath K, Homan S, Campbell DA, Ruffin RE</AU>
<TI>A randomised trial of peak-flow and symptom-based action plans in adults with moderate-to-severe asthma</TI>
<SO>Respirology</SO>
<YR>2001</YR>
<VL>6</VL>
<PG>297-304</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Aiolfi-1995" NAME="Aiolfi 1995" YEAR="1995">
<REFERENCE NOTES="&lt;p&gt;Aiolfi S, Confalonieri M, Scartabellati A, Patrini G, Ghio L, Mauri F, Parigi P, Trogu M, Gandola L. International guidelines and educational experiences in an out-patient clinic for asthma. Monaldi Arch Chest Dis 1995;50:477-481.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Aiolfi S, Confalonieri M, Scartabellati A, Patrini G, Ghio L, Mauri F et al</AU>
<TI>International guidelines and educational experiences in an out-patient clinic for asthma</TI>
<SO>Monaldi Archives for Chest Disease</SO>
<YR>1995</YR>
<VL>50</VL>
<PG>477-81</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Amirav-1995" NAME="Amirav 1995" YEAR="1995">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Amirav I, Goren A, Kravitz RM, Pawlowski N</AU>
<TI>Physician-tarteted program on inhaled therapy for childhood asthma</TI>
<SO>Journal of Allergy and Clinical Immunology</SO>
<YR>1995</YR>
<VL>95</VL>
<PG>818-23</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ayres-1996" NAME="Ayres 1996" YEAR="1996">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ayres JG, Campbell LM</AU>
<TI>A controlled assessment of an asthma self-management plan involving a budesonide dose regimen</TI>
<SO>European Respiratory Journal</SO>
<YR>1996</YR>
<VL>9</VL>
<PG>886-92</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Baldwin-1997" NAME="Baldwin 1997" YEAR="1997">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Baldwin DR, Pathak UA, King R, Vase BC, Pantin CFA</AU>
<TI>Outcome of asthmatics attending asthma clinics utilising self-management plans in general practice</TI>
<SO>Asthma in General Practice</SO>
<YR>1997</YR>
<VL>5</VL>
<PG>31-2</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bolton-1991" MODIFIED="2008-08-20 18:55:55 +0200" MODIFIED_BY="Toby J Lasserson" NAME="Bolton 1991" YEAR="1991">
<REFERENCE NOTES="&lt;p&gt;Bolton MB, Tilley BC, Kuder J, Reeeves T, Schultz LR.  The cost and effectiveness of an education program for adults who have asthma.  J Gen Intern Med 1991;6:401-407.&lt;/p&gt;" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Bolton MB, Tilley BC, Kuder J, Reeeves T, Schultz LR</AU>
<TI>The cost and effectiveness of an education program for adults who have asthma</TI>
<SO>Journal of General Internal Medicine</SO>
<YR>1991</YR>
<VL>6</VL>
<PG>401-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2008-08-20 18:55:55 +0200" MODIFIED_BY="Toby J Lasserson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ford ME, Havstad SL, Tilley BC, Bolton MB</AU>
<TI>Health outcomes among African and American Caucasian adults following a randomized trial of an asthma education program</TI>
<SO>Ethnicity &amp; Health</SO>
<YR>1997</YR>
<VL>2</VL>
<NO>329-39</NO>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Boulet-1995" NAME="Boulet 1995" YEAR="1995">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Boulet LP, Boutin H, Cote J, Leblanc P, Laviolettte M</AU>
<TI>Evaluation of an asthma self-management program</TI>
<SO>Journal of Asthma</SO>
<YR>1995</YR>
<VL>32</VL>
<PG>199-206</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Charlton-1990" NAME="Charlton 1990" YEAR="1990">
<REFERENCE NOTES="&lt;p&gt;Charlton I, Charlton G, Broomfield J, Mullee Ma.  Evaluation of peak flow and symptoms only self management plans for control of asthma in general practice.  BMJ 1990;301:1355-9&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Charlton I, Charlton G, Broomfield J, Mullee M</AU>
<TI>Evaluation of peak flow and symptoms only self management plans for control of asthma in general practice</TI>
<SO>British Medical Journal</SO>
<YR>1990</YR>
<VL>301</VL>
<PG>1355-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Cote-2001" NAME="Cote 2001" YEAR="2001">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Cote J, Bowie DM, Robichaud P, Parent J-G, Battiti L, Boulet L-P</AU>
<TI>Evaluation of two different educational interventions for adult patients consulting with an acute asthma exacerbation</TI>
<SO>American Journal of Respiratory and Critical Care Medicine</SO>
<YR>2001</YR>
<VL>163</VL>
<PG>1415-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Cox-1993" NAME="Cox 1993" YEAR="1993">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Cox NJM, Hendricks JC, Binkhorst Ra, Van Herwaarden CLA</AU>
<TI>A pulmonary rehabilitation program for patients with asthma and mild chronic obstructive pulmonary diseases (COPD)</TI>
<SO>Lung</SO>
<YR>1993</YR>
<VL>171</VL>
<PG>235-44</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Erickson-1998" NAME="Erickson 1998" YEAR="1998">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Erickson SR, Ascione FJ, Kirking DM, Johnson CE</AU>
<TI>Use of a paging system to improve medication self-management in patients with asthma</TI>
<SO>Journal of the American Pharmaceutical Association</SO>
<YR>1998</YR>
<VL>38</VL>
<PG>767-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gergen-1995" NAME="Gergen 1995" YEAR="1995">
<REFERENCE NOTES="&lt;p&gt;Gergen PJ, Goldstein RA. Does asthma education equal asthma intervention? International Archives of Allergy and Immunology 1995;107:166-8.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gergen PJ, Goldstein RA</AU>
<TI>Does asthma education equal asthma intervention?</TI>
<SO>International Archives of Allergy &amp; Immunology</SO>
<YR>1995</YR>
<VL>107</VL>
<PG>166-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Graft-1991" NAME="Graft 1991" YEAR="1991">
<REFERENCE NOTES="&lt;p&gt;Graft DF. A randomised trial to improve self-management  practices of adults with asthma: reviewers comments J Asthma 1991;28:228-9.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Graft DF</AU>
<TI>A randomised trial to improve self-management practices of adults with asthma: reviewers comments</TI>
<SO>Journal of Asthma</SO>
<YR>1991</YR>
<VL>28</VL>
<PG>228-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Grainger_x002d_Rousseau" NAME="Grainger-Rousseau" YEAR="1996">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Grainger-Rousseau T-J, McElnay JC</AU>
<TI>A model for community pharmacist involvement with general practitioners in the management of asthma patients</TI>
<SO>Journal of Applied Therapeutics</SO>
<YR>1996</YR>
<VL>1</VL>
<PG>145-61</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Grampian-1994b" NAME="Grampian 1994b" YEAR="1994">
<REFERENCE NOTES="&lt;p&gt;Grampian Asthma Study of Integrated Care (GRASSIC) Integrated care for asthma: a clinical, social, and economic evaluation. BMJ 1994; 308:559-64.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Grampian Asthma Study of Integrated Care (GRASSIC) Integrated care for asthma: a clinical, social, and economic evaluation</AU>
<SO>British Medical Journal</SO>
<YR>1994</YR>
<VL>308</VL>
<PG>559-64</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hausen-1999" NAME="Hausen 1999" YEAR="1999">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hausen T</AU>
<TI>Patient education-how can the long-term effect be analyzed and how long does it last? (German)</TI>
<SO>Pneumologie</SO>
<YR>1999</YR>
<VL>53</VL>
<PG>289-95</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Heringa-1987" NAME="Heringa 1987" YEAR="1987">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Heringa P, Lawson L, Reda D</AU>
<TI>The effects of a structured education program on knowledge and psychomotor skills of patients using Beclomethasone Dipropionate Aerosol for Steroid Dependent Asthma</TI>
<SO>Health Education Quarterly</SO>
<YR>1987</YR>
<VL>14</VL>
<PG>309-17</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hindi_x002d_Alexander-1987" NAME="Hindi-Alexander 1987" YEAR="1987">
<REFERENCE NOTES="&lt;p&gt;Hindi-Alexander MC. Asthma education programs: their role in asthma morbidity and mortality. J Allergy Clin Immunol 1986;80:492-4.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hindi-Alexander MC</AU>
<TI>Asthma education programs: their role in asthma morbidity and mortality</TI>
<SO>Journal of Allergy and Clinical Immunology</SO>
<YR>1986</YR>
<VL>80</VL>
<PG>492-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hoskins-1996" NAME="Hoskins 1996" YEAR="1996">
<REFERENCE NOTES="&lt;p&gt;Hoskins G, Neville RG, Smith B, Clark RA. Do self-managmeent plans reduce morbidity in patients with asthma? British Journal of General Practice 1996;46:169-71.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hoskins G, Neville RG, Smith B, Clark RA</AU>
<TI>Do self-management plans reduce morbidity in patients with asthma?</TI>
<SO>British Journal of General Practice</SO>
<YR>1996</YR>
<VL>46</VL>
<PG>169-71</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Huss-1992" MODIFIED="2008-08-20 18:56:00 +0200" MODIFIED_BY="Toby J Lasserson" NAME="Huss 1992" YEAR="1992">
<REFERENCE MODIFIED="2008-08-20 18:56:00 +0200" MODIFIED_BY="Toby J Lasserson" NOTES="&lt;p&gt;Huss K, Huss RW, Squire EN, et al.  Computer education for asthmatics: What efffects? J Nurs Care Qual 1992;6:57-66.&lt;/p&gt;" NOTES_MODIFIED="2008-08-20 18:56:00 +0200" NOTES_MODIFIED_BY="Toby J Lasserson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Huss K, Huss RW, Squire EN, et al</AU>
<TI>Computer education for asthmatics: What effects?</TI>
<SO>Journal of Nursing Care Quality</SO>
<YR>1992</YR>
<VL>6</VL>
<PG>57-66</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Jackevicius-1999" NAME="Jackevicius 1999" YEAR="1999">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Jackevicius CA, Chapman KR</AU>
<TI>Inhaler education do hospital based pharmacists: How much is required?</TI>
<SO>Canadian Respiratory Journal</SO>
<YR>1999</YR>
<VL>6</VL>
<PG>237-44</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Janson_x002d_Bjerklie-1988" NAME="Janson-Bjerklie 1988" YEAR="1988">
<REFERENCE NOTES="&lt;p&gt;Jnason-Bjerklie S, Shnell S.  Effect of peak flow information on patterns of self-care in adult asthma.   Heart &amp;amp; Lung 1988;17:543-9.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Janson-Bjerklie S, Shnell S</AU>
<TI>Effect of peak flow information on patterns of self-care in adult asthma</TI>
<SO>Heart &amp; Lung</SO>
<YR>1988</YR>
<VL>17</VL>
<PG>543-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Jenkinson-1988" NAME="Jenkinson 1988" YEAR="1988">
<REFERENCE NOTES="&lt;p&gt;Jenkinson D, Daviison J, Jones S, Hawtin P.  Comaparison of effects of a self management booklet and audio cassette for patients with asthma.  BMJ  1988;297:267-270.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Jenkinson D, Davison J, Jones S, Hawtin P</AU>
<TI>Comaparison of effects of a self management booklet and audio cassette for patients with asthma</TI>
<SO>British Medical Journal</SO>
<YR>1988</YR>
<VL>297</VL>
<PG>267-70</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Jones-1987" NAME="Jones 1987" YEAR="1987">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Jones PK, Jones SL, Katz J</AU>
<TI>Improving compliance for asthmatic patients visiting the emergency department using a health belief model</TI>
<SO>Journal of Asthma</SO>
<YR>1987</YR>
<VL>24</VL>
<PG>199-206</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kauppinen-1998" NAME="Kauppinen 1998" YEAR="1998">
<REFERENCE NOTES="&lt;p&gt;&lt;br&gt;&lt;/p&gt;" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Kauppinen R, Sintonen H, Tukiainen H</AU>
<TI>One-year economic evaluation of intensive versus conventional patient education and supervision for self-management of new asthmatic patients</TI>
<SO>Respiratory Medicine</SO>
<YR>1998</YR>
<VL>92</VL>
<PG>300-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kauppinen R, Sintonen H, Vilkka V, Tukianen H</AU>
<TI>Long-term (3-year) economic evaluation of intensive patient education for self-management during the first year in new asthmatics</TI>
<SO>Respiratory Medicine</SO>
<YR>1999</YR>
<VL>93</VL>
<PG>283-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kauppinen R, Vilkka V, Sintonen H, Klaukka T, Tukianen H</AU>
<TI>Long term economic evaluation of intensive patient education during the first treatment year in newly diagnosed asthma</TI>
<SO>Respiratory Medicine</SO>
<YR>2001</YR>
<VL>95</VL>
<PG>56-63</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kelso-1995" NAME="Kelso 1995" YEAR="1995">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kelso TM, Abou-Shala N, Neilker GM, Arheart KL, Portner TS, Self TH</AU>
<TI>Comprehensive long-term management program for asthma: effect on outcomes in adult African-Americans</TI>
<SO>American Journal of the Medical Sciences</SO>
<YR>1996</YR>
<VL>311</VL>
<PG>272-80</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE NOTES="&lt;p&gt;Kelso TM, Self TH, Rumbak MJ, Stephens MA, Garrett W, Arheart KL.  Educational and Long-Term Therapeutic Intervention in the ED: Effect on Outcomes in Adult Indigent Minority Asthmatics.  American Journal of Emergency Medicine 1995; 13:632-8.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kelso TM, Self TH, Rumbak MJ, Stephens MA, Garrett W, Arheart KL</AU>
<TI>Educational and Long-Term Therapeutic Intervention in the ED: Effect on Outcomes in Adult Indigent Minority Asthmatics</TI>
<SO>American Journal of Emergency Medicine</SO>
<YR>1995</YR>
<VL>13</VL>
<PG>632-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Klein-2001" NAME="Klein 2001" YEAR="2001">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Klein JJ, van der Palen J, Uil SM, Zielhaus GA, Seydel ER, van Herwaarden CLA</AU>
<TI>Benefit from the inclusion of self-treatment guidelines to a self-management programme for adults with asthma</TI>
<SO>European Respiratory Journal</SO>
<YR>2001</YR>
<VL>17</VL>
<PG>386-394</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-LeBaron-1985" NAME="LeBaron 1985" YEAR="1985">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>LeBaron S, Zeltzer LK, Patner P, Kniker WT</AU>
<TI>A controlled study of education for improving compliance with Cromolyn Sodium (Intal): the importance of Physician-patient communication</TI>
<SO>Annals of Allergy</SO>
<YR>1985</YR>
<VL>55</VL>
<PG>811-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Legorreta--2000" MODIFIED="2008-08-20 18:56:09 +0200" MODIFIED_BY="Toby J Lasserson" NAME="Legorreta  2000" YEAR="2000">
<REFERENCE MODIFIED="2008-08-20 18:56:09 +0200" MODIFIED_BY="Toby J Lasserson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Legorreta AP, Leung K-M, Berkbigler D, Evans R, Liu X</AU>
<TI>Outcomes of a population-based asthma management program: quality of life, absenteeism, and utilization</TI>
<SO>Annals of Allergy Asthma &amp; Immunology</SO>
<YR>2000</YR>
<VL>85</VL>
<PG>28-34</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lirsac-1991" MODIFIED="2008-08-20 18:56:25 +0200" MODIFIED_BY="Toby J Lasserson" NAME="Lirsac 1991" YEAR="1991">
<REFERENCE MODIFIED="2008-08-20 18:56:25 +0200" MODIFIED_BY="Toby J Lasserson" NOTES="&lt;p&gt;Lirsac B, Braunstein G. Randimsed evaluation of two teaching methods using aerosol dosers (French). Revue des Maladies respiratories 1991;8:559-65.&lt;/p&gt;" NOTES_MODIFIED="2008-08-20 18:56:25 +0200" NOTES_MODIFIED_BY="Toby J Lasserson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lirsac B, Braunstein G</AU>
<TI>Randomised evaluation of two teaching methods using aerosol inhalers</TI>
<SO>Revue des Maladies Respiratories</SO>
<YR>1991</YR>
<VL>8</VL>
<PG>559-65</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lopez_x002d_Vina-2000" NAME="Lopez-Vina 2000" YEAR="2000">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lopez-Vina A, del Castillo-Arevalo F</AU>
<TI>Influence of peak expiratory flow monitoring on an asthma self-management education programme</TI>
<SO>Respiratory Medicine</SO>
<YR>2000</YR>
<VL>94</VL>
<PG>760-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Maes-1988" NAME="Maes 1988" YEAR="1988">
<REFERENCE NOTES="&lt;p&gt;Maes S, Schlosser M.  Changing health behaviour outcomes in asthmatic patients: A pilot intervention study.  Soc Sci Med 1988;26:359-64.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Maes S, Schlosser M</AU>
<TI>Changing health behaviour outcomes in asthmatic patients: A pilot intervention study</TI>
<SO>Social Science &amp; Medicine</SO>
<YR>1988</YR>
<VL>26</VL>
<PG>359-64</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Maiman-1979" NAME="Maiman 1979" YEAR="1979">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Maiman LA, Green LW, Gibson G, MacKenzie EJ</AU>
<TI>Education for self-treatment by adult asthmatics</TI>
<SO>The Journal of the American Medical Association</SO>
<YR>1979</YR>
<VL>241</VL>
<PG>1919-22</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Moldofsky-1979" NAME="Moldofsky 1979" YEAR="1979">
<REFERENCE NOTES="&lt;p&gt;Moldofsky H, Broder I, Davies G, Leznoff A.  Videotape educational program for people with asthma.  Canadian Med Assoc Journal 1979;120:669-72.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Moldofsky H, Broder I, Davies G, Leznoff A</AU>
<TI>Videotape educational program for people with asthma</TI>
<SO>Canadian Medical Association Journal</SO>
<YR>1979</YR>
<VL>120</VL>
<PG>669-72</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Muhlhauser-1991" NAME="Muhlhauser 1991" YEAR="1991">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Muhlhauser I, Richter B, Kraut D, Weske G, Worth H, Berger M</AU>
<TI>Evaluation of a structured treatment and teaching programme of asthma</TI>
<SO>Journal of Internal Medicine</SO>
<YR>1991</YR>
<VL>230</VL>
<PG>157-64</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Osman-1994" NAME="Osman 1994" YEAR="1994">
<REFERENCE NOTES="&lt;p&gt;Osman LM, Abdalla MI, Beattie JAG, Ross SJ, Russell IT, Friend JA, Legge JS, Douglas JG. Reducing hospital admission through computer supported education for asthma patients. BMJ 1994; 308:568-71.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Osman LM, Abdalla MI, Beattie JAG, Ross SJ, Russell IT, Friend JA et al</AU>
<TI>Reducing hospital admission through computer supported education for asthma patients</TI>
<SO>British Medical Journal</SO>
<YR>1994</YR>
<VL>308</VL>
<PG>568-71</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Perdomo_x002d_Ponce-1996" NAME="Perdomo-Ponce 1996" YEAR="1996">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Perdomo-Ponce D, Benarroch L, Gonzalez-Cerrutti R, Barroso R, Carneiro F, Meijomil P</AU>
<TI>Family education, a model for allergy prevention [Spanish]</TI>
<SO>Investigacion Clinica</SO>
<YR>1996</YR>
<VL>37</VL>
<PG>221-45</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Petro-1995" MODIFIED="2008-08-20 18:56:31 +0200" MODIFIED_BY="Toby J Lasserson" NAME="Petro 1995" YEAR="1995">
<REFERENCE MODIFIED="2008-08-20 18:56:31 +0200" MODIFIED_BY="Toby J Lasserson" NOTES="&lt;p&gt;Petro W, Hollander P, Hamann B, Lauber B, Mzyk C, Prittwitz M.  Patientenschulung in der pneumologischen rehabilitation steigert den terapeutischen Erfolg. Atemwegs und Lungerkrankheiten 1995;S49-58.&lt;/p&gt;" NOTES_MODIFIED="2008-08-20 18:56:31 +0200" NOTES_MODIFIED_BY="Toby J Lasserson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Petro W, Hollander P, Hamann B, Lauber B, Mzyk C, Prittwitz M</AU>
<TI>Patientenschulung in der pneumologischen Rehabilitation steigert den terapeutischen Erfolg</TI>
<SO>Atemwegs und Lungerkrankheiten</SO>
<YR>1995 Suppl</YR>
<VL>49-58</VL>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Premaratne-1999" NAME="Premaratne 1999" YEAR="1999">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Premaratne UN, Sterne JAC, Marks GB, Webb R, Azima H, Burney PGJ</AU>
<TI>Clustered randomised trial of an intervention to improve the management of asthma: Greenwich asthma study</TI>
<SO>British Medical Journal</SO>
<YR>1999</YR>
<VL>318</VL>
<PG>1251-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ringsberg-1990" NAME="Ringsberg 1990" YEAR="1990">
<REFERENCE NOTES="&lt;p&gt;Ringsberg KC, Wiklund I, Wilhelmsen L.  Education of adult patients at an &amp;quot;asthma school&amp;quot;: effects on quality of life, knowledge and need for nursing.  Eur Respir J 1990;3:33-37.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ringsberg KC, Wiklund I, Wilhelmsen L</AU>
<TI>Education of adult patients at an "asthma school": effects on quality of life, knowledge and need for nursing</TI>
<SO>European Respiratory Journal</SO>
<YR>1990</YR>
<VL>3</VL>
<PG>33-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Rydman-1999" NAME="Rydman 1999" YEAR="1999">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Rydman RJ, Sonenthal K, Laksminarayana T, Butki N, McDermott, MF</AU>
<TI>Evaluating the outcome of two teaching methods of breath actuated inhaler in an inner city asthma clinic</TI>
<SO>Journal of Medical Systems</SO>
<YR>1999</YR>
<VL>23</VL>
<PG>349-56</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sondergaard-1992" NAME="Sondergaard 1992" YEAR="1992">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sondergaard B, Davidsen F, Kirkeby B, Rasmussen M, Hey H</AU>
<TI>The economics of an intensive educational programme for asthmatic patients. A prospective controlled trial</TI>
<SO>Pharmacoeconomics</SO>
<YR>1992</YR>
<VL>3</VL>
<PG>207-12</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Thapar-1994" NAME="Thapar 1994" YEAR="1994">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Thapar A</AU>
<TI>Educating asthmatic patients in primary care: a pilot study of small group education</TI>
<SO>Family Practice</SO>
<YR>1994</YR>
<VL>11</VL>
<PG>39-43</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Tougaard-1992" NAME="Tougaard 1992" YEAR="1992">
<REFERENCE NOTES="&lt;p&gt;Tougaard L, Krone T, Sorknaes, Ellegaard H, and the PASTMA group.  Economic benefits of teaching patients with chronic obstructive pulmonary disease about their asthma.  Lancet 1992;339:1517-20.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Tougaard L, Krone T, Sorknaes, Ellegaard H, PASTMA group</AU>
<TI>Economic benefits of teaching patients with chronic obstructive pulmonary disease about their asthma</TI>
<SO>Lancet</SO>
<YR>1992</YR>
<VL>339</VL>
<PG>1517-20</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Turner-1998" NAME="Turner 1998" YEAR="1998">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Turner MO, Taylor D, Bennett R, Fitzgerald JM</AU>
<TI>A randomized trial comparing peak expiratory flow and symptom self-management plans for patients with asthma attending a primary care clinic</TI>
<SO>American Journal of Respiratory and Critical Care Medicine</SO>
<YR>1998</YR>
<VL>157</VL>
<PG>540-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Verver-1996" NAME="Verver 1996" YEAR="1996">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Verver S, Poelman M, Bogels A, Chisholm SL, Dekker FW</AU>
<TI>Effects of instruction by practice assistance on inhaler technique and respiratory symptoms of patients. A controlled randomized videotaped intervention study</TI>
<SO>Family Practice</SO>
<YR>1996</YR>
<VL>13</VL>
<PG>35-40</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-White-1989" NAME="White 1989" YEAR="1989">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>White PT, Pharoah CA, Anderson HR, Freeling P</AU>
<TI>Randomised controlled trial of small group education on the outcome of chronic asthma in general practice</TI>
<SO>Journal of the Royal College of General Practitioners</SO>
<YR>1989</YR>
<VL>39</VL>
<PG>182-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</EXCLUDED_STUDIES>
<AWAITING_STUDIES>
<STUDY DATA_SOURCE="PUB" ID="STD-Im--1993" NAME="Im  1993" YEAR="1993">
<REFERENCE NOTES="&lt;p&gt;awaiting assessment&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Im J</AU>
<TI>Evaluation of effectiveness of an asthma clinic managed by an ambulatory care pharmacist</TI>
<SO>California Journal of Hospital Pharmacy</SO>
<YR>1993</YR>
<VL>5</VL>
<PG>5-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</AWAITING_STUDIES>
<ONGOING_STUDIES>
<STUDY DATA_SOURCE="PUB" ID="STD-Ford-1996" NAME="Ford 1996" YEAR="1996">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ford ME, Edwards G, Rodrigues JL, Gibson RC, Tilley BC</AU>
<TI>An empowerment-centered, church-based asthma education program for African American adults</TI>
<SO>Health and Social Work</SO>
<YR>1996</YR>
<VL>21</VL>
<PG>70-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ploska-1999" NAME="Ploska 1999" YEAR="1999">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ploska JF</AU>
<TI>Asthma education nurses in the hospital (French)</TI>
<TO>Infirmiere educatrice de l'asthme en secteur hospitalier</TO>
<SO>Revue de l Infirmiere</SO>
<YR>1999</YR>
<VL>50</VL>
<PG>35-40</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</ONGOING_STUDIES>
</STUDIES>
<OTHER_REFERENCES MODIFIED="2008-08-20 18:56:48 +0200" MODIFIED_BY="Toby J Lasserson">
<ADDITIONAL_REFERENCES MODIFIED="2008-08-20 18:56:48 +0200" MODIFIED_BY="Toby J Lasserson">
<REFERENCE ID="REF-Anonymous-1992" MODIFIED="2008-08-20 18:48:51 +0200" MODIFIED_BY="Toby J Lasserson" NAME="Anonymous 1992" NOTES="&lt;p&gt;Anonymous.  International Consensus Report on Diagnosis and Treatment of Asthma. US Department of Health and Human Services; 1992 National Heart, Lung, and Blood Institute Bethesda, Maryland.&lt;/p&gt;" NOTES_MODIFIED="2008-08-20 18:48:51 +0200" NOTES_MODIFIED_BY="Toby J Lasserson" TYPE="JOURNAL_ARTICLE">
<AU>Anonymous</AU>
<TI>International Consensus Report on Diagnosis and Treatment of Asthma</TI>
<YR>1992</YR>
<PB>National Heart, Lung, and Blood Institute Bethesda, Maryland</PB>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Anonymous-1996" MODIFIED="2008-08-20 18:48:51 +0200" MODIFIED_BY="Toby J Lasserson" NAME="Anonymous 1996" NOTES="&lt;p&gt;National Asthma Campaign.  Asthma Management Handbook 1996; NAC Ltd, 1996.&lt;/p&gt;" NOTES_MODIFIED="2008-08-20 18:48:51 +0200" NOTES_MODIFIED_BY="Toby J Lasserson" TYPE="JOURNAL_ARTICLE">
<AU>Annonymous</AU>
<SO>Asthma Management Handbook</SO>
<YR>1996</YR>
<PB>National Asthma Campaign, Australia</PB>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Bernard_x002d_Bonnin-1995" MODIFIED="2008-08-20 18:56:44 +0200" MODIFIED_BY="Toby J Lasserson" NAME="Bernard-Bonnin 1995" NOTES="&lt;p&gt;Bernard-Bonnin A et al. Self-management teaching programs and morbididty of pediatric asthma: a meta-analysis. J Allergy and Clin Immunol 1995; 95:23-41.&lt;br&gt;&lt;/p&gt;" NOTES_MODIFIED="2008-08-20 18:56:44 +0200" NOTES_MODIFIED_BY="Toby J Lasserson" TYPE="JOURNAL_ARTICLE">
<AU>Bernard-Bonnin A et al</AU>
<TI>Self-management teaching programs and morbidity of pediatric asthma: a meta-analysis</TI>
<SO>Journal of Allergy &amp; Clinical Immunology</SO>
<YR>1995</YR>
<VL>95</VL>
<PG>23-41</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Clark-1993" MODIFIED="2008-08-20 18:56:48 +0200" MODIFIED_BY="Toby J Lasserson" NAME="Clark 1993" NOTES="&lt;p&gt;Clark NM, gotsch A, Rosenstoc IR.  Patient , professional and public educationon behavioural aspects of asthma: a review of strategies for change and needed research. J Asthma 1993;30:241-55&lt;/p&gt;" NOTES_MODIFIED="2008-08-20 18:56:48 +0200" NOTES_MODIFIED_BY="Toby J Lasserson" TYPE="JOURNAL_ARTICLE">
<AU>Clark NM, Gotsch A, Rosenstoc IR</AU>
<TI>Patient , professional and public education on behavioural aspects of asthma: a review of strategies for change and needed research</TI>
<SO>Journal of Asthma</SO>
<YR>1993</YR>
<VL>30</VL>
<PG>241-55</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Gibson-1993a" MODIFIED="2008-08-20 18:48:51 +0200" MODIFIED_BY="Toby J Lasserson" NAME="Gibson 1993a" NOTES="&lt;p&gt;Gibson PG et al. A prospective audit of asthma management following emergency asthma treatment at a teaching hospital.  Med J Aust 1993;158:775-8.&lt;/p&gt;" NOTES_MODIFIED="2008-08-20 18:48:51 +0200" NOTES_MODIFIED_BY="Toby J Lasserson" TYPE="JOURNAL_ARTICLE">
<AU>Gibson PG et al</AU>
<TI>A prospective audit of asthma management following emergency asthma treatment at a teaching hospital</TI>
<SO>Medical Journal of Australia</SO>
<YR>1993</YR>
<VL>158</VL>
<PG>775-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Gibson-1993b" MODIFIED="2008-08-20 18:48:51 +0200" MODIFIED_BY="Toby J Lasserson" NAME="Gibson 1993b" TYPE="JOURNAL_ARTICLE">
<AU>Gibson PG</AU>
<TI>Asthma guidelines and evidenced-based medicine</TI>
<SO>Lancet</SO>
<YR>1993</YR>
<VL>342</VL>
<PG>1305</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Gibson-1998" MODIFIED="2008-08-20 18:48:51 +0200" MODIFIED_BY="Toby J Lasserson" NAME="Gibson 1998" NOTES="&lt;p&gt;Gibson PG, Coughlan J, Wilson AJ, Hensley MJ, Abramson M, Bauman A, Walters EH.  The effects of limited (information-only) asthma education on health outcomes of adults with asthma.  In: Cates C, Ducharm F, Gibson P, Jones P, Rowe B, Wolf F (eds), Airways Module of the Cochrane Database of Systematic Reviews [updated December 1997].  The Cochrane Collaboration; Issue 1, Oxford: Update Software, 1998.&lt;/p&gt;" NOTES_MODIFIED="2008-08-20 18:48:51 +0200" NOTES_MODIFIED_BY="Toby J Lasserson" TYPE="COCHRANE_REVIEW">
<AU>Gibson PG, Coughlan J, Wilson AJ, Hensley MJ, Abramson M, Bauman A et al</AU>
<TI>The effects of limited (information-only) asthma education on health outcomes of adults with asthma (Cochrane Review)</TI>
<SO>The Cochrane Library</SO>
<YR>1998</YR>
<NO>1</NO>
<PB>Update Software</PB>
<CY>Oxford</CY>
<IDENTIFIERS>
<IDENTIFIER TYPE="OTHER" VALUE="CD001005"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Peat-1994" MODIFIED="2008-08-20 18:48:51 +0200" MODIFIED_BY="Toby J Lasserson" NAME="Peat 1994" NOTES="&lt;p&gt;Peat JK et al.  Changing prevalence of asthma in Australian Children.  Br Med J 1994;308:1591-6.&lt;/p&gt;" NOTES_MODIFIED="2008-08-20 18:48:51 +0200" NOTES_MODIFIED_BY="Toby J Lasserson" TYPE="JOURNAL_ARTICLE">
<AU>Peat JK et al</AU>
<TI>Changing prevalence of asthma in Australian Children</TI>
<SO>British Medical Journal</SO>
<YR>1994</YR>
<VL>308</VL>
<PG>1591-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Woolcock-1989" MODIFIED="2008-08-20 18:48:51 +0200" MODIFIED_BY="Toby J Lasserson" NAME="Woolcock 1989" NOTES="&lt;p&gt;Woolcock A et al. Asthma Managment Plan. Med J Aust 1989; 151:650-3.&lt;/p&gt;" NOTES_MODIFIED="2008-08-20 18:48:51 +0200" NOTES_MODIFIED_BY="Toby J Lasserson" TYPE="JOURNAL_ARTICLE">
<AU>Woolcock A et al</AU>
<TI>Asthma Managment Plan</TI>
<SO>Medical Journal of Australia</SO>
<YR>1989</YR>
<VL>151</VL>
<PG>650-3</PG>
<IDENTIFIERS/>
</REFERENCE>
</ADDITIONAL_REFERENCES>
<OTHER_VERSIONS_REFERENCES/>
<PENDING_REFERENCES/>
</OTHER_REFERENCES>
</STUDIES_AND_REFERENCES>
<CHARACTERISTICS_OF_STUDIES MODIFIED="2008-08-20 18:44:31 +0200" MODIFIED_BY="Toby J Lasserson">
<CHARACTERISTICS_OF_INCLUDED_STUDIES MODIFIED="2008-08-20 18:43:06 +0200" MODIFIED_BY="Toby J Lasserson" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<INCLUDED_CHAR MODIFIED="2008-08-20 18:34:51 +0200" MODIFIED_BY="Toby J Lasserson" STUDY_ID="STD-Abdulwadud-1999">
<CHAR_METHODS>
<P>DESIGN: Randomised controlled trial<BR/>METHOD OF RANDOMISATION: Simple random number table.<BR/>MEANS OF ALLOCATION CONCEALMENT- not concealed<BR/>OUTCOME ASSESSOR BLINDING- none<BR/>WITHDRAWAL/DROPOUTS - all participants accounted for.<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-08-20 18:34:51 +0200" MODIFIED_BY="Toby J Lasserson">
<P>Eligible:175<BR/>Randomised: 125 (Intervention 64, Control 61)<BR/>Completed: 77 (Intervention 30, Control 47)<BR/>Age: Overall mean 46 yrs. Intervention 48 yrs, Control 43 yrs.<BR/>Range: 16 to 82 yrs<BR/>Sex: Male / Female: 50/75<BR/>Asthma Diagnosis: Doctor's diagnosis based on ATS criteria.<BR/>Recruitment: Hospital asthma &amp; allergy clinic.<BR/>Diseases Included:<BR/>Major Exclusions: Those with inadequate English skills, hearing or sight problems or asthma not their major illness.<BR/>Baseline: 96% mod - severe asthma.<BR/>FEV1: Mean % predicted: Intervention 54%, Control 55%.<BR/>PEF: Median PEF variability over 1 week 14.6%.<BR/>Exacerbations: not stated.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Setting: Hospital outpatients<BR/>Type: Basic asthma knowledge, physiology and triggers. Instruction on PEF self monitoring, and asthma action plans - ? individualised. Understanding of medications and inhaler technique.<BR/>Duration: Three 90 minute group sessions over 3 weeks.<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Knowledge, Skills, quality of life,attitudes and beliefs.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Jadad Score = 5</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Allen-1995">
<CHAR_METHODS>
<P>DESIGN: Randomised controlled trial stratified according to peak flow ownership.<BR/>METHOD OF RANDOMISATION: Randomised - stated. Method not described.<BR/>MEANS OF ALLOCATION CONCEALMENT- blinded.<BR/>OUTCOME ASSESSOR BLINDING - not stated.<BR/>WITHDRAWAL/DROPOUTS - all participants accounted for.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Eligible: 116<BR/>Randomised: 58/58 <BR/>Completed: 56/57<BR/>Age: Mean: 40 yrs Range: 19 to 63 <BR/>Sex: Male / Female 46%/54%<BR/>Asthma Diagnosis: Doctors Diagnosis<BR/>Recruitment: volunteer community respondents<BR/>Diseases Included: Asthma - moderate to severe <BR/>Major exclusions: Current smokers or quit in the past 3 months, previous asthma education programme.<BR/>Baseline:<BR/> FEV1: Intervention n = 56. 16% normal (&gt; or = 80%), 77% mild/moderate (50 to 79%), 7% severe (&lt; 50%). Control n = 57. 10% normal, 78% mild/mod, 12% severe.<BR/> PEF: Intervention n = 54. median 58.4, range 35.0 to 77.0. Control n = 26. median 48.3, range 37 to 75.<BR/> Exacerbations - not stated.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Setting: Hospital Based community service asthma education programme<BR/>Type: Education, Self Monitoring of Peak Flow and External Regular Review. (diaries of medications and symptoms were kept by members of both groups for 4 week periods at 3, 6, 9 and 12 months. If control group members owned a PF, they recorded this also. All members of the intervention group recorded PF and were taught in its use and interpretation).<BR/>Duration: weekly 2.5 hour group education sessions over 4 weeks (total 10 hrs)<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Knowledge, Compliance, scheduled and unscheduled doctor and hospital visits, disrupted days (ie being confined to bed or a chair), Frequency of morning wheeze, nocturnal asthma symptoms, bronchodilator medications, pre-bronchodilator FEV1/FVC, asthma symptoms diary, PEF.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-08-20 18:38:21 +0200" MODIFIED_BY="Toby J Lasserson" STUDY_ID="STD-Bailey-1990">
<CHAR_METHODS>
<P>DESIGN: Randomised Controlled Trial. Stratified by 11 physicians and 3 asthma severity levels. Blocked so that 2 out of 4 in a given stratum were assigned to intervention and control.<BR/>METHOD OF RANDOMISATION: Separate randomisation schedule for the 33 strata were prepared in advance. Method of randomisation not stated.<BR/>METHOD OF CONCEALMENT: closed envelope technique.<BR/>OUTCOME ASSESSOR BLINDING: not stated.<BR/>WITDHRAWAL/DROPOUTS: all subjects accounted for.<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-08-20 18:38:21 +0200" MODIFIED_BY="Toby J Lasserson">
<P>Eligible: not stated<BR/>Randomised: 267 Intervention 132, Control 135<BR/>Completed: 225 Intervention 124, Control 101<BR/>Age: &lt;20 yrs Int 1.6%, Cont 5.1%; 20-39 yrs Int 27.4%, Cont 31.6%; 50-59 yrs Int 37.1%, Cont 30.6 %; &gt;/= 60 yrs Int 33.9%, Cont 32.7%.<BR/>Sex: Male / Female Intervention 39/61 Control 29/71.<BR/>Asthma Diagnosis: Doctor's diagnosis.<BR/>Recruitment: Regular Clinic Visits<BR/>Diseases Excluded: Another pulmonary or severely debilitation disease (e.g. CF, CA, severe rheumatoid arthritis.<BR/>Other exclusions: Under 18 years, refusal (5 %)<BR/>Baseline:<BR/>FEV1: not reported<BR/>PEF: not reported<BR/>Exacerbations: Intervention Mild 37.1%, Mod 47.6%, Severe 16.3%; Control Mild 38.6%, Moderate 44.6%, Severe 16.8%.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Setting: Outpatient clinic<BR/>Type: Education, peak flow self monitoring and regular review.<BR/>Duration: one hour, one to one session - Subjects were provided information about attack management but not an individualised written action plan.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-08-20 18:35:11 +0200" MODIFIED_BY="Toby J Lasserson">
<P>Skills, Hospitalisations, ER visits, Days off work/school, Compliance, Severity of asthma symptoms, bothered by asthma symptoms, 5 or more days coughing or dyspnoea.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-08-20 18:38:34 +0200" MODIFIED_BY="Toby J Lasserson" STUDY_ID="STD-Bailey-1999">
<CHAR_METHODS>
<P>DESIGN: Randomised controlled trial of two interventions.<BR/>METHOD OF RANDOMISATION: Stratified by severity and blocked to ensure 2 of every 6 participants were assigned in each group<BR/>MEANS OF ALLOCATION CONCEALMENT- Closed envelope technique<BR/>OUTCOME ASSESSOR BLINDING- Blinded<BR/>WITHDRAWAL/DROPOUTS- 7% attrition rate. All participants not accounted for.<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-08-20 18:38:34 +0200" MODIFIED_BY="Toby J Lasserson">
<P>Eligible: Not stated<BR/>Randomised: 236<BR/>Completed: 221<BR/>Age: Mean: not stated<BR/>Range: 94 (41%) &lt; 40 yrs, 138 (59%) &gt;= 40 yrs<BR/>Sex: Male/Female: 71 / 161<BR/>Asthma Diagnosis: Doctor diagnosis and objective lung function.<BR/>Recruitment: Pulmonary clinic visit<BR/>Diseases Included: Not stated.<BR/>Major Exclusions: Not stated.<BR/>Baseline:<BR/>FEV1: not reported<BR/>PEF: not reported<BR/>Exacerbations: moderate to severe asthmatics</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-08-20 18:38:32 +0200" MODIFIED_BY="Toby J Lasserson">
<P>Setting: Outpatients clinic<BR/>Type: Two self management interventions, one modified, and a usual care control group.<BR/>(1) Counselling re use of skill-oriented self help work book including info on asthma physiology, medications, trigger avoidance detection, response to asthma attacks and inhaler technique. No individualised action plan.<BR/>(2) Instruction of use of a modified work book, inhaler technique and peak flow meter use.<BR/>(3) control group received usual care and some asthma literature.<BR/>Duration:<BR/>(a) One 1 hour individual session and 2 asthma support group meetings.<BR/>(b) One 15 minute individual session plus a 1 week follow-up phone call and at 2 weeks a letter to encourage adherence.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Medication &amp; inhaler adherence, symptoms, respiratory illness, functional impairment &amp; use of health care services.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Jadad Score = 4</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Berg-1997">
<CHAR_METHODS>
<P>DESIGN: Randomised Controlled Trial<BR/>METHOD OF RANDOMISATION: the word "random" stated ; stratified according to severity (moderate/severe)<BR/>METHOD OF ALLOCATION CONCEALMENT: not described.<BR/>OUTCOME ASSESSOR BLINDING: not stated.<BR/>WITHDRAWAL/DROPOUTS: all subjects accounted for.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Eligible: 68<BR/>Randomised: 55<BR/>Completed: 54 (Intervention 31; Control 24)<BR/>Age: Overall mean: 50 yrs (sd 16) <BR/>Sex: Male / Female 19/36<BR/>Asthma Diagnosis: Doctor's diagnosis<BR/>Recruitment: Rural community<BR/>Diseases Included: not specified - but smokers were included<BR/>Major exclusions: Not specified<BR/>Baseline:<BR/> FEV1: Patients described their asthma as moderate to severe.<BR/> PEF: am intervention 360 (sd 105); control 365 (sd 137)<BR/> pm intervention 347 (sd 107); control 371 (sd 140)<BR/> Exacerbations: not stated</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Setting: community based education program<BR/>Type: Small group education and self monitoring of peak flow and symptoms.<BR/>Control: No special education. Controls kept an asthma diary (symptoms and PEF) for one week at baseline and one week at the end of the study for outcome assessment.<BR/>Duration: 6 x 2 hour training sessions ie 1/week over 6 weeks.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Compliance, symptoms, am PEFR, pm PEFR, Asthma self-efficacy, Asthma self-management.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Blixen-2001">
<CHAR_METHODS>
<P>DESIGN: Randomised Controlled Trial<BR/>METHOD OF RANDOMISATION: Not stated<BR/>MEANS OF ALLOCATION CONCEALMENT- Not stated<BR/>OUTCOME ASSESSOR BLINDING- blinded<BR/>WITHDRAWAL/DROPOUTS- all participants accounted for<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Eligible: 40<BR/>Randomised: 28 (14/14)<BR/>Completed: 13 (Intervention 7, Control 6)<BR/>Age: Mean overall: 36 yrs Range: 18 to 50<BR/>Sex: Male/Female: 7/20<BR/>Asthma Diagnosis: Doctor diagnosis<BR/>Recruitment: Hospital admissions<BR/>Diseases Included: Not stated<BR/>Major Exclusions: not stated<BR/>Baseline: 54% asthma &gt; 10yrs<BR/> FEV1: <BR/> PEF:<BR/> Exacerbations: In previous 2 weeks 57% had mild intermittent or persistent asthma, 32% moderate persistent &amp; 11% severe asthma</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Setting: Hospital <BR/>Type: Individual sessions while an inpatient covering rationale and skills of asthma self management, explanation of "asthma self management workbook" and self monitoring techniques. Video on peak flow monitoring and written reinforcement materials sent at 3 and 6 months.<BR/>Duration:Three 1hour sessions</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Hospitalisation, aer visits, unscheduled Dr visits, quality of life and depression scale</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Jadad Score = 3</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Brewin-1995">
<CHAR_METHODS>
<P>DESIGN: not randomised - all participants for intervention group were admitted to Pembury Hospital.<BR/>METHOD OF ALLOCATION CONCEALMENT: Inadequate. Participants for the "control group" were allocated systematically according to a pre-set hospital rotation.<BR/>OUTCOME ASSESSOR BLINDING: implied but unclear.<BR/>WITHDRAWAL/DROPOUTS: No dropouts.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Eligible: ?<BR/>Randomised 83 <BR/>Completed: 45 Intervention 33; Control 12.<BR/>Age: Overall mean: N/S Range: N/S <BR/>Sex: Male / Female - N/S<BR/>Asthma Diagnosis: Doctor's Diagnosis<BR/>Recruitment: Patients admitted to hospital for asthma<BR/>Diseases Included: N/S<BR/>Major exclusions: N/S<BR/>Baseline:<BR/> FEV1: N/S<BR/> PEF: N/S<BR/> Exacerbations: N/S</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Setting: inpatient <BR/>Type: one to one sessions with a respiratory nurse, peak flow self monitoring.<BR/>Duration: at least 30 minutes</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Knowledge, symptoms, days off work, nocturnal waking, need for and frequency of bronchodilator use.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Cote-1997">
<CHAR_METHODS>
<P>DESIGN: Randomised controlled trial of two interventions <BR/>METHOD OF RANDOMISATION: Randomised - stratified randomisation<BR/>MEANS OF ALLOCATION CONCEALMENT- not stated.<BR/>OUTCOME ASSESSOR BLINDING - not blinded.<BR/>WITHDRAWAL/DROPOUTS - all subjects accounted for.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Eligible: not specified<BR/>Randomised: 188 (Peak Flow 62, Symptoms Only 52, Control 74)<BR/>Completed: 149 (Peak Flow 50, Symptoms Only 45, Control 54) <BR/>Age: Overall mean: 36 yrs Range: <BR/>Sex: Male/Female -<BR/>Asthma Diagnosis: Doctor's diagnosis and objective lung function <BR/>Recruitment: Hospital admissions or visit to a clinic. <BR/>Diseases Included: <BR/>Major exclusions: current and ex-smokers 40 yr of age or older in whom the best FEV1 after salbutamol was &lt; 80% of predicted, patients with significant concurrent diseases, those requiring &gt; 7.5 mg prednisone to control asthma symptoms and those who had already taken part in an asthma education program.<BR/>Baseline:<BR/> FEV1: not stated<BR/> PEF: % predicted: Peak Flow 93+/-3; Symptoms 91+/-3; Control 95+/-3. <BR/> Exacerbations not stated</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Setting: tertiary care setting<BR/>Type: Two optimal interventions and an active control.<BR/>(1) Education, peak flow self monitoring, regular review and individualised written action plan based on peak flow enabling self adjustment of medications in the event of worsening asthma.<BR/>(2) Education, symptoms self monitoring, regular review and a symptoms based written action plan enabling self adjustment of medications in the event of worsening asthma. <BR/>(3) Control group: Taught inhaler technique by the educator and about medication use and triggers by their pulmonologist. Their physician may have provided a verbal action plan.<BR/>Duration: A minimum of 1 x one hour one to one counselling sessions for both educated groups</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Knowledge, compliance, hospitalisations, ER visits, oral corticosteroids, days lost from work or school.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Jadad Score = 4</P>
<P>Treatment was optimised for all subjects during baseline.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-08-20 18:41:12 +0200" MODIFIED_BY="Toby J Lasserson" STUDY_ID="STD-Cowie-1997">
<CHAR_METHODS>
<P>DESIGN: Randomised controlled trial of two interventions <BR/>METHOD OF RANDOMISATION: Random numbers list<BR/>MEANS OF ALLOCATION CONCEALMENT- sequentially administered identical opaque closed envelope technique<BR/>OUTCOME ASSESSOR BLINDING - outcome assessors blinded<BR/>WITHDRAWAL/DROPOUTS - all subjects accounted for.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-08-20 18:41:12 +0200" MODIFIED_BY="Toby J Lasserson">
<P>Eligible: not specified<BR/>Randomised: 151 (one withdrawn: not asthma)<BR/>Completed: 139 (Peak Flow 46, Symptoms Only 45, Control 48)<BR/>Age: Overall mean: 36.4 yrs Standard Deviation: 15.9 yrs<BR/>Sex: Male / Female - (Peak Flow 17/29, Symptoms Only 20/25, Control 19/29)<BR/>Asthma Diagnosis: Doctor's diagnosis and objective lung function<BR/>Recruitment: Urgent emergency room treatment for asthma.<BR/>Diseases Included: Not specified. Included those who already had a peak flow meter.<BR/>Major exclusions: Those who already had a written action plan.<BR/>Baseline:<BR/>FEV1: not stated<BR/>PEF: not stated<BR/>Exacerbations All subjects had required urgent treatment for asthma in the previous 12 months.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Setting: individual nurse led education<BR/>Type: Two optimal interventions and an active control.<BR/>(1) Education (as per control), peak flow self monitoring, medication assessment within the program and advised to seek regular review outside the program and individualised written action plan based on peak flow enabling self adjustment of medications in the event of worsening asthma.<BR/>(2) Education (as per control), NO symptoms or peak flow self monitoring, medication assessment within the program and advised to seek regular review outside the program and a symptoms based written action plan enabling self adjustment of medications in the event of worsening asthma. <BR/>(3) Control group: 45 minutes education by the nurse educator about asthma, triggers, medication use and devices as per the interventions above. Medications assessed and if inadequate, patients physician was notified. Patients advised that their dose of corticosteroid may need to be adjusted from time to time.<BR/>Duration: 45 minutes one to one counselling sessions for all groups</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Hospital admissions, ER visits.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Jadad Score = 5</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-de-Oliveira-1999">
<CHAR_METHODS>
<P>DESIGN:Randomised Controlled Trial<BR/>METHOD OF RANDOMISATION: Randomised - stated. Method not described<BR/>MEANS OF ALLOCATION CONCEALMENT- closed envelope technique<BR/>OUTCOME ASSESSOR BLINDING- Not stated<BR/>WITHDRAWAL/DROPOUTS-<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Eligible: 80<BR/>Randomised: 53 (26/27)<BR/>Completed: 42 (22/20)<BR/>Age: Mean overall 39.6 yrs. intervention 41 (sd15), Control 38 (sd17)<BR/>Range: not stated<BR/>Sex: Male / Female: 5/37<BR/>Asthma Diagnosis: history airflow obstruction and ICRDMA criteria<BR/>Recruitment: Outpatient clinic database<BR/>Diseases Included: not stated<BR/>Major Exclusions: not stated<BR/>Baseline:<BR/> FEV1: percent predicted: Intervention 70%(sd22), Control 80% (sd19)<BR/> PEF:<BR/> Exacerbations:</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Setting: Outpatients clinic<BR/>Type: concepts of asthma, asthma management, triggers, preventive measures. Video with introduction to treatment plan and inhaler technique. Symptom self monitoring. Medcially assessed at baseline and completion. Treament adjusted according to ICRDMA recommendations.<BR/>Controls received routine schedule of asthma clinic. Medically assessed at baseline and completion<BR/>Duration: Monthly visits for 6 months ? length of time but including 1 x individual session and 2 x 1hr group sessions at 3 and 4 months .</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Knowledge, skills, hospitalisations, ER visits, PEF, rescue medications, oral &amp; inhaled corticosteroids, symptom frequency and quality of life.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Jadad Score = 4</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-08-20 18:41:21 +0200" MODIFIED_BY="Toby J Lasserson" STUDY_ID="STD-Gallefoss-1999">
<CHAR_METHODS>
<P>DESIGN: Randomised Controlled Trial.<BR/>METHOD OF RANDOMISATION: Randomised - stated. Method not described.<BR/>MEANS OF ALLOCATION CONCEALMENT- Not stated.<BR/>OUTCOME ASSESSOR BLINDING- for spirometry, ? for other outcomes.<BR/>WITHDRAWAL/DROPOUTS- All subjects accounted for.<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Eligible: 85<BR/>Randomised: 78 (Intervention 39, Control 39)<BR/>Completed: 71 (Intervention 32, Control 39).<BR/>Age: mean overall: 45 yrs. Intervention 44, Control 41<BR/>Range: 18 to 70 yrs eligible.<BR/>Sex: Male/Female: 23/55<BR/>Asthma Diagnosis: Objective lung function.<BR/>Recruitment: Outpatients clinic.<BR/>Diseases Included: <BR/>Major Exclusions: Unstable CHD, heart failure, hypertension, diabetes, kidney or liver failure.<BR/>Baseline:<BR/> FEV1: &gt; 80% predicted.<BR/> PEF:<BR/> Exacerbations: mild to moderate asthma.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-08-20 18:41:21 +0200" MODIFIED_BY="Toby J Lasserson">
<P>Setting: Outpatients clinic<BR/>Type: Basic introduction to asthma, anatomy and physiology, prevention &amp; triggers, pharmacology of asthma drugs. Subjects received a 19 page booklet including self-care and self-management plan. Instructions on PEF and symptom self-monitoring. Patients received an individual treatment plan.<BR/>Controls followed by their GP.<BR/>Duration: Two 2 hour group sessions on two separate days with a Doctor and pharmacist followed by 1-2 individual sessions with a nurse and 1-2 individual sessions with a physiotherapist.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>FEV1, quality of life, rescue medications, compliance, hospitalisations, unscheduled Dr visits, days off work, costs, patient satisfaction</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Jadad Score = 4</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-08-20 18:41:28 +0200" MODIFIED_BY="Toby J Lasserson" STUDY_ID="STD-Garret-1994">
<CHAR_METHODS>
<P>DESIGN: Randomised Controlled Trial.<BR/>METHOD OF RANDOMISATION: randomised.<BR/>METHOD OF ALLOCATION CONCEALMENT: closed envelope technique.<BR/>OUTCOME ASSESSOR BLINDING: outcome assessors were blinded.<BR/>WITHDRAWAL/DROPOUTS: all subjects accounted for.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Eligible: 980<BR/>Randomised: 500: Intervention 251; Control 249. <BR/>Completed: 451<BR/>Age: 2-5 years: Intervention 25% Control 26%. 6-14 years:Intervention 19% Control 21%. 15-29 years Intervention 30% Control 32%. 30-55 years: Intervention 25% Control 21%. <BR/>Sex: Male / Female Intervention 38/62% Control 46/54%<BR/>Asthma Diagnosis: Doctor's diagnosis<BR/>Recruitment: Emergency Room Attenders (whether hospitalisation was required or not)<BR/>Diseases Included: not stated<BR/>Major exclusions: not stated<BR/>Baseline:<BR/> FEV1: not stated<BR/> PEF: not stated<BR/> Exacerbations: not stated</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Setting: Community Education Centre.<BR/>Type: Education, self-monitoring of symptoms and peak flow, regular review (advised to seek regular review from their GP).<BR/>Participants were advised to obtain a written action plan from their GP which allowed self adjustment of medications in the event of worsening asthma but as this was not a part of the intervention, it was not characterised as Optimal Self Management but Self Monitoring and Regular Review.<BR/>Duration: Not stated</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-08-20 18:41:28 +0200" MODIFIED_BY="Toby J Lasserson">
<P>Hospital admissions, ER visits, Unscheduled doctor visits, days lost from work or school, nocturnal awakening, asthma status (same worse better), PEF variability, Symptoms, dyspnoea on exercise.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2008-08-20 18:39:19 +0200" MODIFIED_BY="Toby J Lasserson">
<P>Only about 60% of data refers to adults.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-08-20 18:39:28 +0200" MODIFIED_BY="Toby J Lasserson" STUDY_ID="STD-George-1999">
<CHAR_METHODS MODIFIED="2008-08-20 18:39:22 +0200" MODIFIED_BY="Toby J Lasserson">
<P>DESIGN: Randomised Controlled Trial<BR/>METHOD OF RANDOMISATION: random number generation<BR/>MEANS OF ALLOCATION CONCEALMENT- Not stated<BR/>OUTCOME ASSESSOR BLINDING- Not stated<BR/>WITHDRAWAL/DROPOUTS- all participants accounted for.<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-08-20 18:39:24 +0200" MODIFIED_BY="Toby J Lasserson">
<P>Eligible: 88<BR/>Randomised: 77 (Intervention 44, Control 33)<BR/>Completed: 77 (44/33)<BR/>Age: Overall Mean: 29 yrs, Intevention 29yrs, Control 29yrs. Range: 18 to 45yrs<BR/>Sex: Male/Female: 16/61<BR/>Asthma Diagnosis: Doctor diagnosis on admission<BR/>Recruitment: Hospital admissions<BR/>Diseases Included: N/S<BR/>Major Exclusions: comorbid disease, non-English speaking, no home telephone, pregnancy, intensive care admission.<BR/>Baseline:<BR/>FEV1: not reported<BR/>PEF: not reported<BR/>Exacerbations: enrolled on acute admission to hospital</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-08-20 18:39:28 +0200" MODIFIED_BY="Toby J Lasserson">
<P>Setting: In hospital<BR/>Type: Asthma instruction, inhaler technique, early warning signs, and action plans for appropriate responses. Importance of regular follow-up stressed.<BR/>Controls received routine care. Education at "discretion of staff"<BR/>Duration: repetitive sessions while in hospital and 7 day follow-up in outpatients</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Hospitalisation, ER visits, length of hospital stay, outpatient visits.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Jadad Score = 5</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Ghosh-1998">
<CHAR_METHODS>
<P>DESIGN: Randomised Controlled Trial<BR/>METHOD OF RANDOMISATION: Not stated<BR/>MEANS OF ALLOCATION CONCEALMENT- Not stated.<BR/>OUTCOME ASSESSOR BLINDING- Not stated<BR/>WITHDRAWAL/DROPOUTS- all subjects accounted for<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Eligible: Not stated<BR/>Randomised: 303 (Intervention 153, Control 150)<BR/>Completed: 276 (Intervention 140, Control 136).<BR/>Age: 10 to 19 yrs Int. 27%, Cont. 33%, 20 to 29yrs Int. 23% Cont 18%, 30 to 39 yrs Int 29%, Cont 31%, 40 to 45 yrs Int 21% Cont 18%. Range: 10 to 45 yrs<BR/>Sex: Male/Female: 113/163<BR/>Asthma Diagnosis: Doctor diagnosis and objective lung function.<BR/>Recruitment: Asthma &amp; Allergy Clinic<BR/>Diseases Included: not stated<BR/>Major Exclusions: chronic respiratory infections, bronchitis, emphysema, multisystem disorders, history of smoking.<BR/>Baseline:<BR/> FEV1: &gt;15% reversibility<BR/> PEF: Mean (SD) Int 281 (65) , Cont 274(67)<BR/> Exacerbations: at least one admission or ER visit in past 12 months. drug therapy at least 50% of the days in a month</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Setting: outpatients clinic<BR/>Type: Asthma self-management training in first month following baseline interview. Audiovisual aides used to highlight preventative measures, detailed teaching of PEFR and significance of variation. Individual written action plan. Self monitoring for 4 single months. Medically assessed and treatment adjusted at baseline.<BR/>Controls kept 4 x 1 month diaries and medically assessed at baseline. No education given<BR/>Duration: 4 x 2 hour sessions</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Hospitalisations, ER visits, PEF, Days off work, costs.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Jadad Score = 4</P>
<P>Intervention 27% 10 to 19 yrs age, Control 33%</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Grampian-1994">
<CHAR_METHODS>
<P>DESIGN: 2x2x2 block randomised trial stratified by physician.<BR/>METHOD OF RANDOMISATION: the word "random" stated ; method not described.<BR/>METHOD OF ALLOCATION CONCEALMENT: not described.<BR/>OUTCOME ASSESSOR BLINDING: not stated.<BR/>WITHDRAWAL/DROPOUTS: dropouts (6%) not accounted for.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Eligible: 801 consented but 232 already had peak flow meter and could not be randomised for this arm.<BR/>Randomised: 569: Peak flow self monitoring 285, Conventional monitoring 284<BR/>Completed: 458: Peak flow self monitoring 230, Conventional monitoring 228.<BR/>Age: Mean Intervention 51.1 yrs Control 50.5 years Range: &gt; 16 years. <BR/>Sex: Male/Female Intervention 48/52% Control 40/60%<BR/>Asthma Diagnosis: Doctor's diagnosis and objective lung function<BR/>Recruitment: Hospital outpatient clinics and general practices in north east Scotland.<BR/>Diseases Included: N/S<BR/>Major exclusions: N/S<BR/>Baseline:<BR/> FEV1: % of predicted: Intervention 77.3%; Control 78.1%<BR/> PEF: Mean: Intervention 344.5; Control 341.6. <BR/> Exacerbations: N/S</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Setting: <BR/>Type: education, self monitoring of peak flow, and regular review and written action plan to enable self adjustment of medications in response to worsening asthma based on peak flow. (due to the factorial design, some of the intervention group were randomised to receive enhanced education while the others had conventional education. Similarly, some were randomised to receive integrated care while others had conventional care). <BR/>Control: Some had enhanced education but none had peak flow meters.<BR/>Duration: not stated</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Hospitalisation, unscheduled doctor visits, FEV1 % predicted, use of rescue medication, quality of life, days off work, inhaled steroids, disrupted days, nocturnal asthma.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Jadad Score = 3</P>
<P>Confounding due to factorial design.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-08-20 18:41:44 +0200" MODIFIED_BY="Toby J Lasserson" STUDY_ID="STD-Hayward-1996">
<CHAR_METHODS>
<P>DESIGN: Randomised Controlled Trial <BR/>METHOD OF RANDOMISATION: Random stated, method not described<BR/>METHOD OF ALLOCATION CONCEALMENT: not stated <BR/>OUTCOME ASSESSOR BLINDING: not stated.<BR/>WITHDRAWAL/DROPOUTS:</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Eligible: 84 <BR/>Randomised: 44( Intervention 23, Control 21)<BR/>Completed: 42 (Intervention 23, Control 19)<BR/>Age: Mean Intervention 51.1 Range: 6 to 74 yrs<BR/>Sex: Male/Female <BR/>Asthma Diagnosis: not stated<BR/>Recruitment: GP<BR/>Diseases Included: N/S<BR/>Major exclusions: N/S<BR/>Baseline:<BR/> FEV1: <BR/> PEF: Mean: <BR/> Exacerbations:</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-08-20 18:41:44 +0200" MODIFIED_BY="Toby J Lasserson">
<P>
<BR/>Setting: ? GP clinic<BR/>Type: Training from an asthma nurse specialist by telephone or attending a clinic monthly for 1 year. Education in knowledge, triggers, symptoms, reliever vs preventer medication and inhaler technique. Written support materials given. peak flow self monitoring and action plan - ? written.<BR/>Duration:Monthly clinic visit or telephone call for 12 months</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Knowledge, hospitalisation, unscheduled Dr visits, rescue medication, days off work or school, exacerbations, symptom score, symptoms</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Jadad Score = 3</P>
<P>Includes children</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Heard-1999">
<CHAR_METHODS>
<P>DESIGN: Randomised Controlled Trial.<BR/>METHOD OF RANDOMISATION: Randomised - stated. Method not described<BR/>MEANS OF ALLOCATION CONCEALMENT- not concealed- randomisation chart for each practice.<BR/>OUTCOME ASSESSOR BLINDING- None<BR/>WITHDRAWAL/DROPOUTS - All subjects accounted for.<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Eligible: Not stated<BR/>Randomised: 195 (Intervention 98, Control 97)<BR/>Completed: 191 (Intervention 97, Control 94).<BR/>Age: Mean Intervetion 27.5 yrs, Control 26.3 yrs.<BR/>Range: eligible 5 to 64 yrs<BR/>Sex: Male/Female:<BR/>Asthma Diagnosis:<BR/>Recruitment: 8 General Practices<BR/>Diseases Included:<BR/>Major Exclusions:<BR/>Baseline:<BR/> FEV1:<BR/> PEF:<BR/> Exacerbations:</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Setting: GP Asthma Clinic<BR/>Type: Nurse counselling, asthma management strategies, spirometry, peak flow and inhaler use. Explanation of diary card use for PEF self monitoring and written action plan. Assessed by GP at end of each clinic session.<BR/>Controls received standard medical treatment<BR/>Duration: 3 x 3 hour sessions over 6 months</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Knowledge, hospitalisation, ER visits, unscheduled Dr visits, preventer medication, days off work, productive days lost, nocturnal asthma, use of action plan, owning a peak flow meter, smoking status, morning asthma symptoms</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Jadad Score = 3</P>
<P>Includes children</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Hilton-1986">
<CHAR_METHODS>
<P>DESIGN: Controlled Clinical Trial<BR/>METHOD OF RANDOMISATION: allocated systematically in the order in which they were recruited.<BR/>METHOD OF ALLOCATION CONCEALMENT: systematically allocated - not concealed.<BR/>OUTCOME ASSESSOR BLINDING: unclear.<BR/>WITHDRAWAL/DROPOUTS: all subjects accounted for.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Eligibility Criteria: 5 to 70 yrs, asthma diagnosis by GP, anti-asthma treatment given on at least two occasions in the past year, no other asthma patient in the family or household recruited to the study.<BR/>Eligible:415<BR/>Randomised: 339<BR/>Completed: 274<BR/>Age: mean: Not specified; Range Not specified.<BR/>Sex: Male/Female - not specified. <BR/>Asthma Diagnosis: by General Practitioner.<BR/>Recruitment: from 14 general practices in South and West London.<BR/>Major exclusions: not specified<BR/>Baseline<BR/> FEV1 not stated;<BR/> PEF not stated, <BR/> Exacerbations not stated.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Setting: <BR/>Type: Maximum Education Group: Education with GP, and regular review (ie 3 monthly appointments with the doctor in addition to their routine consultations for asthma).<BR/>Duration: 10 to 15 minutes semi-structured interview with their GP plus a booklet and a cassette tape.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Knowledge, skills, ER visits, patient satisfaction, days off work, compliance, avoiding activities, Wheeze (frequency, severity), nocturnal asthma, exacerbations.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Ignacio_x002d_Garcia-1995">
<CHAR_METHODS>
<P>DESIGN: Randomised Controlled trial<BR/>METHOD OF RANDOMISATION: the word "random" stated; "randomly allocated in the order in which they were recruited" by alternation.<BR/>METHOD OF ALLOCATION CONCEALMENT: alternation, not concealed.<BR/>OUTCOME ASSESSOR BLINDING: outcome assessor of intervention group not blinded; outcome assessor of control group was "blinded with regard to registers of peak flow monitoring until the end of the study".<BR/>WITHDRAWAL/DROPOUTS: all participants accounted for.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Eligible: not stated.<BR/>Randomised: 94 (Intervention 50, Control 44) <BR/>Completed: 70 (Intervention 35, Control 35) but a further 11 in Intervention group and 5 in control group were excluded at 3 months due to poor inhalation technique, lack of PEF monitoring &amp; non compliance with prescribed medication regimens leaving 54 (Intervention 24, Control 30).<BR/>Age: Overall mean: 42 Years Range: 16 to 64 years. <BR/>Sex: Male/Female 32/38 of the study population of 70.<BR/>Asthma Diagnosis: Doctor's diagnosis.<BR/>Recruitment: Outpatient asthma clinic<BR/>Diseases Included: not specified<BR/>Major exclusions: not specified<BR/>Baseline:<BR/> FEV1: % of predicted (Intervention 69.03 Control 65.34)<BR/> PEF: not stated<BR/> Exacerbations: not stated</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Setting: <BR/>Type: Optimal self management including education, peak flow self monitoring, regular review and a written action plan based on peak flow which enabled self adjustment of medications in the event of worsening asthma.<BR/>Control group: Self monitoring of symptoms and regular review. Collected PEF as an outcome but based their treatment on physicians advice.<BR/>Duration: not stated. Study period was 7 months.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Hospitalisation, ER visits, doctor visits, lung function - % predicted, use of rescue medication, days off work, antibiotic therapy, nocturnal asthma, exacerbations, PEF - mean daily peak flow rate.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-08-20 18:39:40 +0200" MODIFIED_BY="Toby J Lasserson" STUDY_ID="STD-Jones-1995">
<CHAR_METHODS>
<P>DESIGN: Randomised Controlled Trial. Stratified by centre in blocks of six.<BR/>METHOD OF RANDOMISATION: the word "random" stated ; method not described.<BR/>METHOD OF ALLOCATION CONCEALMENT: not described.<BR/>OUTCOME ASSESSOR BLINDING: not clear - "data rendered anonymous" before analysis.<BR/>WITHDRAWAL/DROPOUTS: not described.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Eligible: not stated<BR/>Randomised: 127<BR/>Completed: 72 (Intervention self management 33; planned visits 39) <BR/>Age: self managed : mean 30.4 yrs SD 11.5 yrs planned visits: mean 28.6 SD 7 yrs. <BR/>Sex: Male/Female Self managed 14/19 planned visits 12/26.<BR/>Asthma Diagnosis: Doctor's diagnosis<BR/>Recruitment: General practices<BR/>Diseases Included: Not specified<BR/>Major exclusions: Those on regular oral steroids and those who were regularly conducting home PEF monitoring.<BR/>Baseline:<BR/> FEV1: % predicted: self management 85.1 (sd 20.8), planned visits 80.2 (sd19.9)<BR/> PEF: % predicted: self management 88.2 (sd 15.4), planned visits 86.8 (sd 13.7) <BR/> Exacerbations</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Setting: General Practice <BR/>Type: Optimal self management: education, peak flow self monitoring, regular review and an individualised written action plan based on peak flow enabling self adjustment of medications in the event of worsening asthma.<BR/>Control: regular review and kept a daily diary for morbidity and bronchodilator use for outcomes.<BR/>Duration:</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Lung Function - % predicted, Use of rescue medication, quality of life, days off work, wheeze (frequency, severity), nocturnal asthma, oral corticosteroid use, cough, shortness of breath, disrupted days.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2008-08-20 18:39:40 +0200" MODIFIED_BY="Toby J Lasserson">
<P>Jadad Score = 4</P>
<P>Oral corticosteroids was given for 2 weeks to optimise lung function in both groups during baseline.<BR/>Drop outs were more likely to be younger and male with lower initial FVC values then the completers.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-08-20 18:39:47 +0200" MODIFIED_BY="Toby J Lasserson" STUDY_ID="STD-Knoell-1998">
<CHAR_METHODS MODIFIED="2008-08-20 18:39:42 +0200" MODIFIED_BY="Toby J Lasserson">
<P>DESIGN: Non-randomised Controlled Trial<BR/>MEANS OF ALLOCATION CONCEALMENT- Inadequate. Subjects alternately assigned to a study group.<BR/>OUTCOME ASSESSOR BLINDING- Yes<BR/>WITHDRAWAL/DROPOUTS - Not described<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Eligible: 188<BR/>Randomised: 100 (Intervention 45, Control 55)<BR/>Completed: 100 (45,55)<BR/>Age: &lt; 25 Int 4 Cont 8, 25 to 65 Int 37, Cont 41, &gt; 65 Int 4 Cont 6.<BR/>Range:<BR/>Sex: Male/Female: Not stated<BR/>Asthma Diagnosis: Based on EPRII guidelines and symptoms.<BR/>Recruitment: Outpatients clinic<BR/>Diseases Included: All adults with asthma<BR/>Major Exclusions: COPD<BR/>Baseline: According to EPRII guidelines: Intermittent Int 4.4% Cont 7.3%, Mild persistent Int 13.3% Cont 16.4%, Moderate Int 77.8% Cont 56.4%, Severe Int 4.4% Cont 20.0%.<BR/> FEV1: <BR/> PEF:<BR/> Exacerbations:</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-08-20 18:39:47 +0200" MODIFIED_BY="Toby J Lasserson">
<P>Setting: Outpatients Clinic<BR/>Type: Joint pharmacist and physician consultation covering general asthma concepts, triggers, medications and written action plan. Provided with diary and instructed in use of peak flow monitoring. Assessed by physician at the clinic.<BR/>Control group received routine outpatient care and were provided with a peak flow meter and diary.<BR/>Duration: 1 x 30-60minutes</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Knowledge, hospitalisation, ER visits, Dr visits, Days off work, quality of life, compliance, quality of care, drug costs, patient satisfaction</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Jadad Score = 2</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Kotses-1995">
<CHAR_METHODS>
<P>DESIGN: Randomised Controlled Trial<BR/>METHOD OF RANDOMISATION: the word "random" stated ; method not described.<BR/>METHOD OF ALLOCATION CONCEALMENT: not described.<BR/>OUTCOME ASSESSOR BLINDING: not stated.<BR/>WITHDRAWAL/DROPOUTS: all subjects accounted for.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Eligible: 126<BR/>Randomised: 85 <BR/>Completed: 76 (Intervention 36; Control 40)<BR/>Age: Overall mean: 49.8 yrs (sd 12.4) Range: 27 to 70 yrs<BR/>Sex: Male / Female 27/49<BR/>Asthma Diagnosis: as per American Thoracic Society <BR/>Recruitment: participants whose asthma was generally under control<BR/>Diseases Included: not specified<BR/>Major exclusions: Fixed airways, concurrent uncontrolled medical conditions, occupational asthma, drug abuse, obesity, low weight, cognitive or intellectual deficits.<BR/>Baseline:<BR/> FEV1: Patients described their asthma as moderate to severe.<BR/> PEF: am (intervention 331+/- 92; control 333 +/- 123.7)<BR/> Exacerbations: not stated</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Setting: not specified (? allergy clinic)<BR/>Type: Education and self monitoring of peak flow and symptoms<BR/>Control: No special education. Controls kept an asthma diary (symptoms and PEF) for 6 months on a daily basis and again for 2 weeks prior to the 12 months follow-up.<BR/>Duration: 7 x 90 minute training sessions 1/week over 7 weeks.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Knowledge, Hospitalisation, ER visits, doctor visits, PEF - evening daily average, quality of life (Beck Depression Inventory, Quality of Well-Being Scale), Wheeze, Exacerbations, Breathing difficulty, Coughing, Chest tightness.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Kotses-1996">
<CHAR_METHODS>
<P>DESIGN: <BR/>METHOD OF RANDOMISATION: Randomised - stated. Method not described.<BR/>MEANS OF ALLOCATION CONCEALMENT- not stated.<BR/>OUTCOME ASSESSOR BLINDING - not stated.<BR/>WITHDRAWAL/DROPOUTS - all subjects accounted for.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Eligible: not stated<BR/>Randomised: 45 <BR/>Completed: 34<BR/>Age: Overall mean: 42 yrs Range: Not stated<BR/>Sex: Male/Female - 7/27<BR/>Asthma Diagnosis: Self Reported moderate asthma for an average of 16.5 years. <BR/>Recruitment: community respondents to advertisements for research participants<BR/>Diseases Included: Not specified<BR/>Major exclusions: Not specified<BR/>Baseline:<BR/> FEV1: not specified.<BR/> PEF: Individual 327 +/-91.6 group 387 +/- 127.7, control 310 +/- 105.2.<BR/> Exacerbations</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Setting: not stated <BR/>Type: Individual: daily self monitoring of PEFR, attacks &amp; contact with precipitants<BR/>Group: Group education and daily PF monitoring<BR/>Duration: Individual: 60 minute one to one session, Group: 2 x 2.5 hr education sessions</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Outcomes measured after one month: ER visits, FEV1-(l/min evening), PEF(l/min evening), Activity Limitation, Asthma Attacks.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Lahdensuo-1996">
<CHAR_METHODS>
<P>DESIGN: Randomised Controlled Trial<BR/>METHOD OF RANDOMISATION: Randomised - blocks of variable sizes and stratified by centre<BR/>MEANS OF ALLOCATION CONCEALMENT- sealed number envelopes.<BR/>OUTCOME ASSESSOR BLINDING - single blind.<BR/>WITHDRAWAL/DROPOUTS - all subjects accounted for.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Eligible: 122<BR/>Randomised: 122 (Intervention 60, Control 62)<BR/>Completed: 115 (Intervention 56, Control 59)<BR/>Age: Overall mean: 41.7 yrs (sd 14.7)<BR/>Sex: Male/Female Intervention 43/59<BR/>Asthma Diagnosis: Objective lung function<BR/>Recruitment: Out patient clinics in Finland - mild to moderately severe asthma.<BR/>Diseases Included: Smokers<BR/>Major exclusions: Not stated<BR/>Baseline:<BR/> FEV1: % Predicted Intervention 82.4 (sd 15.8), Control 81.7 (16.6)<BR/> PEF: <BR/> Exacerbations: No oral corticosteroids in the last 4 weeks before entry.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Setting: Outpatient clinics in Finland <BR/>Type: Optimal self management including a written action plan allowing self adjustment of anti-inflammatory medications according to peak flow, self monitoring of peak flow, regular review within the program and education.<BR/>Duration: At the first visit, one to one education was provided which took an extra 1.5hrs longer then the control visit.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Hosptialisations, Unscheduled doctor visits, FEV1, (%predicted - pre bronchodilator), oral corticosteroids, days off work or school, quality of life, courses of antibiotics, costs.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Jadad Score = 3</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-08-20 18:42:18 +0200" MODIFIED_BY="Toby J Lasserson" STUDY_ID="STD-Levy-2000">
<CHAR_METHODS>
<P>DESIGN: Randomised Controlled Trial<BR/>METHOD OF RANDOMISATION: computer generated equal blocks of 4<BR/>MEANS OF ALLOCATION CONCEALMENT- Random number list<BR/>OUTCOME ASSESSOR BLINDING - blinded<BR/>WITHDRAWAL/DROPOUTS- all participants accounted for.<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Eligible: <BR/>Randomised: 211 (intervention 103, Control 108)<BR/>Completed: 179 (Intervention 83, Control 96).<BR/>Age: Mean(SE) Intervention 43(2), Control 40(2).<BR/>Range: not stated.<BR/>Sex: Male/Female: 80/131<BR/>Asthma Diagnosis: not stated<BR/>Recruitment: prospective rolling recruitment over 13 months through hospital admissions and ER visits.<BR/>Diseases Included:<BR/>Major Exclusions: COPD<BR/>Baseline: severe<BR/> FEV1: <BR/> PEF: % predicted before A&amp;E therapy: Int 49.1%, Cont 44.8%, after therapy Int62.8% Cont 59.5%. <BR/> Exacerbations:</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-08-20 18:42:18 +0200" MODIFIED_BY="Toby J Lasserson">
<P>Setting: Outpatients clinic<BR/>Type: Nurse advice and education of use of self-management plans, recognition and self treatment of uncontrolled asthma and when to seek medical help. Instructed when to step up medication if necessary using PEF or symptoms. Use of "credit card" action plan.<BR/>Control group received usual care.<BR/>Both groups kept 1 week diary cards over 3 periods for data collection.<BR/>Duration: 1x1hr and 2xhalf hr sessions at 6 weekly intervals.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>ER visits, unscheduled &amp; scheduled Dr visits, PEF, rescue medication, inhaled corticosteroids, days off work, symptom score, quality of life.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Jadad Score = 4</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-08-20 18:40:07 +0200" MODIFIED_BY="Toby J Lasserson" STUDY_ID="STD-Mayo-1990">
<CHAR_METHODS>
<P>DESIGN: Randomised controlled cross-over <BR/>METHOD OF RANDOMISATION: The word 'random' stated. Method of randomisation last digit on hospital chart.<BR/>METHOD OF ALLOCATION CONCEALMENT: last digit on hospital chart.<BR/>OUTCOME ASSESSOR BLINDING: not stated.<BR/>WITHDRAWAL/DROPOUTS: all subjects accounted for.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Eligible: 212<BR/>Randomised: 104 (Intervention 47, Control 57; 19 crossed to Intervention)<BR/>Completed: not stated<BR/>Age: Overall mean: 44.3 yrs Range: not stated <BR/>Sex: Male/Female - not stated<BR/>Asthma Diagnosis: American Thoriacic Society<BR/>Recruitment: Outpatients with prior hospitalisation for asthma<BR/>Diseases Included: Not stated<BR/>Major exclusions: Severe alcoholism, overt CNS or mental illness, deaf, mute.<BR/>Baseline: <BR/> FEV1: Not stated<BR/> PEF: Not stated<BR/> Exacerbations Not stated</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-08-20 18:40:07 +0200" MODIFIED_BY="Toby J Lasserson">
<P>Setting: outpatient clinic<BR/>Type: Education, peak flow self monitoring and regular medical review. Patients were encouraged to initiate self-treatment in the event of an exacerbation based on the physician's advice.<BR/>Duration: at least 2 hours one to one discussion with physician</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Skills, Hospitalisation, Mortality, Exacerbations, oral corticosteroids, inhaled corticosteroids.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-08-20 18:42:25 +0200" MODIFIED_BY="Toby J Lasserson" STUDY_ID="STD-Moudgil-2000">
<CHAR_METHODS>
<P>DESIGN: Randomised Controlled Trial<BR/>METHOD OF RANDOMISATION: Computer randomisation<BR/>MEANS OF ALLOCATION CONCEALMENT- Randomised prior to initial appointment<BR/>OUTCOME ASSESSOR BLINDING- open<BR/>WITHDRAWAL/DROPOUTS- all subjects accounted for<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-08-20 18:42:25 +0200" MODIFIED_BY="Toby J Lasserson">
<P>Eligible: 1217<BR/>Randomised: 689 (Intervention 343, Control 346)<BR/>Completed: 593 (Intervention 304, Control 289).<BR/>Age: Overall Mean (sd) 34.5(15) Int 33.6(15.2), Cont 35.4(15.5)<BR/>Range: eligible 11 to 59<BR/>Sex: Male/Female: 337/352<BR/>Asthma Diagnosis: Doctor diagnosis and objective lung function.<BR/>Recruitment: 12 inner-city General Practices<BR/>Diseases Included: not stated<BR/>Major Exclusions: not stated<BR/>Baseline:<BR/>FEV1: Mean (sd) Int 2.4(0.89), Cont 2.42(0.88)<BR/>PEF:<BR/>Exacerbations: n(%) past asthma admissions: Int 115(33.5), Cont 116(33.5)</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Setting: ? at GP practices<BR/>Type: Emphasis on appropriate prescribing, optimising treatment, compliance, knowledge of disease severity. Provision of peak flow meters and diaries for self monitoring throughout 12 months of study. Individual written action plans.<BR/>Controls received usual care.<BR/>Duration: Individual 40 minute sessions reinforced at 4 and 8 months.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-08-20 18:40:14 +0200" MODIFIED_BY="Toby J Lasserson">
<P>Hospitalisation, ER visits, scheduled &amp; unscheduled Dr visits, oral/inhaled corticosteroids, quality of life, antibiotic use.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Jadad Score = 4</P>
<P>White European and Indian subcontinent ethnic groups</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-08-20 18:42:30 +0200" MODIFIED_BY="Toby J Lasserson" STUDY_ID="STD-Mulloy-1996">
<CHAR_METHODS>
<P>DESIGN: <BR/>METHOD OF RANDOMISATION: Randomised - stated. Method not described.<BR/>MEANS OF ALLOCATION CONCEALMENT- not stated.<BR/>OUTCOME ASSESSOR BLINDING - not stated.<BR/>WITHDRAWAL/DROPOUTS - all participants accounted for.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Eligible: Not stated<BR/>Randomised: 60 (Intervention 30, Control 30)<BR/>Completed: 46 (after 1 month: Intervention 18, Control 28) (after 12 months: Intervention 12, Control 21)<BR/>Age: Overall mean: 28.5 years Range: not stated <BR/>Sex: Male/Female: Intervention 47%/53% Control 50%/50%<BR/>Asthma Diagnosis: Objective lung function<BR/>Recruitment: Hospital out patients<BR/>Diseases Included: not stated<BR/>Major exclusions: not stated<BR/>Baseline:<BR/> FEV1: Intervention mean 2.98 Control 2.72<BR/> PEF: mean and standard error of the mean: Intervention 394 (32) Control 361 (22)<BR/> Exacerbations Not stated</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Setting: Outpatient clinic program run by an asthma nurse specialist <BR/>Type: Education via video and booklet, peak flow self monitoring and advised to seek regular review outside the program. <BR/>Duration: one to one session of at least one hour.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-08-20 18:42:30 +0200" MODIFIED_BY="Toby J Lasserson">
<P>Knowledge, Inhaler technique, PEF, FEV1- baseline only, asthma symptom severity</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Neri-1996">
<CHAR_METHODS>
<P>DESIGN: <BR/>METHOD OF RANDOMISATION: Randomised - stated. Method: alternation.<BR/>MEANS OF ALLOCATION CONCEALMENT- Not concealed, participants alternated.<BR/>OUTCOME ASSESSOR BLINDING - not blinded<BR/>WITHDRAWAL/DROPOUTS - all participants accounted for.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Eligible: not stated<BR/>Randomised: 80 (Complete program 40, Reduced program 40)<BR/>Completed: 65 (Complete 33, Reduced 32)<BR/>Age: Overall mean: 45.5 years Range: not stated <BR/>Sex: Male/Female: 25/40<BR/>Asthma Diagnosis: according to international guidelines - Dr diagnosis implied.<BR/>Recruitment: Outpatients department.<BR/>Diseases Included: Smokers<BR/>Major exclusions: not stated<BR/>Baseline:<BR/> FEV1: Complete 78.3 (sd 15.3), Reduced 73.4 (sd 16.9)<BR/> PEF: not stated<BR/> Exacerbations: not stated</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Setting: Asthma School<BR/>Type: Intervention: Group asthma education in an asthma school including a booklet and video. Content included self monitoring of peak flow, interpretation and use of drugs, mechanisms and triggers.<BR/>Control: reduced education program involving self reading of a booklet and peak-flow monitoring and recording.<BR/>Duration: 6 x 1hr lessons in groups of 10. (2 per week for 5 lessons and the last lesson after 3 months as a reinforcer.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>FEV1 (% predicted), admission days, urgent doctor visits, rescue medication, morbidity savings, days of work or school.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-08-20 18:40:30 +0200" MODIFIED_BY="Toby J Lasserson" STUDY_ID="STD-Schott_x002d_Baer-1999">
<CHAR_METHODS>
<P>DESIGN: Randomised Controlled Trial<BR/>METHOD OF RANDOMISATION: Random stated but assigned to groups according to the last digit of their hospital record number -even to intervention, odd to control group.<BR/>MEANS OF ALLOCATION CONCEALMENT- not concealed<BR/>OUTCOME ASSESSOR BLINDING- not stated<BR/>WITHDRAWAL/DROPOUTS-<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-08-20 18:40:26 +0200" MODIFIED_BY="Toby J Lasserson">
<P>Eligible: not stated<BR/>Randomised: 36 (Intervention 17, Control 19)<BR/>Completed: 22 (Intervention 15, Control 7)<BR/>Age: Mean Int 44yrs, Cont 52 yrs<BR/>Range: 24-74 yrs<BR/>Sex: Male / Female: 4 / 32<BR/>Asthma Diagnosis: Doctor diagnosis. Recently diagnosed asthma.<BR/>Recruitment: Outpatient clinics<BR/>Diseases Included:<BR/>Major Exclusions: COPD, chronic bronchitis.<BR/>Baseline:<BR/>FEV1:<BR/>PEF:<BR/>Exacerbations:</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-08-20 18:40:30 +0200" MODIFIED_BY="Toby J Lasserson">
<P>Setting: Outpatients Clinic<BR/>Type: Education on disease process, daily self monitoring, self- management techniques, and daily log completion including peak flow, triggers, and ratings of benefits.<BR/>Controls received standard care and some information on medications and instruction on daily recording of peak flow-not self monitoring diary.<BR/>Duration: 1 x 3hr session -? individual or group. 3 reinforcement phone calls</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Knowledge, ER visits, Peak flow, clinic visits</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Jadad Score = 4</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Shields-1986">
<CHAR_METHODS>
<P>DESIGN: Block randomised according to the number of ER visits or hospitalisations<BR/>METHOD OF RANDOMISATION: Randomised - stated. Method: not described.<BR/>MEANS OF ALLOCATION CONCEALMENT- not described.<BR/>OUTCOME ASSESSOR BLINDING -not described.<BR/>WITHDRAWAL/DROPOUTS - not described.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Eligibility Criteria: &gt; 18 years, at least 1 ER visits or hospitalisation for asthma in prior 4 years.<BR/>Eligible:103<BR/>Randomised: 103<BR/>Completed: 87<BR/>Age: mean: Not specified; Range Not specified.<BR/>Sex: Male/Female - not specified. <BR/>Asthma Diagnosis: Dr diagnosis implied as previously hospitalised or visited ER for asthma<BR/>Recruitment: from prior ER visit or Hospitalisation<BR/>Major exclusions: not specified<BR/>Baseline<BR/> FEV1 not stated;<BR/> PEF not stated, <BR/> Exacerbations: ER visit or hospitalisation in previous 4 years.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Setting: HMO classes<BR/>Type: Group education in 4 x 1.5 hour classes OR telephone counselling. Classes or counselling were followed by telephone follow-up according to individual patients' needs. <BR/>Content: physiology of asthma, medications, respiratory infections, inflammation, use of HMO resources.<BR/>Duration: Classes 4 x 1.5 hours.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>ER visits, cost.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Snyder-1987">
<CHAR_METHODS>
<P>DESIGN: Randomised Controlled Trial<BR/>METHOD OF RANDOMISATION: Random stated. Method not described.<BR/>METHOD OF ALLOCATION CONCEALMENT: not described.<BR/>OUTCOME ASSESSOR BLINDING: unclear<BR/>WITHDRAWAL/DROPOUTS: all subjects accounted for.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Eligible: ?<BR/>Randomised: 79 <BR/>Completed: 75<BR/>Age: Overall mean: 27.6 Range: not stated <BR/>Sex: Male/Female: 34/41<BR/>Asthma Diagnosis: Doctor Diagnosis / Objective Lung Function <BR/>Recruitment: Community volunteers<BR/>Diseases Included: not stated<BR/>Major exclusions: smoking, fixed airway disease, other uncontrolled diseases, substance abuse, potential complicating physical disorders / obesity / little obstruction.<BR/>Baseline:<BR/> FEV1:<BR/> PEF: <BR/> Exacerbations</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Setting: not stated.<BR/>Type: education and probably peak flow self-monitoring<BR/>Duration: 2 x 2.5 hrs group education sessions</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Knowledge, hospital visits, ER visits, Doctor visits, quality of life (asthma attitude survey for adults), days of work, amounts and type of medications for asthma, exacerbations.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Outcomes data are not provided in a form appropriate for meta-analysis. Several attempts have been made to contact the authors.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Sommaruga-1995">
<CHAR_METHODS>
<P>DESIGN: <BR/>METHOD OF RANDOMISATION: Randomised - stated. Method not described.<BR/>MEANS OF ALLOCATION CONCEALMENT- not stated.<BR/>OUTCOME ASSESSOR BLINDING - not stated.<BR/>WITHDRAWAL/DROPOUTS - all participants accounted for.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Eligible: not stated<BR/>Randomised: 40 (Intervention 20, Control 20)<BR/>Completed: 36 (Intervention 20, Control 16)<BR/>Age: Overall mean: 48 Range: +/-16 yrs <BR/>Sex: Male/Female : 21/19<BR/>Asthma Diagnosis: Dr diagnosis implied: International Guidelines<BR/>Recruitment: Hospital inpatients at a Respiratory Medical Centre<BR/>Diseases Included: Not stated<BR/>Major exclusions: Not stated<BR/>Baseline:<BR/> FEV1: 76+/- 18% predicted before and 94+/- 5% predicted after salbutamol.<BR/> PEF: not stated<BR/> Exacerbations: not stated.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Setting: Inpatient education programme <BR/>Type: Education, peak flow medications and symptoms self monitoring, medical review every 2 months with the same physician, written action plan allowing the patient to alter medications in response to worsening asthma. (plus a psychological intervention).<BR/>Duration: 2 lessons during admissions of unknown duration and quarterly lessons during the ensuring year.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Hospitalisation, ER visits, Days off work, Asthma Attacks, Resp. Illness Opinion Survey, Health Locus of Control, STA1 x 2 (anxiety, AD (Depression) APF (psychophysiological disorders), Asthma Symptom Checklist. - Only reported the psychological outcomes.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Jadad Score = 3</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-08-20 18:40:38 +0200" MODIFIED_BY="Toby J Lasserson" STUDY_ID="STD-Wilson-1993">
<CHAR_METHODS MODIFIED="2008-08-20 18:40:38 +0200" MODIFIED_BY="Toby J Lasserson">
<P>DESIGN: Randomised controlled trial.<BR/>METHOD OF RANDOMISATION: Random stated. Blocked according to severity. Method not described.<BR/>METHOD OF ALLOCATION CONCEALMENT: not described.<BR/>OUTCOME ASSESSOR BLINDING: physicians who assessed asthma status were blinded as to group assignment of patients. Unclear whether the nurse who administered questionnaires and assessed MDI technique was blinded.<BR/>WITHDRAWAL/DROPOUTS: participants not accounted for.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Eligible: 579<BR/>Randomised: 323 (at 5 months = 271) (at 12 months = 277)<BR/>Completed: not described<BR/>Age: (eligibility was 18 to 50 years) Overall mean: ? Group mean ? Individual mean ?; Information Only mean ? Range: ? (p566 "no significant difference with respect to gender, age, level of education, asthma severity.<BR/>Sex: Male/Female - not stated - see above<BR/>Asthma Diagnosis: Dr diagnosis and objective lung function<BR/>Recruitment: Community: patients of the Kaiser Medical Centers in California.<BR/>Included: Moderate - severe asthma, Dr's diagnosis.<BR/>Major exclusions: Irreversible respiratory disease, emphysema, COPD.<BR/>Baseline: recurrent wheeziness<BR/> FEV1: &gt; 15% change <BR/> PEF: 20% variability<BR/> Exacerbations: History of recurrent episodes of wheezing and/or objective evidence of airflow obstruction during episodes and improved airflow when treated with a bronchodilator.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Setting: Kaiser Permanente Patients <BR/>Type: 3 Types of intervention as follows:<BR/>(1) Group education, symptoms and peak flow monitoring, reviewed at 5 and 12 months.<BR/>(2) Individual education, (as per intervention 1 except individual education).<BR/>(3) Information Only control: patients were given a workbook to read and reviewed at 5 and 12 months.<BR/>Controls were given no special education but were reviewed at 5 and 12 months.<BR/>Duration: Individual - 180 minutes per patient, Group 45 to 60 minutes per patient.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Knowledge, hospitalisation, ER Visits, PEF (l/min), FEV1(% predicted), rescue medication, oral corticosteroids, inhaled corticosteroids, symptomatic days, physician evaluation of asthma status, relative bother, change in physical activity, improvement in bedroom environment, inhaler technique.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-08-20 18:40:42 +0200" MODIFIED_BY="Toby J Lasserson" STUDY_ID="STD-Yoon-1993">
<CHAR_METHODS>
<P>DESIGN: Randomised Controlled Trial<BR/>METHOD OF RANDOMISATION: Random stated. Method not described.<BR/>METHOD OF ALLOCATION CONCEALMENT: not described.<BR/>OUTCOME ASSESSOR BLINDING: not stated.<BR/>WITHDRAWAL/DROPOUTS: all participants accounted for.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-08-20 18:40:42 +0200" MODIFIED_BY="Toby J Lasserson">
<P>Eligible: not stated<BR/>Randomised: 76 (Intervention 37, Control 39)<BR/>Completed: 56 after 10 months<BR/>Age: Overall mean: 32yrs Range: 16 to 65 years<BR/>Sex: Male/Female: not stated<BR/>Asthma Diagnosis: Objective Lung Function<BR/>Recruitment: hospital admission for asthma<BR/>Diseases Included: not stated<BR/>Major exclusions: irreversible airway obstruction, significant concurrent diseases.<BR/>Baseline:<BR/>FEV1: reversibility of at least 15% predicted.<BR/>PEF: not stated<BR/>Exacerbations: not stated.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Setting: Asthma education centre connected with a tertiary teaching hospital <BR/>Type: Optimal self management including education, peak flow self monitoring, regular review and a written action plan enabling self adjustment of medications based on peak flow for worsening asthma. <BR/>Duration: 3 hours total</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Knowledge, Hospitalisation, ER visits, Lung function (l/min), Inhaled corticosteroids, quality of life (psychosocial disturbance du to asthma) days off work, wheeze (frequency and severity).</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-08-20 18:43:06 +0200" MODIFIED_BY="Toby J Lasserson" STUDY_ID="STD-Zeiger-1991">
<CHAR_METHODS MODIFIED="2008-08-20 18:43:03 +0200" MODIFIED_BY="Toby J Lasserson">
<P>DESIGN: Controlled Clinical Trial<BR/>METHOD OF RANDOMISATION: Not randomised<BR/>MEANS OF ALLOCATION CONCEALMENT- alternation / day of their ER visit, not concealed.<BR/>OUTCOME ASSESSOR BLINDING - "evaluated blindly" - p1160.<BR/>WITHDRAWAL/DROPOUTS - all subjects accounted for.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Eligible: not stated<BR/>Randomised: 309 (Intervention 149, Control 160)<BR/>Completed: 249 (Intervention 110, Control 139)<BR/>Age: Overall mean: 24.4 sd: 14.5 <BR/>Sex: Male/Female: 42.6%/57.4%<BR/>Asthma Diagnosis: as per American Thoracic Society<BR/>Recruitment: Emergency Room<BR/>Diseases Included: smokers<BR/>Major exclusions: previous allergy or pulmonary care. COPD<BR/>Baseline:<BR/> FEV1: not stated<BR/> PEF: % pred. on admission: mean (sd) Intervention 46.7 (19.9), Control 52 (24.9)<BR/> Exacerbations acute wheezing or dyspnea at the time of the index visit.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Setting: Allergy Clinic - HMO<BR/>Type: Expedited allegy assessment and education; peak flow self monitoring, regular review and written action plan enabling self adjustment of medications in response to worsening asthma <BR/>Duration: one to one sessions of unknown number and duration.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Hospitalisation, ER Visits, Inhaled Corticosteroids, Nocturnal Asthma, Perception of Asthma.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2008-08-20 18:43:06 +0200" MODIFIED_BY="Toby J Lasserson">
<P>Possible contamination: 21 control subjects referred to an allergist</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_INCLUDED_STUDIES>
<CHARACTERISTICS_OF_EXCLUDED_STUDIES SORT_BY="STUDY">
<EXCLUDED_CHAR STUDY_ID="STD-Abdulwadud-1997">
<CHAR_REASON_FOR_EXCLUSION>
<P>Baseline data only</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Adams-2001">
<CHAR_REASON_FOR_EXCLUSION>
<P>Comparison of two educational interventions</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Aiolfi-1995">
<CHAR_REASON_FOR_EXCLUSION>
<P>Information only education</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Amirav-1995">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not patient education</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Ayres-1996">
<CHAR_REASON_FOR_EXCLUSION>
<P>Comparison of two educational interventions</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Baldwin-1997">
<CHAR_REASON_FOR_EXCLUSION>
<P>Comparison of two educational interventions</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Bolton-1991">
<CHAR_REASON_FOR_EXCLUSION>
<P>Information only education</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Boulet-1995">
<CHAR_REASON_FOR_EXCLUSION>
<P>Methodological problems</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Charlton-1990">
<CHAR_REASON_FOR_EXCLUSION>
<P>Comparison of two educational interventions</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Cote-2001">
<CHAR_REASON_FOR_EXCLUSION>
<P>Comparison of two educational interventions</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Cox-1993">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not an education intervention</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Erickson-1998">
<CHAR_REASON_FOR_EXCLUSION>
<P>Sample size too small, not an RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Gergen-1995">
<CHAR_REASON_FOR_EXCLUSION>
<P>Non-RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Graft-1991">
<CHAR_REASON_FOR_EXCLUSION>
<P>Non-RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Grainger_x002d_Rousseau">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not randomised. Children included. Mean age unknown</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Grampian-1994b">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not education intervention</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Hausen-1999">
<CHAR_REASON_FOR_EXCLUSION>
<P>Non-RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Heringa-1987">
<CHAR_REASON_FOR_EXCLUSION>
<P>Inappropriate outcomes</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Hindi_x002d_Alexander-1987">
<CHAR_REASON_FOR_EXCLUSION>
<P>non-RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Hoskins-1996">
<CHAR_REASON_FOR_EXCLUSION>
<P>Methodological problems</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Huss-1992">
<CHAR_REASON_FOR_EXCLUSION>
<P>Information only education</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Jackevicius-1999">
<CHAR_REASON_FOR_EXCLUSION>
<P>Inhaler technique</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Janson_x002d_Bjerklie-1988">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not an education intervention</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Jenkinson-1988">
<CHAR_REASON_FOR_EXCLUSION>
<P>Information only education</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Jones-1987">
<CHAR_REASON_FOR_EXCLUSION>
<P>Outcomes not appropriate</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Kauppinen-1998">
<CHAR_REASON_FOR_EXCLUSION>
<P>Comparison of two educational interventions</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Kelso-1995">
<CHAR_REASON_FOR_EXCLUSION>
<P>Non-RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Klein-2001">
<CHAR_REASON_FOR_EXCLUSION>
<P>Comparison of two educational interventions</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-LeBaron-1985">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not an education intervention</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Legorreta--2000">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not an RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Lirsac-1991">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not a education intervention</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Lopez_x002d_Vina-2000">
<CHAR_REASON_FOR_EXCLUSION>
<P>Comparison of two educational interventions</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Maes-1988">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not an education intervention</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Maiman-1979">
<CHAR_REASON_FOR_EXCLUSION>
<P>Information only education</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Moldofsky-1979">
<CHAR_REASON_FOR_EXCLUSION>
<P>Information only education</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Muhlhauser-1991">
<CHAR_REASON_FOR_EXCLUSION>
<P>Non-RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Osman-1994">
<CHAR_REASON_FOR_EXCLUSION>
<P>Information only education</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Perdomo_x002d_Ponce-1996">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not an RCT. Focus on allergic diseases and therapeutic compliance</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Petro-1995">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not predominantly asthma</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Premaratne-1999">
<CHAR_REASON_FOR_EXCLUSION>
<P>Nurse education</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Ringsberg-1990">
<CHAR_REASON_FOR_EXCLUSION>
<P>Information only education</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Rydman-1999">
<CHAR_REASON_FOR_EXCLUSION>
<P>Inhaler technique</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Sondergaard-1992">
<CHAR_REASON_FOR_EXCLUSION>
<P>Information only education</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Thapar-1994">
<CHAR_REASON_FOR_EXCLUSION>
<P>Information only education</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Tougaard-1992">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not predominantly asthma</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Turner-1998">
<CHAR_REASON_FOR_EXCLUSION>
<P>Comparison of two educational interventions</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Verver-1996">
<CHAR_REASON_FOR_EXCLUSION>
<P>Inhaler technique only</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-White-1989">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not patient education</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_EXCLUDED_STUDIES>
<CHARACTERISTICS_OF_AWAITING_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<AWAITING_CHAR STUDY_ID="STD-Im--1993">
<CHAR_METHODS/>
<CHAR_PARTICIPANTS/>
<CHAR_INTERVENTIONS/>
<CHAR_OUTCOMES/>
<CHAR_NOTES/>
</AWAITING_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_AWAITING_STUDIES>
<CHARACTERISTICS_OF_ONGOING_STUDIES MODIFIED="2008-08-20 18:44:31 +0200" MODIFIED_BY="Toby J Lasserson" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<ONGOING_CHAR MODIFIED="2008-08-20 18:44:28 +0200" MODIFIED_BY="Toby J Lasserson" STUDY_ID="STD-Ford-1996">
<CHAR_STUDY_NAME MODIFIED="2008-08-20 18:44:28 +0200" MODIFIED_BY="Toby J Lasserson">
<P>An empowerment-centered, church-based asthma education program for African American adults</P>
</CHAR_STUDY_NAME>
<CHAR_METHODS/>
<CHAR_PARTICIPANTS>
<P>African-American adults with asthma</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>General physiology of asthma, , identification of stressors, problem solving, medications, PEF monitoring</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>knowledge, ED visits, PEFV and inhaler technique, quality of life, perceived illness</P>
</CHAR_OUTCOMES>
<CHAR_STARTING_DATE>
<P>1996</P>
</CHAR_STARTING_DATE>
<CHAR_CONTACT_INFORMATION/>
<CHAR_NOTES/>
</ONGOING_CHAR>
<ONGOING_CHAR MODIFIED="2008-08-20 18:44:31 +0200" MODIFIED_BY="Toby J Lasserson" STUDY_ID="STD-Ploska-1999">
<CHAR_STUDY_NAME>
<P>An education based hospital nursing programme in the treatment of asthma</P>
</CHAR_STUDY_NAME>
<CHAR_METHODS/>
<CHAR_PARTICIPANTS>
<P>Moderate asthmatics<BR/>No. of participants: 80<BR/>Age group: 18-75<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS/>
<CHAR_OUTCOMES MODIFIED="2008-08-20 18:44:31 +0200" MODIFIED_BY="Toby J Lasserson">
<P>Respiratory function tests, use of corticosteroid/bronchodilator treatments, quality of life</P>
</CHAR_OUTCOMES>
<CHAR_STARTING_DATE>
<P>Unknown</P>
</CHAR_STARTING_DATE>
<CHAR_CONTACT_INFORMATION/>
<CHAR_NOTES/>
</ONGOING_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_ONGOING_STUDIES>
</CHARACTERISTICS_OF_STUDIES>
<QUALITY_ITEMS MODIFIED="2008-08-20 18:44:17 +0200" MODIFIED_BY="Toby J Lasserson">
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-01" LEVEL="STUDY" NO="1">
<NAME>Adequate sequence generation?</NAME>
<DESCRIPTION>
<P>Was the allocation sequence adequately generated?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-02" LEVEL="STUDY" MODIFIED="2008-08-20 18:44:17 +0200" MODIFIED_BY="Toby J Lasserson" NO="2">
<NAME>Allocation concealment?</NAME>
<DESCRIPTION>
<P>Was allocation adequately concealed?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-08-20 18:36:38 +0200" MODIFIED_BY="Toby J Lasserson" RESULT="NO" STUDY_ID="STD-Abdulwadud-1999">
<DESCRIPTION>
<P>Study investigators aware as to order of treatment group assignment (Cochrane Grade C)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-08-20 18:37:31 +0200" MODIFIED_BY="Toby J Lasserson" RESULT="YES" STUDY_ID="STD-Allen-1995">
<DESCRIPTION>
<P>Study investigators unaware as to order of treatment group assignment (Cochrane Grade A) </P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-08-20 18:38:17 +0200" MODIFIED_BY="Toby J Lasserson" RESULT="YES" STUDY_ID="STD-Bailey-1990">
<DESCRIPTION>
<P>Study investigators unaware as to order of treatment group assignment (Cochrane Grade A)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-08-20 18:38:40 +0200" MODIFIED_BY="Toby J Lasserson" RESULT="YES" STUDY_ID="STD-Bailey-1999">
<DESCRIPTION>
<P>Study investigators unaware as to order of treatment group assignment (Cochrane Grade A)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-08-20 18:38:57 +0200" MODIFIED_BY="Toby J Lasserson" RESULT="UNKNOWN" STUDY_ID="STD-Berg-1997">
<DESCRIPTION>
<P>Information not available (Cochrane Grade B)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-08-20 18:41:05 +0200" MODIFIED_BY="Toby J Lasserson" RESULT="UNKNOWN" STUDY_ID="STD-Blixen-2001">
<DESCRIPTION>
<P>Information not available (Cochrane Grade B)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-08-20 18:43:30 +0200" MODIFIED_BY="Toby J Lasserson" RESULT="NO" STUDY_ID="STD-Brewin-1995">
<DESCRIPTION>
<P>Study investigators aware as to order of treatment group assignment (Cochrane Grade C)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-08-20 18:41:09 +0200" MODIFIED_BY="Toby J Lasserson" RESULT="UNKNOWN" STUDY_ID="STD-Cote-1997">
<DESCRIPTION>
<P>Information not available (Cochrane Grade B)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-08-20 18:39:11 +0200" MODIFIED_BY="Toby J Lasserson" RESULT="YES" STUDY_ID="STD-Cowie-1997">
<DESCRIPTION>
<P>Study investigators unaware as to order of treatment group assignment (Cochrane Grade A)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-08-20 18:41:23 +0200" MODIFIED_BY="Toby J Lasserson" RESULT="UNKNOWN" STUDY_ID="STD-Gallefoss-1999">
<DESCRIPTION>
<P>Information not available (Cochrane Grade B)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-08-20 18:39:18 +0200" MODIFIED_BY="Toby J Lasserson" RESULT="YES" STUDY_ID="STD-Garret-1994">
<DESCRIPTION>
<P>Study investigators unaware as to order of treatment group assignment (Cochrane Grade A)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-08-20 18:41:32 +0200" MODIFIED_BY="Toby J Lasserson" RESULT="UNKNOWN" STUDY_ID="STD-George-1999">
<DESCRIPTION>
<P>Information not available (Cochrane Grade B)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-08-20 18:41:37 +0200" MODIFIED_BY="Toby J Lasserson" RESULT="UNKNOWN" STUDY_ID="STD-Ghosh-1998">
<DESCRIPTION>
<P>Information not available (Cochrane Grade B)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-08-20 18:41:40 +0200" MODIFIED_BY="Toby J Lasserson" RESULT="UNKNOWN" STUDY_ID="STD-Grampian-1994">
<DESCRIPTION>
<P>Information not available (Cochrane Grade B)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-08-20 18:41:48 +0200" MODIFIED_BY="Toby J Lasserson" RESULT="UNKNOWN" STUDY_ID="STD-Hayward-1996">
<DESCRIPTION>
<P>Information not available (Cochrane Grade B)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-08-20 18:41:52 +0200" MODIFIED_BY="Toby J Lasserson" RESULT="UNKNOWN" STUDY_ID="STD-Heard-1999">
<DESCRIPTION>
<P>Information not available (Cochrane Grade B)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-08-20 18:41:57 +0200" MODIFIED_BY="Toby J Lasserson" RESULT="UNKNOWN" STUDY_ID="STD-Hilton-1986">
<DESCRIPTION>
<P>Information not available (Cochrane Grade B)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-08-20 18:43:47 +0200" MODIFIED_BY="Toby J Lasserson" RESULT="NO" STUDY_ID="STD-Ignacio_x002d_Garcia-1995">
<DESCRIPTION>
<P>Study investigators aware as to order of treatment group assignment (Cochrane Grade C)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-08-20 18:42:04 +0200" MODIFIED_BY="Toby J Lasserson" RESULT="UNKNOWN" STUDY_ID="STD-Jones-1995">
<DESCRIPTION>
<P>Information not available (Cochrane Grade B)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-08-20 18:43:52 +0200" MODIFIED_BY="Toby J Lasserson" RESULT="NO" STUDY_ID="STD-Knoell-1998">
<DESCRIPTION>
<P>Study investigators aware as to order of treatment group assignment (Cochrane Grade C)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-08-20 18:42:09 +0200" MODIFIED_BY="Toby J Lasserson" RESULT="UNKNOWN" STUDY_ID="STD-Kotses-1995">
<DESCRIPTION>
<P>Information not available (Cochrane Grade B)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-08-20 18:42:12 +0200" MODIFIED_BY="Toby J Lasserson" RESULT="UNKNOWN" STUDY_ID="STD-Kotses-1996">
<DESCRIPTION>
<P>Information not available (Cochrane Grade B)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-08-20 18:39:56 +0200" MODIFIED_BY="Toby J Lasserson" RESULT="YES" STUDY_ID="STD-Lahdensuo-1996">
<DESCRIPTION>
<P>Study investigators unaware as to order of treatment group assignment (Cochrane Grade A)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-08-20 18:40:01 +0200" MODIFIED_BY="Toby J Lasserson" RESULT="YES" STUDY_ID="STD-Levy-2000">
<DESCRIPTION>
<P>Study investigators unaware as to order of treatment group assignment (Cochrane Grade A)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-08-20 18:44:00 +0200" MODIFIED_BY="Toby J Lasserson" RESULT="NO" STUDY_ID="STD-Mayo-1990">
<DESCRIPTION>
<P>Study investigators aware as to order of treatment group assignment (Cochrane Grade C)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-08-20 18:40:18 +0200" MODIFIED_BY="Toby J Lasserson" RESULT="YES" STUDY_ID="STD-Moudgil-2000">
<DESCRIPTION>
<P>Study investigators unaware as to order of treatment group assignment (Cochrane Grade A) </P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-08-20 18:42:36 +0200" MODIFIED_BY="Toby J Lasserson" RESULT="UNKNOWN" STUDY_ID="STD-Mulloy-1996">
<DESCRIPTION>
<P>Information not available (Cochrane Grade B)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-08-20 18:44:05 +0200" MODIFIED_BY="Toby J Lasserson" RESULT="NO" STUDY_ID="STD-Neri-1996">
<DESCRIPTION>
<P>Study investigators aware as to order of treatment group assignment (Cochrane Grade C)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-08-20 18:44:09 +0200" MODIFIED_BY="Toby J Lasserson" RESULT="NO" STUDY_ID="STD-Schott_x002d_Baer-1999">
<DESCRIPTION>
<P>Study investigators aware as to order of treatment group assignment (Cochrane Grade C)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-08-20 18:42:46 +0200" MODIFIED_BY="Toby J Lasserson" RESULT="UNKNOWN" STUDY_ID="STD-Shields-1986">
<DESCRIPTION>
<P>Information not available (Cochrane Grade B)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-08-20 18:42:49 +0200" MODIFIED_BY="Toby J Lasserson" RESULT="UNKNOWN" STUDY_ID="STD-Snyder-1987">
<DESCRIPTION>
<P>Information not available (Cochrane Grade B)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-08-20 18:42:53 +0200" MODIFIED_BY="Toby J Lasserson" RESULT="UNKNOWN" STUDY_ID="STD-Sommaruga-1995">
<DESCRIPTION>
<P>Information not available (Cochrane Grade B)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-08-20 18:42:57 +0200" MODIFIED_BY="Toby J Lasserson" RESULT="UNKNOWN" STUDY_ID="STD-Wilson-1993">
<DESCRIPTION>
<P>Information not available (Cochrane Grade B)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-08-20 18:43:00 +0200" MODIFIED_BY="Toby J Lasserson" RESULT="UNKNOWN" STUDY_ID="STD-Yoon-1993">
<DESCRIPTION>
<P>Information not available (Cochrane Grade B)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-08-20 18:44:17 +0200" MODIFIED_BY="Toby J Lasserson" RESULT="NO" STUDY_ID="STD-Zeiger-1991">
<DESCRIPTION>
<P>Study investigators aware as to order of treatment group assignment (Cochrane Grade C)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-08-20 18:41:17 +0200" MODIFIED_BY="Toby J Lasserson" RESULT="UNKNOWN" STUDY_ID="STD-de-Oliveira-1999">
<DESCRIPTION>
<P>Information not available (Cochrane Grade B)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-03" LEVEL="GROUP" NO="3">
<NAME>Blinding?</NAME>
<DESCRIPTION>
<P>Was knowledge of the allocated interventions adequately prevented during the study?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-04" LEVEL="GROUP" NO="4">
<NAME>Incomplete outcome data addressed?</NAME>
<DESCRIPTION>
<P>Were incomplete outcome data adequately addressed?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-05" LEVEL="STUDY" NO="5">
<NAME>Free of selective reporting?</NAME>
<DESCRIPTION>
<P>Are reports of the study free of suggestion of selective outcome reporting?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-06" LEVEL="STUDY" NO="6">
<NAME>Free of other bias?</NAME>
<DESCRIPTION>
<P>Was the study apparently free of other problems that could put it at a high risk of bias?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
</QUALITY_ITEMS>
<SOF_TABLES/>
<ADDITIONAL_TABLES/>
<ANALYSES_AND_DATA CALCULATED_DATA="YES">
<COMPARISON ID="CMP-001" NO="1">
<NAME>Self Management versus Usual Care</NAME>
<DICH_OUTCOME CHI2="8.096032374053545" CI_END="0.8163288811228" CI_START="0.5004524673470971" CI_STUDY="95" CI_TOTAL="95" DF="11.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.6391664906146132" ESTIMABLE="YES" EVENTS_1="85" EVENTS_2="139" I2="0.0" I2_Q="0.0" ID="CMP-001.01" LOG_CI_END="-0.088134838205491" LOG_CI_START="-0.3006371652359559" LOG_EFFECT_SIZE="-0.19438600172072348" METHOD="MH" NO="1" P_CHI2="0.7046765603521461" P_Q="0.0" P_Z="3.361174684305116E-4" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="12" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="1200" TOTAL_2="1218" WEIGHT="100.0" Z="3.5857448508480507">
<NAME>Hospitalisations (% subjects hospitalised)</NAME>
<GROUP_LABEL_1>Self Management</GROUP_LABEL_1>
<GROUP_LABEL_2>Usual Care</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Self M'gment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Usual Care</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="6.630838138309951" CI_END="0.76821810745973" CI_START="0.43164743682393997" DF="8.0" EFFECT_SIZE="0.5758466610189995" ESTIMABLE="YES" EVENTS_1="59" EVENTS_2="101" I2="0.0" ID="CMP-001.01.01" LOG_CI_END="-0.11451546041327751" LOG_CI_START="-0.36487083363970896" LOG_EFFECT_SIZE="-0.23969314702649325" NO="1" P_CHI2="0.5769344556960122" P_Z="1.747415637565301E-4" STUDIES="9" TAU2="0.0" TOTAL_1="905" TOTAL_2="903" WEIGHT="75.39357904575705" Z="3.7529846430585203">
<NAME>Optimal Self Management</NAME>
<DICH_DATA CI_END="7.380245497582827" CI_START="0.15804352312968703" EFFECT_SIZE="1.08" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" LOG_CI_END="0.8680708084994968" LOG_CI_START="-0.8012232975255974" LOG_EFFECT_SIZE="0.03342375548694973" ORDER="1079" O_E="0.0" SE="0.9805516210182315" STUDY_ID="STD-Cote-1997" TOTAL_1="50" TOTAL_2="54" VAR="0.9614814814814815" WEIGHT="1.417311705374565"/>
<DICH_DATA CI_END="1.6360939812979192" CI_START="0.0739462330101047" EFFECT_SIZE="0.34782608695652173" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="6" LOG_CI_END="0.21380824700449275" LOG_CI_START="-1.1310839450557915" LOG_EFFECT_SIZE="-0.4586378490256493" ORDER="1080" O_E="0.0" SE="0.7899963309399295" STUDY_ID="STD-Cowie-1997" TOTAL_1="46" TOTAL_2="48" VAR="0.6240942028985507" WEIGHT="4.327927147986331"/>
<DICH_DATA CI_END="1.0472808165773488" CI_START="0.5204581114162999" EFFECT_SIZE="0.7382857142857143" ESTIMABLE="YES" EVENTS_1="38" EVENTS_2="50" LOG_CI_END="0.020063148477119916" LOG_CI_START="-0.2836142185315782" LOG_EFFECT_SIZE="-0.13177553502722913" ORDER="1081" O_E="0.0" SE="0.17838158860811976" STUDY_ID="STD-Ghosh-1998" TOTAL_1="140" TOTAL_2="136" VAR="0.03181999115435648" WEIGHT="37.384163822923306"/>
<DICH_DATA CI_END="1.9491517604210322" CI_START="0.07708796246219675" EFFECT_SIZE="0.38762886597938145" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="5" LOG_CI_END="0.289845654483215" LOG_CI_START="-1.1130134331603827" LOG_EFFECT_SIZE="-0.4115838893385838" ORDER="1082" O_E="0.0" SE="0.8240463723463287" STUDY_ID="STD-Heard-1999" TOTAL_1="97" TOTAL_2="94" VAR="0.6790524237771441" WEIGHT="3.7428901790101072"/>
<DICH_DATA CI_END="1.5841806669505898" CI_START="0.005216868872554625" EFFECT_SIZE="0.09090909090909091" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="5" LOG_CI_END="0.199804708936189" LOG_CI_START="-2.282590079252639" LOG_EFFECT_SIZE="-1.041392685158225" ORDER="1083" O_E="0.0" SE="1.4581709866344983" STUDY_ID="STD-Ignacio_x002d_Garcia-1995" TOTAL_1="35" TOTAL_2="35" VAR="2.1262626262626263" WEIGHT="4.053511477371256"/>
<DICH_DATA CI_END="4.0477093442870125" CI_START="0.12188103450754895" EFFECT_SIZE="0.7023809523809523" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="3" LOG_CI_END="0.6072093193692156" LOG_CI_START="-0.9140638682086906" LOG_EFFECT_SIZE="-0.1534272744197375" ORDER="1084" O_E="0.0" SE="0.8936034008069897" STUDY_ID="STD-Lahdensuo-1996" TOTAL_1="56" TOTAL_2="59" VAR="0.7985270379338175" WEIGHT="2.1533278362003823"/>
<DICH_DATA CI_END="1.1248791098422402" CI_START="0.24796915182505025" EFFECT_SIZE="0.5281432748538012" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="18" LOG_CI_END="0.05110585155893011" LOG_CI_START="-0.6056023434699539" LOG_EFFECT_SIZE="-0.2772482459555119" ORDER="1085" O_E="0.0" SE="0.3857536445179595" STUDY_ID="STD-Moudgil-2000" TOTAL_1="304" TOTAL_2="289" VAR="0.14880587425888828" WEIGHT="13.601603436563243"/>
<DICH_DATA CI_END="1.0863737507704487" CI_START="0.01878558208059868" EFFECT_SIZE="0.14285714285714285" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="7" LOG_CI_END="0.03597926353319491" LOG_CI_START="-1.7261753435617087" LOG_EFFECT_SIZE="-0.8450980400142569" ORDER="1086" O_E="0.0" SE="1.035098339013531" STUDY_ID="STD-Yoon-1993" TOTAL_1="28" TOTAL_2="28" VAR="1.0714285714285712" WEIGHT="5.1590146075634165"/>
<DICH_DATA CI_END="2.1803984376839485" CI_START="0.08461581639230847" EFFECT_SIZE="0.42953020134228187" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="5" LOG_CI_END="0.3385358621717097" LOG_CI_START="-1.0725484510284835" LOG_EFFECT_SIZE="-0.3670062944283869" ORDER="1087" O_E="0.0" SE="0.8288779105537961" STUDY_ID="STD-Zeiger-1991" TOTAL_1="149" TOTAL_2="160" VAR="0.6870385906040268" WEIGHT="3.553828832764443"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.3911131310762757" CI_START="0.4527607546922514" DF="0.0" EFFECT_SIZE="0.7936254980079681" ESTIMABLE="YES" EVENTS_1="20" EVENTS_2="25" I2="0.0" ID="CMP-001.01.02" LOG_CI_END="0.14336245005264103" LOG_CI_START="-0.3441312248393575" LOG_EFFECT_SIZE="-0.10038438739335821" NO="2" P_CHI2="1.0" P_Z="0.419557567246859" STUDIES="1" TAU2="0.0" TOTAL_1="251" TOTAL_2="249" WEIGHT="18.498752378548822" Z="0.8071890735595187">
<NAME>Self Monitoring and Regular Review</NAME>
<DICH_DATA CI_END="1.3911131310762759" CI_START="0.45276075469225135" EFFECT_SIZE="0.7936254980079681" ESTIMABLE="YES" EVENTS_1="20" EVENTS_2="25" LOG_CI_END="0.14336245005264112" LOG_CI_START="-0.34413122483935754" LOG_EFFECT_SIZE="-0.10038438739335821" ORDER="1088" O_E="0.0" SE="0.2863561977641692" STUDY_ID="STD-Garret-1994" TOTAL_1="251" TOTAL_2="249" VAR="0.08199987199795197" WEIGHT="18.498752378548822"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.22524252611418444" CI_END="2.207717045156322" CI_START="0.41135361481823274" DF="1.0" EFFECT_SIZE="0.9529702970297032" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="13" I2="0.0" ID="CMP-001.01.03" LOG_CI_END="0.3439434107230114" LOG_CI_START="-0.3857846819272198" LOG_EFFECT_SIZE="-0.020920635602104207" NO="3" P_CHI2="0.6350741036619405" P_Z="0.9105215241356233" STUDIES="2" TAU2="0.0" TOTAL_1="44" TOTAL_2="66" WEIGHT="6.107668575694126" Z="0.11238074216080458">
<NAME>Self Monitoring Only</NAME>
<DICH_DATA CI_END="2.852485279834384" CI_START="0.42419149664122124" EFFECT_SIZE="1.1" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="10" LOG_CI_END="0.45522341193225224" LOG_CI_START="-0.3724380416158022" LOG_EFFECT_SIZE="0.04139268515822507" ORDER="1089" O_E="0.0" SE="0.4861724348043977" STUDY_ID="STD-Brewin-1995" TOTAL_1="12" TOTAL_2="33" VAR="0.23636363636363636" WEIGHT="3.9306777962387933"/>
<DICH_DATA CI_END="3.8464669410552284" CI_START="0.12288062194298566" EFFECT_SIZE="0.6875" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="3" LOG_CI_END="0.5850620041911614" LOG_CI_START="-0.9105165991865608" LOG_EFFECT_SIZE="-0.16272729749769974" ORDER="1090" O_E="0.0" SE="0.8785102748575585" STUDY_ID="STD-Neri-1996" TOTAL_1="32" TOTAL_2="33" VAR="0.771780303030303" WEIGHT="2.176990779455332"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="1.9292904298410336" CI_END="0.15345949885788027" CI_START="-0.16639648380824199" CI_STUDY="95" CI_TOTAL="95" DF="2.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.006468492475180868" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-001.02" NO="2" P_CHI2="0.3811184711363562" P_Q="1.0" P_Z="0.9368152795197529" Q="0.0" RANDOM="NO" SCALE="4.0" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="367" TOTAL_2="377" UNITS="" WEIGHT="100.0" Z="0.07927325404356522">
<NAME>Hospitalisations (mean)</NAME>
<GROUP_LABEL_1>Self Management</GROUP_LABEL_1>
<GROUP_LABEL_2>Usual Care</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Self M'gment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Usual Care</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="1.9292904298410336" CI_END="0.15345949885788027" CI_START="-0.16639648380824199" DF="2.0" EFFECT_SIZE="-0.006468492475180868" ESTIMABLE="YES" I2="0.0" ID="CMP-001.02.01" NO="1" P_CHI2="0.3811184711363562" P_Z="0.9368152795197529" STUDIES="4" TAU2="0.0" TOTAL_1="345" TOTAL_2="357" WEIGHT="100.0" Z="0.07927325404356522">
<NAME>Optimal Self Management</NAME>
<CONT_DATA CI_END="0.3846651826238411" CI_START="-0.3846651826238411" EFFECT_SIZE="0.0" ESTIMABLE="YES" MEAN_1="0.04" MEAN_2="0.04" ORDER="1091" SD_1="0.28" SD_2="0.29" SE="0.19626135258506328" STUDY_ID="STD-Cote-1997" TOTAL_1="50" TOTAL_2="54" WEIGHT="17.285550213551534"/>
<CONT_DATA CI_END="0.21170175683062772" CI_START="-0.15465293620528484" EFFECT_SIZE="0.028524410312671448" ESTIMABLE="YES" MEAN_1="0.13" MEAN_2="0.12" ORDER="1092" SD_1="0.35" SD_2="0.35" SE="0.09345954719721168" STUDY_ID="STD-Grampian-1994" TOTAL_1="230" TOTAL_2="228" WEIGHT="76.22640500759839"/>
<CONT_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" MEAN_1="0.0" MEAN_2="0.56" ORDER="1093" SD_1="0.0" SD_2="3.41" SE="0.0" STUDY_ID="STD-Knoell-1998" TOTAL_1="45" TOTAL_2="55" WEIGHT="0.0"/>
<CONT_DATA CI_END="0.19304210570404812" CI_START="-1.0626916216294644" EFFECT_SIZE="-0.43482475796270814" ESTIMABLE="YES" MEAN_1="20.2" MEAN_2="24.3" ORDER="1094" SD_1="6.9" SD_2="11.1" SE="0.3203461229998561" STUDY_ID="STD-Sommaruga-1995" TOTAL_1="20" TOTAL_2="20" WEIGHT="6.488044778850076"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-001.02.02" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="22" TOTAL_2="20" WEIGHT="0.0" Z="0.0">
<NAME>Self Monitoring &amp; Regular Review</NAME>
<CONT_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" MEAN_1="0.0" MEAN_2="0.5" ORDER="1095" SD_1="0.0" SD_2="0.8" SE="0.0" STUDY_ID="STD-de-Oliveira-1999" TOTAL_1="22" TOTAL_2="20" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="16.917253228899657" CI_END="0.9357772045671455" CI_START="0.7256136813160654" CI_STUDY="95" CI_TOTAL="95" DF="12.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.8240222947818968" ESTIMABLE="YES" EVENTS_1="291" EVENTS_2="354" I2="29.066498930804787" I2_Q="0.0" ID="CMP-001.03" LOG_CI_END="-0.028827538382223843" LOG_CI_START="-0.1392945373260524" LOG_EFFECT_SIZE="-0.08406103785413813" METHOD="MH" NO="3" P_CHI2="0.1527366601760921" P_Q="0.0" P_Z="0.002855211167202025" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="13" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="1457" TOTAL_2="1445" WEIGHT="99.99999999999999" Z="2.982910883293682">
<NAME>ER Visits (% subjects)</NAME>
<GROUP_LABEL_1>Self Management</GROUP_LABEL_1>
<GROUP_LABEL_2>Usual Care</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Self M'gment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Usual Care</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="11.338748057195378" CI_END="0.9061822825753644" CI_START="0.6655522511500226" DF="8.0" EFFECT_SIZE="0.7766026384968697" ESTIMABLE="YES" EVENTS_1="184" EVENTS_2="242" I2="29.44547352453664" ID="CMP-001.03.01" LOG_CI_END="-0.04278443327907251" LOG_CI_START="-0.17681784327670183" LOG_EFFECT_SIZE="-0.10980113827788715" NO="1" P_CHI2="0.1832341288978402" P_Z="0.0013216657561286105" STUDIES="9" TAU2="0.0" TOTAL_1="952" TOTAL_2="952" WEIGHT="67.7931373495371" Z="3.211233325929223">
<NAME>Optimal Self Management</NAME>
<DICH_DATA CI_END="1.2417776763126915" CI_START="0.48693238051715493" EFFECT_SIZE="0.7776" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="25" LOG_CI_END="0.0940438481807985" LOG_CI_START="-0.3125313443443622" LOG_EFFECT_SIZE="-0.10924374808178185" ORDER="1096" O_E="0.0" SE="0.23882428066894085" STUDY_ID="STD-Cote-1997" TOTAL_1="50" TOTAL_2="54" VAR="0.05703703703703704" WEIGHT="6.814937266723793"/>
<DICH_DATA CI_END="0.6742551278145321" CI_START="0.11183438662825673" EFFECT_SIZE="0.2745995423340961" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="19" LOG_CI_END="-0.1711757419858057" LOG_CI_START="-0.9514246398597883" LOG_EFFECT_SIZE="-0.561300190922797" ORDER="1097" O_E="0.0" SE="0.45832206490551214" STUDY_ID="STD-Cowie-1997" TOTAL_1="46" TOTAL_2="48" VAR="0.2100591151792525" WEIGHT="5.271919470605326"/>
<DICH_DATA CI_END="1.1056897154318526" CI_START="0.6644665924780433" EFFECT_SIZE="0.8571428571428571" ESTIMABLE="YES" EVENTS_1="60" EVENTS_2="68" LOG_CI_END="0.043633270023096166" LOG_CI_START="-0.17752684928432255" LOG_EFFECT_SIZE="-0.06694678963061322" ORDER="1098" O_E="0.0" SE="0.1299105488414244" STUDY_ID="STD-Ghosh-1998" TOTAL_1="140" TOTAL_2="136" VAR="0.016876750700280115" WEIGHT="19.557487214602585"/>
<DICH_DATA CI_END="27.45420096203815" CI_START="0.30785480734215076" EFFECT_SIZE="2.9072164948453607" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="1" LOG_CI_END="1.4386088083503497" LOG_CI_START="-0.5116540602441173" LOG_EFFECT_SIZE="0.4634773740531162" ORDER="1099" O_E="0.0" SE="1.1455940629692865" STUDY_ID="STD-Heard-1999" TOTAL_1="97" TOTAL_2="94" VAR="1.3123857571104773" WEIGHT="0.28795429171396697"/>
<DICH_DATA CI_END="1.5766787444742656" CI_START="0.6342446129274383" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="18" LOG_CI_END="0.19774321285013854" LOG_CI_START="-0.19774321285013857" LOG_EFFECT_SIZE="0.0" ORDER="1100" O_E="0.0" SE="0.2323106841457232" STUDY_ID="STD-Ignacio_x002d_Garcia-1995" TOTAL_1="35" TOTAL_2="35" VAR="0.05396825396825397" WEIGHT="5.103025025322776"/>
<DICH_DATA CI_END="1.3925645441174939" CI_START="0.6727187237862051" EFFECT_SIZE="0.9678864824495892" ESTIMABLE="YES" EVENTS_1="36" EVENTS_2="39" LOG_CI_END="0.14381533347194062" LOG_CI_START="-0.1721664844268095" LOG_EFFECT_SIZE="-0.01417557547743447" ORDER="1101" O_E="0.0" SE="0.18560928396895043" STUDY_ID="STD-Levy-2000" TOTAL_1="103" TOTAL_2="108" VAR="0.034450806295466485" WEIGHT="10.794550566993992"/>
<DICH_DATA CI_END="1.5279391144497199" CI_START="0.262881455965742" EFFECT_SIZE="0.6337719298245614" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="12" LOG_CI_END="0.18410604875187994" LOG_CI_START="-0.5802400485676542" LOG_EFFECT_SIZE="-0.19806699990788712" ORDER="1102" O_E="0.0" SE="0.44898068113969675" STUDY_ID="STD-Moudgil-2000" TOTAL_1="304" TOTAL_2="289" VAR="0.20158365203666603" WEIGHT="3.488071068461211"/>
<DICH_DATA CI_END="1.4913009896502123" CI_START="0.1231632451547129" EFFECT_SIZE="0.42857142857142855" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="7" LOG_CI_END="0.17356530606323722" LOG_CI_START="-0.9095188766524261" LOG_EFFECT_SIZE="-0.36797678529459443" ORDER="1103" O_E="0.0" SE="0.6362090102803518" STUDY_ID="STD-Yoon-1993" TOTAL_1="28" TOTAL_2="28" VAR="0.40476190476190477" WEIGHT="1.9845097320699683"/>
<DICH_DATA CI_END="0.970834662890021" CI_START="0.4604667705836925" EFFECT_SIZE="0.6686083322780803" ESTIMABLE="YES" EVENTS_1="33" EVENTS_2="53" LOG_CI_END="-0.012854725919505582" LOG_CI_START="-0.33680170503899615" LOG_EFFECT_SIZE="-0.17482821547925084" ORDER="1104" O_E="0.0" SE="0.19028805909819732" STUDY_ID="STD-Zeiger-1991" TOTAL_1="149" TOTAL_2="160" VAR="0.036209545435359036" WEIGHT="14.490682713043494"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.25130915391504216" CI_END="1.259660424860886" CI_START="0.7932083783840449" DF="1.0" EFFECT_SIZE="0.9995865159747107" ESTIMABLE="YES" EVENTS_1="102" EVENTS_2="98" I2="0.0" ID="CMP-001.03.02" LOG_CI_END="0.10025348520857955" LOG_CI_START="-0.10061270714104052" LOG_EFFECT_SIZE="-1.7961096623045694E-4" NO="2" P_CHI2="0.6161548014930867" P_Z="0.9972033168807279" STUDIES="2" TAU2="0.0" TOTAL_1="375" TOTAL_2="350" WEIGHT="28.33980697890242" Z="0.0035051296678876025">
<NAME>Self Monitoring and Regular Review</NAME>
<DICH_DATA CI_END="1.625115857165261" CI_START="0.4608641504738516" EFFECT_SIZE="0.8654233870967742" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="16" LOG_CI_END="0.2108843279819453" LOG_CI_START="-0.33642707329643196" LOG_EFFECT_SIZE="-0.06277137265724332" ORDER="1105" O_E="0.0" SE="0.32149342634604916" STUDY_ID="STD-Bailey-1990" TOTAL_1="124" TOTAL_2="101" VAR="0.10335802318372254" WEIGHT="4.999704518637228"/>
<DICH_DATA CI_END="1.3172385787925691" CI_START="0.8027807616115307" EFFECT_SIZE="1.028325721504227" ESTIMABLE="YES" EVENTS_1="85" EVENTS_2="82" LOG_CI_END="0.11966444168106229" LOG_CI_START="-0.09540304379051386" LOG_EFFECT_SIZE="0.012130698945274233" ORDER="1106" O_E="0.0" SE="0.12633170556722656" STUDY_ID="STD-Garret-1994" TOTAL_1="251" TOTAL_2="249" VAR="0.01595969983152442" WEIGHT="23.340102460265193"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-001.03.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Self Monitoring Only</NAME>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.6023290820562692" CI_END="0.9882282298478144" CI_START="0.13756436593546523" DF="1.0" EFFECT_SIZE="0.3687071871262368" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="14" I2="0.0" ID="CMP-001.03.04" LOG_CI_END="-0.0051427441604070916" LOG_CI_START="-0.8614940492531071" LOG_EFFECT_SIZE="-0.4333183967067571" NO="4" P_CHI2="0.4376909217406628" P_Z="0.047311074227077025" STUDIES="2" TAU2="0.0" TOTAL_1="130" TOTAL_2="143" WEIGHT="3.867055671560464" Z="1.9835047750454426">
<NAME>Regular Review Only</NAME>
<DICH_DATA CI_END="1.5783057571282164" CI_START="0.023796301130212548" EFFECT_SIZE="0.1937984496124031" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="6" LOG_CI_END="0.19819114067981708" LOG_CI_START="-1.6234905439342397" LOG_EFFECT_SIZE="-0.7126497016272113" ORDER="1107" O_E="0.0" SE="1.0700648390120677" STUDY_ID="STD-Hilton-1986" TOTAL_1="86" TOTAL_2="100" VAR="1.1450387596899225" WEIGHT="1.5729754558342608"/>
<DICH_DATA CI_END="1.5039553882118812" CI_START="0.1587583632727613" EFFECT_SIZE="0.48863636363636365" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="8" LOG_CI_END="0.17723495398118203" LOG_CI_START="-0.7992633871223462" LOG_EFFECT_SIZE="-0.3110142165705821" ORDER="1108" O_E="0.0" SE="0.5735999593089586" STUDY_ID="STD-Shields-1986" TOTAL_1="44" TOTAL_2="43" VAR="0.32901691331923894" WEIGHT="2.2940802157262032"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="8.658253783055999" CI_END="-0.20598832083096333" CI_START="-0.5043164177975153" CI_STUDY="95" CI_TOTAL="95" DF="6.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.3551523693142393" ESTIMABLE="YES" I2="30.701961962100714" I2_Q="43.203371249187136" ID="CMP-001.04" NO="4" P_CHI2="0.19372951437717556" P_Q="0.1719300459421449" P_Z="3.0625556172791354E-6" Q="3.5213357623296897" RANDOM="NO" SCALE="4.0" SORT_BY="STUDY" STUDIES="8" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="359" TOTAL_2="372" UNITS="" WEIGHT="99.99999999999999" Z="4.6665792458564255">
<NAME>ER Visits (Mean)</NAME>
<GROUP_LABEL_1>Self Management</GROUP_LABEL_1>
<GROUP_LABEL_2>Usual Care</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Self M'gment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Usual Care</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="5.136918020726309" CI_END="-0.19741418764976454" CI_START="-0.523930183156353" DF="4.0" EFFECT_SIZE="-0.3606721854030588" ESTIMABLE="YES" I2="22.13229831854627" ID="CMP-001.04.01" NO="1" P_CHI2="0.2735352442243001" P_Z="1.4912027792369865E-5" STUDIES="5" TAU2="0.0" TOTAL_1="290" TOTAL_2="300" WEIGHT="83.47941412715043" Z="4.329983849756507">
<NAME>Optimal Self Management</NAME>
<CONT_DATA CI_END="0.315922078212535" CI_START="-0.45364488323321256" EFFECT_SIZE="-0.06886140251033877" ESTIMABLE="YES" MEAN_1="0.7" MEAN_2="0.8" ORDER="1109" SD_1="1.41" SD_2="1.47" SE="0.19632170986711836" STUDY_ID="STD-Cote-1997" TOTAL_1="50" TOTAL_2="54" WEIGHT="15.02780276203529"/>
<CONT_DATA CI_END="-0.2448829466433321" CI_START="-0.7238033719796488" EFFECT_SIZE="-0.48434315931149047" ESTIMABLE="YES" MEAN_1="11.6" MEAN_2="21.8" ORDER="1110" SD_1="16.2" SD_2="25.0" SE="0.12217582290133389" STUDY_ID="STD-Ghosh-1998" TOTAL_1="140" TOTAL_2="136" WEIGHT="38.80266876360625"/>
<CONT_DATA CI_END="-0.13408267925441336" CI_START="-1.0942476407685446" EFFECT_SIZE="-0.614165160011479" ESTIMABLE="YES" MEAN_1="0.65" MEAN_2="1.91" ORDER="1111" SD_1="0.71" SD_2="2.78" SE="0.24494454211602612" STUDY_ID="STD-Ignacio_x002d_Garcia-1995" TOTAL_1="35" TOTAL_2="35" WEIGHT="9.653762459488261"/>
<CONT_DATA CI_END="0.13960310467356007" CI_START="-0.6516518629306479" EFFECT_SIZE="-0.2560243791285439" ESTIMABLE="YES" MEAN_1="0.04" MEAN_2="0.13" ORDER="1112" SD_1="0.21" SD_2="0.43" SE="0.201854466165074" STUDY_ID="STD-Knoell-1998" TOTAL_1="45" TOTAL_2="55" WEIGHT="14.21527993068833"/>
<CONT_DATA CI_END="0.49733017750608555" CI_START="-0.7435618305885957" EFFECT_SIZE="-0.1231158265412551" ESTIMABLE="YES" MEAN_1="9.2" MEAN_2="10.4" ORDER="1113" SD_1="9.3" SD_2="9.8" SE="0.3165599005600815" STUDY_ID="STD-Sommaruga-1995" TOTAL_1="20" TOTAL_2="20" WEIGHT="5.779900211332309"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="-0.18617622285514845" CI_START="-1.451940902314378" DF="0.0" EFFECT_SIZE="-0.8190585625847632" ESTIMABLE="YES" I2="0.0" ID="CMP-001.04.02" NO="2" P_CHI2="1.0" P_Z="0.011195702707488025" STUDIES="1" TAU2="0.0" TOTAL_1="22" TOTAL_2="20" WEIGHT="5.554978342331752" Z="2.53653038348506">
<NAME>Self Monitoring &amp; Regular Review</NAME>
<CONT_DATA CI_END="-0.18617622285514845" CI_START="-1.451940902314378" EFFECT_SIZE="-0.8190585625847632" ESTIMABLE="YES" MEAN_1="0.7" MEAN_2="2.0" ORDER="1114" SD_1="1.0" SD_2="2.0" SE="0.32290508638001" STUDY_ID="STD-de-Oliveira-1999" TOTAL_1="22" TOTAL_2="20" WEIGHT="5.554978342331752"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.3723268566392653" CI_START="-0.5285756779423594" DF="0.0" EFFECT_SIZE="-0.07812441065154706" ESTIMABLE="YES" I2="0.0" ID="CMP-001.04.03" NO="3" P_CHI2="1.0" P_Z="0.7339106957004953" STUDIES="2" TAU2="0.0" TOTAL_1="47" TOTAL_2="52" WEIGHT="10.965607530517802" Z="0.3399280728221247">
<NAME>Self Monitoring Only</NAME>
<CONT_DATA CI_END="0.37232685663926535" CI_START="-0.5285756779423595" EFFECT_SIZE="-0.07812441065154706" ESTIMABLE="YES" MEAN_1="0.03" MEAN_2="0.04" ORDER="1115" SD_1="0.11" SD_2="0.14" SE="0.2298262982605367" STUDY_ID="STD-Kotses-1995" TOTAL_1="36" TOTAL_2="40" WEIGHT="10.965607530517802"/>
<CONT_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" MEAN_1="0.0" MEAN_2="0.33" ORDER="1116" SD_1="0.0" SD_2="0.09" SE="0.0" STUDY_ID="STD-Kotses-1996" TOTAL_1="11" TOTAL_2="12" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="30.72091580027779" CI_END="0.05511712296586051" CI_START="-0.19003906935318748" CI_STUDY="95" CI_TOTAL="95" DF="6.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.06746097319366348" ESTIMABLE="YES" I2="80.46933223277885" I2_Q="50.07215779090992" ID="CMP-001.05" NO="5" P_CHI2="2.865625102688174E-5" P_Q="0.11118915480378955" P_Z="0.28073574313226124" Q="6.0086714491615005" RANDOM="NO" SCALE="4.0" SORT_BY="STUDY" STUDIES="7" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="515" TOTAL_2="527" UNITS="" WEIGHT="100.0" Z="1.0786680652106804">
<NAME>Unscheduled Dr Visits (mean)</NAME>
<GROUP_LABEL_1>Self Management</GROUP_LABEL_1>
<GROUP_LABEL_2>Usual Care</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Self M'gment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Usual Care</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="24.71224435111629" CI_END="0.0984309455845405" CI_START="-0.19198034684832094" DF="3.0" EFFECT_SIZE="-0.04677470063189022" ESTIMABLE="YES" I2="87.86026895260736" ID="CMP-001.05.01" NO="1" P_CHI2="1.7734495960097796E-5" P_Z="0.5278065549108162" STUDIES="4" TAU2="0.0" TOTAL_1="366" TOTAL_2="377" WEIGHT="71.2621195900279" Z="0.6313578777060949">
<NAME>Optimal Self Management</NAME>
<CONT_DATA CI_END="0.3426327703151785" CI_START="-0.02428777891488859" EFFECT_SIZE="0.15917249570014497" ESTIMABLE="YES" MEAN_1="2.6" MEAN_2="2.2" ORDER="1117" SD_1="2.7" SD_2="2.3" SE="0.0936039009196826" STUDY_ID="STD-Grampian-1994" TOTAL_1="230" TOTAL_2="228" WEIGHT="44.64179666546454"/>
<CONT_DATA CI_END="-0.4993558495141147" CI_START="-1.4962720525391302" EFFECT_SIZE="-0.9978139510266225" ESTIMABLE="YES" MEAN_1="1.51" MEAN_2="4.51" ORDER="1118" SD_1="1.2" SD_2="4.03" SE="0.2543200311047967" STUDY_ID="STD-Ignacio_x002d_Garcia-1995" TOTAL_1="35" TOTAL_2="35" WEIGHT="6.047396238137182"/>
<CONT_DATA CI_END="0.4877080839737818" CI_START="-0.30067083310417825" EFFECT_SIZE="0.09351862543480179" ESTIMABLE="YES" MEAN_1="0.58" MEAN_2="0.49" ORDER="1119" SD_1="1.06" SD_2="0.86" SE="0.20112076632443052" STUDY_ID="STD-Knoell-1998" TOTAL_1="45" TOTAL_2="55" WEIGHT="9.669760802517827"/>
<CONT_DATA CI_END="-0.11571090963719388" CI_START="-0.8581597916366638" EFFECT_SIZE="-0.48693535063692883" ESTIMABLE="YES" MEAN_1="0.5" MEAN_2="1.0" ORDER="1120" SD_1="1.02" SD_2="1.02" SE="0.18940370533739698" STUDY_ID="STD-Lahdensuo-1996" TOTAL_1="56" TOTAL_2="59" WEIGHT="10.90316588390835"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.31863846495994014" CI_START="-0.31863846495994014" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="YES" I2="0.0" ID="CMP-001.05.02" NO="2" P_CHI2="1.0" P_Z="1.0" STUDIES="1" TAU2="0.0" TOTAL_1="81" TOTAL_2="71" WEIGHT="14.798896782422492" Z="0.0">
<NAME>Self Monitoring and Regular Review</NAME>
<CONT_DATA CI_END="0.31863846495994014" CI_START="-0.31863846495994014" EFFECT_SIZE="0.0" ESTIMABLE="YES" MEAN_1="3.5" MEAN_2="3.5" ORDER="1121" SD_1="2.79" SD_2="2.7" SE="0.16257363271637626" STUDY_ID="STD-Wilson-1993" TOTAL_1="81" TOTAL_2="71" WEIGHT="14.798896782422492"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.5446674385793646" CI_START="-0.35639827440271676" DF="0.0" EFFECT_SIZE="0.09413458208832393" ESTIMABLE="YES" I2="0.0" ID="CMP-001.05.03" NO="3" P_CHI2="1.0" P_Z="0.6821610653626178" STUDIES="1" TAU2="0.0" TOTAL_1="36" TOTAL_2="40" WEIGHT="7.402404378763881" Z="0.40951594969081495">
<NAME>Self Monitoring Only</NAME>
<CONT_DATA CI_END="0.5446674385793646" CI_START="-0.35639827440271676" EFFECT_SIZE="0.09413458208832393" ESTIMABLE="YES" MEAN_1="1.07" MEAN_2="0.92" ORDER="1122" SD_1="1.99" SD_2="1.08" SE="0.22986792616843288" STUDY_ID="STD-Kotses-1995" TOTAL_1="36" TOTAL_2="40" WEIGHT="7.402404378763881"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-001.05.04" NO="4" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Regular Review Only</NAME>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="-0.1492728147458236" CI_START="-1.1081601927575973" DF="0.0" EFFECT_SIZE="-0.6287165037517104" ESTIMABLE="YES" I2="0.0" ID="CMP-001.05.05" NO="5" P_CHI2="1.0" P_Z="0.010164255002247035" STUDIES="1" TAU2="0.0" TOTAL_1="32" TOTAL_2="39" WEIGHT="6.536579248785736" Z="2.5701906857807533">
<NAME>Written Action Plan not Optimal</NAME>
<CONT_DATA CI_END="-0.1492728147458236" CI_START="-1.1081601927575973" EFFECT_SIZE="-0.6287165037517104" ESTIMABLE="YES" MEAN_1="0.7" MEAN_2="2.6" ORDER="1123" SD_1="2.0" SD_2="3.6" SE="0.24461862196840217" STUDY_ID="STD-Gallefoss-1999" TOTAL_1="32" TOTAL_2="39" WEIGHT="6.536579248785736"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="24.85257959668162" CI_END="0.8093979505654788" CI_START="0.5630074866709602" CI_STUDY="95" CI_TOTAL="95" DF="6.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.6750534096384495" ESTIMABLE="YES" EVENTS_1="112" EVENTS_2="170" I2="75.85763692393068" I2_Q="0.0" ID="CMP-001.06" LOG_CI_END="-0.09183789959756604" LOG_CI_START="-0.24948583001851582" LOG_EFFECT_SIZE="-0.17066186480804094" METHOD="MH" NO="6" P_CHI2="3.6359433511001793E-4" P_Q="0.0" P_Z="2.2004030766603205E-5" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="7" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="784" TOTAL_2="772" WEIGHT="99.99999999999999" Z="4.243520453012603">
<NAME>Unscheduled Dr Visits (% subjects)</NAME>
<GROUP_LABEL_1>Self Management</GROUP_LABEL_1>
<GROUP_LABEL_2>Usual Care</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Self M'gment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Usual Care</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="12.85064465490099" CI_END="0.9085515409876073" CI_START="0.583342237839419" DF="3.0" EFFECT_SIZE="0.7280085776363926" ESTIMABLE="YES" EVENTS_1="54" EVENTS_2="75" I2="76.65486766956973" ID="CMP-001.06.01" LOG_CI_END="-0.041650430676705805" LOG_CI_START="-0.23407657663621131" LOG_EFFECT_SIZE="-0.13786350365645855" NO="1" P_CHI2="0.004970994588192501" P_Z="0.004978399110846002" STUDIES="4" TAU2="0.0" TOTAL_1="492" TOTAL_2="477" WEIGHT="44.594270720415295" Z="2.808428143710032">
<NAME>Optimal Self Management</NAME>
<DICH_DATA CI_END="15.269197756387982" CI_START="0.06150296013325277" EFFECT_SIZE="0.9690721649484536" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.1838162198248292" LOG_CI_START="-1.2111039811579216" LOG_EFFECT_SIZE="-0.013643880666546192" ORDER="1124" O_E="0.0" SE="1.4067879811034583" STUDY_ID="STD-Heard-1999" TOTAL_1="97" TOTAL_2="94" VAR="1.979052423777144" WEIGHT="0.6072586794760694"/>
<DICH_DATA CI_END="1.040288937976416" CI_START="0.7991192144269249" EFFECT_SIZE="0.9117647058823529" ESTIMABLE="YES" EVENTS_1="31" EVENTS_2="34" LOG_CI_END="0.01715398039558754" LOG_CI_START="-0.09738842681155244" LOG_EFFECT_SIZE="-0.04011722320798245" ORDER="1125" O_E="0.0" SE="0.06728277698753403" STUDY_ID="STD-Ignacio_x002d_Garcia-1995" TOTAL_1="35" TOTAL_2="35" VAR="0.004526972079154239" WEIGHT="20.32751476555461"/>
<DICH_DATA CI_END="1.0327347960086413" CI_START="0.3962059008427895" EFFECT_SIZE="0.6396683673469388" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="28" LOG_CI_END="0.013988809983017584" LOG_CI_START="-0.40207906063902066" LOG_EFFECT_SIZE="-0.19404512532800153" ORDER="1126" O_E="0.0" SE="0.24440032677256118" STUDY_ID="STD-Lahdensuo-1996" TOTAL_1="56" TOTAL_2="59" VAR="0.05973151972653469" WEIGHT="16.303602635493416"/>
<DICH_DATA CI_END="1.110376602021632" CI_START="0.14130441556883896" EFFECT_SIZE="0.39610745614035087" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="12" LOG_CI_END="0.04547030170592062" LOG_CI_START="-0.8498442668335444" LOG_EFFECT_SIZE="-0.4021869825638119" ORDER="1127" O_E="0.0" SE="0.5259122094386725" STUDY_ID="STD-Moudgil-2000" TOTAL_1="304" TOTAL_2="289" VAR="0.27658365203666607" WEIGHT="7.355894639891202"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.135967291454147" CI_START="0.5334715450101923" DF="0.0" EFFECT_SIZE="0.7784640171858217" ESTIMABLE="YES" EVENTS_1="39" EVENTS_2="49" I2="0.0" ID="CMP-001.06.02" LOG_CI_END="0.055365826669470666" LOG_CI_START="-0.2728887405780858" LOG_EFFECT_SIZE="-0.10876145695430757" NO="2" P_CHI2="1.0" P_Z="0.19401252746583852" STUDIES="1" TAU2="0.0" TOTAL_1="228" TOTAL_2="223" WEIGHT="29.62032019835348" Z="1.2988001374907487">
<NAME>Self Management and Regular Review</NAME>
<DICH_DATA CI_END="1.135967291454147" CI_START="0.5334715450101923" EFFECT_SIZE="0.7784640171858217" ESTIMABLE="YES" EVENTS_1="39" EVENTS_2="49" LOG_CI_END="0.055365826669470666" LOG_CI_START="-0.2728887405780858" LOG_EFFECT_SIZE="-0.10876145695430757" ORDER="1128" O_E="0.0" SE="0.1928183576875284" STUDY_ID="STD-Garret-1994" TOTAL_1="228" TOTAL_2="223" VAR="0.03717891906131564" WEIGHT="29.62032019835348"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.9235950676164677" CI_START="0.2878633179702134" DF="0.0" EFFECT_SIZE="0.515625" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="20" I2="0.0" ID="CMP-001.06.03" LOG_CI_END="-0.03451839506264664" LOG_CI_START="-0.5408136731493527" LOG_EFFECT_SIZE="-0.28766603410599967" NO="3" P_CHI2="1.0" P_Z="0.025932684452565802" STUDIES="1" TAU2="0.0" TOTAL_1="32" TOTAL_2="33" WEIGHT="11.773402217153802" Z="2.2272183479723213">
<NAME>Self Monitoring Only</NAME>
<DICH_DATA CI_END="0.9235950676164678" CI_START="0.28786331797021336" EFFECT_SIZE="0.515625" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="20" LOG_CI_END="-0.03451839506264659" LOG_CI_START="-0.5408136731493528" LOG_EFFECT_SIZE="-0.28766603410599967" ORDER="1129" O_E="0.0" SE="0.29740035255017727" STUDY_ID="STD-Neri-1996" TOTAL_1="32" TOTAL_2="33" VAR="0.08844696969696972" WEIGHT="11.773402217153802"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-001.06.04" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="4" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Regular Review Only</NAME>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.766162103309412" CI_START="0.2322987718346126" DF="0.0" EFFECT_SIZE="0.421875" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="26" I2="0.0" ID="CMP-001.06.05" LOG_CI_END="-0.11567933333785001" LOG_CI_START="-0.6339530863119498" LOG_EFFECT_SIZE="-0.3748162098248998" NO="5" P_CHI2="1.0" P_Z="0.00458405076589342" STUDIES="1" TAU2="0.0" TOTAL_1="32" TOTAL_2="39" WEIGHT="14.012006864077412" Z="2.834896684861925">
<NAME>Written Action Plan not Optimal</NAME>
<DICH_DATA CI_END="0.766162103309412" CI_START="0.2322987718346126" EFFECT_SIZE="0.421875" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="26" LOG_CI_END="-0.11567933333785001" LOG_CI_START="-0.6339530863119498" LOG_EFFECT_SIZE="-0.3748162098248998" ORDER="1130" O_E="0.0" SE="0.3044365679934392" STUDY_ID="STD-Gallefoss-1999" TOTAL_1="32" TOTAL_2="39" VAR="0.09268162393162394" WEIGHT="14.012006864077412"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="8.038024819929229" CI_END="0.9256859922873684" CI_START="0.6709958169726301" CI_STUDY="95" CI_TOTAL="95" DF="6.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.7881189178385344" ESTIMABLE="YES" EVENTS_1="141" EVENTS_2="180" I2="25.354796303641827" I2_Q="0.0" ID="CMP-001.07" LOG_CI_END="-0.03353630807402993" LOG_CI_START="-0.1732801872399006" LOG_EFFECT_SIZE="-0.10340824765696525" METHOD="MH" NO="7" P_CHI2="0.23533078561700282" P_Q="0.0" P_Z="0.0037234875413111644" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="7" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="360" TOTAL_2="372" WEIGHT="100.00000000000001" Z="2.900684342267058">
<NAME>Days off work (% subjects)</NAME>
<GROUP_LABEL_1>Self Management</GROUP_LABEL_1>
<GROUP_LABEL_2>Usual Care</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Self M'gment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Usual Care</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="2.802436480041388" CI_END="1.0084170590185493" CI_START="0.6461044307298688" DF="3.0" EFFECT_SIZE="0.8071819682422721" ESTIMABLE="YES" EVENTS_1="76" EVENTS_2="94" I2="0.0" ID="CMP-001.07.01" LOG_CI_END="0.0036401838657308867" LOG_CI_START="-0.18969728072900777" LOG_EFFECT_SIZE="-0.09302854843163844" NO="1" P_CHI2="0.4230990840922466" P_Z="0.05927352467073298" STUDIES="4" TAU2="0.0" TOTAL_1="216" TOTAL_2="216" WEIGHT="53.40808351383217" Z="1.88615905191728">
<NAME>Optimal Self Management</NAME>
<DICH_DATA CI_END="1.3291638523456832" CI_START="0.6302118273448507" EFFECT_SIZE="0.9152348224513173" ESTIMABLE="YES" EVENTS_1="34" EVENTS_2="36" LOG_CI_END="0.12357852178793192" LOG_CI_START="-0.20051345057108858" LOG_EFFECT_SIZE="-0.03846746439157835" ORDER="1131" O_E="0.0" SE="0.19037322884482535" STUDY_ID="STD-Heard-1999" TOTAL_1="97" TOTAL_2="94" VAR="0.03624196626080424" WEIGHT="20.794615271423833"/>
<DICH_DATA CI_END="1.0843352039396343" CI_START="0.6316302628163597" EFFECT_SIZE="0.8275862068965517" ESTIMABLE="YES" EVENTS_1="24" EVENTS_2="29" LOG_CI_END="0.03516355777211454" LOG_CI_START="-0.19953707014681457" LOG_EFFECT_SIZE="-0.08218675618735007" ORDER="1132" O_E="0.0" SE="0.13786431062642424" STUDY_ID="STD-Ignacio_x002d_Garcia-1995" TOTAL_1="35" TOTAL_2="35" VAR="0.01900656814449919" WEIGHT="16.492178406130673"/>
<DICH_DATA CI_END="0.9607001581418331" CI_START="0.31242573079214536" EFFECT_SIZE="0.5478571428571428" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="25" LOG_CI_END="-0.017412137808673907" LOG_CI_START="-0.5052532056498402" LOG_EFFECT_SIZE="-0.2613326717292571" ORDER="1133" O_E="0.0" SE="0.2865602581021332" STUDY_ID="STD-Lahdensuo-1996" TOTAL_1="56" TOTAL_2="59" VAR="0.08211678152356121" WEIGHT="13.846506607845843"/>
<DICH_DATA CI_END="4.174828576074551" CI_START="0.3742668642622843" EFFECT_SIZE="1.25" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="4" LOG_CI_END="0.6206386474858859" LOG_CI_START="-0.42681862146977323" LOG_EFFECT_SIZE="0.09691001300805642" ORDER="1134" O_E="0.0" SE="0.6152815847816581" STUDY_ID="STD-Yoon-1993" TOTAL_1="28" TOTAL_2="28" VAR="0.3785714285714286" WEIGHT="2.274783228431817"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.1516807665753424" CI_START="0.7282142625379495" DF="0.0" EFFECT_SIZE="0.9157894736842105" ESTIMABLE="YES" EVENTS_1="58" EVENTS_2="57" I2="0.0" ID="CMP-001.07.02" LOG_CI_END="0.061332114045589456" LOG_CI_START="-0.13774081938604796" LOG_EFFECT_SIZE="-0.03820435267022926" NO="2" P_CHI2="1.0" P_Z="0.45188353166179795" STUDIES="1" TAU2="0.0" TOTAL_1="100" TOTAL_2="90" WEIGHT="34.121748426477254" Z="0.752278614631756">
<NAME>Self Monitoring and Regular Review</NAME>
<DICH_DATA CI_END="1.1516807665753424" CI_START="0.7282142625379495" EFFECT_SIZE="0.9157894736842105" ESTIMABLE="YES" EVENTS_1="58" EVENTS_2="57" LOG_CI_END="0.061332114045589456" LOG_CI_START="-0.13774081938604796" LOG_EFFECT_SIZE="-0.03820435267022926" ORDER="1135" O_E="0.0" SE="0.11693642652465706" STUDY_ID="STD-Garret-1994" TOTAL_1="100" TOTAL_2="90" VAR="0.01367412784835652" WEIGHT="34.121748426477254"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="2.3909431097778118" CI_END="0.7802280997302979" CI_START="0.1634703568498694" DF="1.0" EFFECT_SIZE="0.35713326068458995" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="29" I2="58.17550003969232" ID="CMP-001.07.03" LOG_CI_END="-0.10777841272961758" LOG_CI_START="-0.7865609893260667" LOG_EFFECT_SIZE="-0.44716970102784215" NO="3" P_CHI2="0.12204016796237782" P_Z="0.009812212074567483" STUDIES="2" TAU2="0.0" TOTAL_1="44" TOTAL_2="66" WEIGHT="12.470168059690588" Z="2.582377742772189">
<NAME>Self Monitoring Only</NAME>
<DICH_DATA CI_END="1.227328893309302" CI_START="0.005117787996887748" EFFECT_SIZE="0.07925407925407925" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="16" LOG_CI_END="0.0889609583336478" LOG_CI_START="-2.2909177086185863" LOG_EFFECT_SIZE="-1.100978375142469" ORDER="1136" O_E="0.0" SE="1.3979525095571386" STUDY_ID="STD-Brewin-1995" TOTAL_1="12" TOTAL_2="33" VAR="1.9542712189771014" WEIGHT="5.190861728708773"/>
<DICH_DATA CI_END="1.2108984926505681" CI_START="0.25464172049864087" EFFECT_SIZE="0.5552884615384616" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="13" LOG_CI_END="0.08310773857705539" LOG_CI_START="-0.5940704400462522" LOG_EFFECT_SIZE="-0.25548135073459843" ORDER="1137" O_E="0.0" SE="0.3977778142093768" STUDY_ID="STD-Neri-1996" TOTAL_1="32" TOTAL_2="33" VAR="0.15822718947718947" WEIGHT="7.2793063309818145"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-001.07.04" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="4" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Regular Review Only</NAME>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="26.84590979916385" CI_END="-0.0876708650995648" CI_START="-0.2777369229172897" CI_STUDY="95" CI_TOTAL="95" DF="12.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.18270389400842724" ESTIMABLE="YES" I2="55.30045325424674" I2_Q="67.23435645395703" ID="CMP-001.08" NO="8" P_CHI2="0.008131615784839674" P_Q="0.015870379553093006" P_Z="1.6450107750312163E-4" Q="12.207909160639916" RANDOM="NO" SCALE="4.0" SORT_BY="STUDY" STUDIES="13" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="856" TOTAL_2="872" UNITS="" WEIGHT="100.00000000000003" Z="3.7680904860472815">
<NAME>Days off work (mean)</NAME>
<GROUP_LABEL_1>Self Management</GROUP_LABEL_1>
<GROUP_LABEL_2>Usual Care</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Self M'gment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Usual Care</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="14.638000638523932" CI_END="-0.15956781048113958" CI_START="-0.38708631348796174" DF="8.0" EFFECT_SIZE="-0.27332706198455065" ESTIMABLE="YES" I2="45.34772748304304" ID="CMP-001.08.01" NO="1" P_CHI2="0.06657855515462341" P_Z="2.4873245957811497E-6" STUDIES="9" TAU2="0.0" TOTAL_1="594" TOTAL_2="615" WEIGHT="69.78718667648178" Z="4.709165983513903">
<NAME>Optimal Self Management</NAME>
<CONT_DATA CI_END="0.14992010852804932" CI_START="-0.622187768904523" EFFECT_SIZE="-0.23613383018823686" ESTIMABLE="YES" MEAN_1="2.2" MEAN_2="5.2" ORDER="1138" SD_1="12.73" SD_2="12.5" SE="0.19696991463181485" STUDY_ID="STD-Cote-1997" TOTAL_1="50" TOTAL_2="54" WEIGHT="6.059728512570351"/>
<CONT_DATA CI_END="-0.2706857695747553" CI_START="-0.7503736736755964" EFFECT_SIZE="-0.5105297216251758" ESTIMABLE="YES" MEAN_1="17.6" MEAN_2="34.1" ORDER="1139" SD_1="24.2" SD_2="38.8" SE="0.122371611898116" STUDY_ID="STD-Ghosh-1998" TOTAL_1="140" TOTAL_2="136" WEIGHT="15.699708881921065"/>
<CONT_DATA CI_END="0.932784068171465" CI_START="-0.2909787965442836" EFFECT_SIZE="0.3209026358135907" ESTIMABLE="YES" MEAN_1="0.38" MEAN_2="0.23" ORDER="1140" SD_1="0.56" SD_2="0.29" SE="0.3121901408313198" STUDY_ID="STD-Hayward-1996" TOTAL_1="23" TOTAL_2="19" WEIGHT="2.412207111400052"/>
<CONT_DATA CI_END="0.18007077604446342" CI_START="-0.38766110766516615" EFFECT_SIZE="-0.10379516581035135" ESTIMABLE="YES" MEAN_1="2.09" MEAN_2="2.66" ORDER="1141" SD_1="5.93" SD_2="4.95" SE="0.14483222349691785" STUDY_ID="STD-Heard-1999" TOTAL_1="97" TOTAL_2="94" WEIGHT="11.207856569522555"/>
<CONT_DATA CI_END="-0.29332191776260885" CI_START="-1.2674233283712733" EFFECT_SIZE="-0.7803726230669411" ESTIMABLE="YES" MEAN_1="4.92" MEAN_2="20.0" ORDER="1142" SD_1="6.05" SD_2="26.34" SE="0.24849982405091423" STUDY_ID="STD-Ignacio_x002d_Garcia-1995" TOTAL_1="35" TOTAL_2="35" WEIGHT="3.807157025727551"/>
<CONT_DATA CI_END="0.2019335385340992" CI_START="-0.587889441018022" EFFECT_SIZE="-0.1929779512419614" ESTIMABLE="YES" MEAN_1="0.85" MEAN_2="2.31" ORDER="1143" SD_1="4.75" SD_2="9.16" SE="0.20148915637790898" STUDY_ID="STD-Knoell-1998" TOTAL_1="45" TOTAL_2="55" WEIGHT="5.790947180501448"/>
<CONT_DATA CI_END="0.12258597987238293" CI_START="-0.6115548501859519" EFFECT_SIZE="-0.2444844351567845" ESTIMABLE="YES" MEAN_1="2.8" MEAN_2="4.8" ORDER="1144" SD_1="9.0" SD_2="7.2" SE="0.18728426538679893" STUDY_ID="STD-Lahdensuo-1996" TOTAL_1="56" TOTAL_2="59" WEIGHT="6.7027091898482105"/>
<CONT_DATA CI_END="0.1325290842023607" CI_START="-1.128179442906563" EFFECT_SIZE="-0.4978251793521012" ESTIMABLE="YES" MEAN_1="24.1" MEAN_2="31.8" ORDER="1145" SD_1="11.8" SD_2="17.9" SE="0.3216152278953164" STUDY_ID="STD-Sommaruga-1995" TOTAL_1="20" TOTAL_2="20" WEIGHT="2.27289699004962"/>
<CONT_DATA CI_END="0.08847260339658586" CI_START="-0.389177181669722" EFFECT_SIZE="-0.15035228913656806" ESTIMABLE="YES" MEAN_1="1.4" MEAN_2="2.3" ORDER="1146" SD_1="3.3" SD_2="7.6" SE="0.12185167401899942" STUDY_ID="STD-Zeiger-1991" TOTAL_1="128" TOTAL_2="143" WEIGHT="15.833975214940931"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.31436601986218105" CI_START="-0.21748625652663914" DF="0.0" EFFECT_SIZE="0.04843988166777094" ESTIMABLE="YES" I2="0.0" ID="CMP-001.08.02" NO="2" P_CHI2="1.0" P_Z="0.721078315783034" STUDIES="1" TAU2="0.0" TOTAL_1="119" TOTAL_2="100" WEIGHT="12.7710642351373" Z="0.3570180206009127">
<NAME>Self Monitoring and Regular Review</NAME>
<CONT_DATA CI_END="0.31436601986218105" CI_START="-0.21748625652663914" EFFECT_SIZE="0.04843988166777094" ESTIMABLE="YES" MEAN_1="6.23" MEAN_2="5.71" ORDER="1147" SD_1="12.2" SD_2="8.57" SE="0.13567909425479321" STUDY_ID="STD-Garret-1994" TOTAL_1="119" TOTAL_2="100" WEIGHT="12.7710642351373"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.22949718620490195" CI_START="-0.7473598993421038" DF="0.0" EFFECT_SIZE="-0.2589313565686009" ESTIMABLE="YES" I2="0.0" ID="CMP-001.08.03" NO="3" P_CHI2="1.0" P_Z="0.29878677660466524" STUDIES="1" TAU2="0.0" TOTAL_1="32" TOTAL_2="33" WEIGHT="3.7857076456587118" Z="1.0390386492582515">
<NAME>Self Monitoring Only</NAME>
<CONT_DATA CI_END="0.22949718620490195" CI_START="-0.7473598993421038" EFFECT_SIZE="-0.2589313565686009" ESTIMABLE="YES" MEAN_1="2.1" MEAN_2="5.1" ORDER="1148" SD_1="8.0" SD_2="14.0" SE="0.24920281526914007" STUDY_ID="STD-Neri-1996" TOTAL_1="32" TOTAL_2="33" WEIGHT="3.7857076456587118"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="3.5450415739360036E-32" CI_END="0.4826478608473588" CI_START="-0.09520552037489963" DF="0.0" EFFECT_SIZE="0.19372117023622956" ESTIMABLE="YES" I2="100.00000000000001" ID="CMP-001.08.04" NO="4" P_CHI2="0.0" P_Z="0.18880329291319173" STUDIES="1" TAU2="0.0" TOTAL_1="86" TOTAL_2="100" WEIGHT="10.818668571809562" Z="1.314127524538702">
<NAME>Regular Review Only</NAME>
<CONT_DATA CI_END="0.4826478608473587" CI_START="-0.09520552037489965" EFFECT_SIZE="0.19372117023622953" ESTIMABLE="YES" MEAN_1="0.73" MEAN_2="0.47" ORDER="1149" SD_1="1.48" SD_2="1.2" SE="0.14741428561450418" STUDY_ID="STD-Hilton-1986" TOTAL_1="86" TOTAL_2="100" WEIGHT="10.818668571809562"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.23646024854206021" CI_START="-0.8918963190796427" DF="0.0" EFFECT_SIZE="-0.32771803526879123" ESTIMABLE="YES" I2="0.0" ID="CMP-001.08.05" NO="5" P_CHI2="1.0" P_Z="0.2549128355911747" STUDIES="1" TAU2="0.0" TOTAL_1="25" TOTAL_2="24" WEIGHT="2.8373728709126556" Z="1.138497465504013">
<NAME>Written Action Plan not Optimal</NAME>
<CONT_DATA CI_END="0.23646024854206021" CI_START="-0.8918963190796427" EFFECT_SIZE="-0.32771803526879123" ESTIMABLE="YES" MEAN_1="8.0" MEAN_2="26.0" ORDER="1150" SD_1="32.0" SD_2="70.0" SE="0.28785135250495303" STUDY_ID="STD-Gallefoss-1999" TOTAL_1="25" TOTAL_2="24" WEIGHT="2.8373728709126556"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="107.02435123469787" CI_END="0.7917262708656038" CI_START="0.5640375813555175" CI_STUDY="95" CI_TOTAL="95" DF="4.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.6682539718659803" ESTIMABLE="YES" EVENTS_1="133" EVENTS_2="198" I2="96.26253282187318" I2_Q="0.0" ID="CMP-001.09" LOG_CI_END="-0.10142494416894735" LOG_CI_START="-0.24869195837202687" LOG_EFFECT_SIZE="-0.17505845127048714" METHOD="MH" NO="9" P_CHI2="2.220446049250313E-16" P_Q="0.0" P_Z="3.1670804615868916E-6" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="567" TOTAL_2="569" WEIGHT="100.0" Z="4.659675644762818">
<NAME>Nocturnal Asthma (% subjects)</NAME>
<GROUP_LABEL_1>Self Management</GROUP_LABEL_1>
<GROUP_LABEL_2>Usual Care</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Self M'gment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Usual Care</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="194.54312570449918" CI_END="0.7214349120908697" CI_START="0.44886053188930913" DF="2.0" EFFECT_SIZE="0.5690550574106382" ESTIMABLE="YES" EVENTS_1="52" EVENTS_2="93" I2="98.97195031037083" ID="CMP-001.09.01" LOG_CI_END="-0.14180284488216455" LOG_CI_START="-0.34788858024382024" LOG_EFFECT_SIZE="-0.2448457125629924" NO="1" P_CHI2="4.440892098500626E-16" P_Z="3.2057625314595814E-6" STUDIES="3" TAU2="0.0" TOTAL_1="281" TOTAL_2="289" WEIGHT="46.39868574919159" Z="4.6571760782022515">
<NAME>Optimal Self Management</NAME>
<DICH_DATA CI_END="0.8096858978978603" CI_START="0.1574289291902073" EFFECT_SIZE="0.3570265870862724" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="19" LOG_CI_END="-0.09168342465919992" LOG_CI_START="-0.8029154585510367" LOG_EFFECT_SIZE="-0.44729944160511836" ORDER="1151" O_E="0.0" SE="0.41778121736341306" STUDY_ID="STD-Heard-1999" TOTAL_1="97" TOTAL_2="94" VAR="0.1745411455816554" WEIGHT="9.74614220106075"/>
<DICH_DATA CI_END="1.0836670317563382" CI_START="0.9227926758824286" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="34" EVENTS_2="34" LOG_CI_END="0.03489586109120096" LOG_CI_START="-0.03489586109120092" LOG_EFFECT_SIZE="0.0" ORDER="1152" O_E="0.0" SE="0.0409960030845394" STUDY_ID="STD-Ignacio_x002d_Garcia-1995" TOTAL_1="35" TOTAL_2="35" VAR="0.001680672268907564" WEIGHT="17.17076707913416"/>
<DICH_DATA CI_END="0.5538323862833638" CI_START="0.1574542791128033" EFFECT_SIZE="0.2953020134228188" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="40" LOG_CI_END="-0.2566216517451869" LOG_CI_START="-0.8028455321069863" LOG_EFFECT_SIZE="-0.5297335919260866" ORDER="1153" O_E="0.0" SE="0.32085461117633596" STUDY_ID="STD-Zeiger-1991" TOTAL_1="149" TOTAL_2="160" VAR="0.10294768151311774" WEIGHT="19.481776468996685"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.5591594172227086" CI_END="0.9571373494774159" CI_START="0.5941693553752008" DF="1.0" EFFECT_SIZE="0.754123121210671" ESTIMABLE="YES" EVENTS_1="81" EVENTS_2="105" I2="0.0" ID="CMP-001.09.02" LOG_CI_END="-0.019025736371510848" LOG_CI_START="-0.22608975094138986" LOG_EFFECT_SIZE="-0.12255774365645038" NO="2" P_CHI2="0.4545992304746529" P_Z="0.020333298720771973" STUDIES="2" TAU2="0.0" TOTAL_1="286" TOTAL_2="280" WEIGHT="53.6013142508084" Z="2.3201401179447383">
<NAME>Self Monitoring and Regular Review</NAME>
<DICH_DATA CI_END="1.1277537934457957" CI_START="0.3307210677925658" EFFECT_SIZE="0.6107142857142858" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="20" LOG_CI_END="0.052214296616394665" LOG_CI_START="-0.4805381385165253" LOG_EFFECT_SIZE="-0.21416192095006534" ORDER="1154" O_E="0.0" SE="0.31294141756416277" STUDY_ID="STD-Allen-1995" TOTAL_1="56" TOTAL_2="57" VAR="0.09793233082706768" WEIGHT="10.01106669892257"/>
<DICH_DATA CI_END="1.019459738907506" CI_START="0.6076371317609283" EFFECT_SIZE="0.7870588235294118" ESTIMABLE="YES" EVENTS_1="69" EVENTS_2="85" LOG_CI_END="0.008370079044449898" LOG_CI_START="-0.21635569493738913" LOG_EFFECT_SIZE="-0.10399280794646959" ORDER="1155" O_E="0.0" SE="0.13200503204745417" STUDY_ID="STD-Garret-1994" TOTAL_1="230" TOTAL_2="223" VAR="0.017425328485849403" WEIGHT="43.59024755188583"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="9.464550907584528" CI_END="0.21673458696023185" CI_START="-0.023508547786959252" CI_STUDY="95" CI_TOTAL="95" DF="6.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.09661301958663629" ESTIMABLE="YES" I2="36.605549924277646" I2_Q="0.0" ID="CMP-001.10" NO="10" P_CHI2="0.14908818000626878" P_Q="0.40030173768961796" P_Z="0.11493671613375511" Q="0.7074210899223239" RANDOM="NO" SCALE="1.0" SORT_BY="STUDY" STUDIES="7" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="526" TOTAL_2="546" UNITS="" WEIGHT="100.0" Z="1.5763866803247657">
<NAME>FEV1 (mean)</NAME>
<GROUP_LABEL_1>Self Management</GROUP_LABEL_1>
<GROUP_LABEL_2>Usual Care</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Usual Care</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Self M'gment</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="8.757129817662204" CI_END="0.2074707086339754" CI_START="-0.040360835151458524" DF="5.0" EFFECT_SIZE="0.08355493674125844" ESTIMABLE="YES" I2="42.90366702209291" ID="CMP-001.10.01" NO="1" P_CHI2="0.11915255139676661" P_Z="0.1863078830634016" STUDIES="6" TAU2="0.0" TOTAL_1="494" TOTAL_2="513" WEIGHT="93.96990929086358" Z="1.321580491667939">
<NAME>Optimal Self Management</NAME>
<CONT_DATA CI_END="0.1448325433570635" CI_START="-0.2024069832644003" EFFECT_SIZE="-0.02878721995366839" ESTIMABLE="YES" MEAN_1="74.6" MEAN_2="75.4" ORDER="1156" SD_1="27.8" SD_2="27.7" SE="0.08858313962920872" STUDY_ID="STD-Grampian-1994" TOTAL_1="250" TOTAL_2="260" WEIGHT="47.86782129609768"/>
<CONT_DATA CI_END="1.195647081438433" CI_START="0.22768475096884677" EFFECT_SIZE="0.7116659162036398" ESTIMABLE="YES" MEAN_1="80.45" MEAN_2="65.48" ORDER="1157" SD_1="19.52" SD_2="22.01" SE="0.2469337034008659" STUDY_ID="STD-Ignacio_x002d_Garcia-1995" TOTAL_1="35" TOTAL_2="35" WEIGHT="6.160061655678063"/>
<CONT_DATA CI_END="0.5728685285548807" CI_START="-0.35501429605110313" EFFECT_SIZE="0.10892711625188879" ESTIMABLE="YES" MEAN_1="83.2" MEAN_2="81.2" ORDER="1158" SD_1="18.0" SD_2="18.3" SE="0.23670915178161567" STUDY_ID="STD-Jones-1995" TOTAL_1="33" TOTAL_2="39" WEIGHT="6.703717434591608"/>
<CONT_DATA CI_END="0.4599040570248497" CI_START="-0.2718332727676366" EFFECT_SIZE="0.09403539212860655" ESTIMABLE="YES" MEAN_1="80.9" MEAN_2="79.4" ORDER="1159" SD_1="16.1" SD_2="15.6" SE="0.18667111629712" STUDY_ID="STD-Lahdensuo-1996" TOTAL_1="56" TOTAL_2="59" WEIGHT="10.779324584304055"/>
<CONT_DATA CI_END="0.4988891328272434" CI_START="-0.5487995466769406" EFFECT_SIZE="-0.024955206924848608" ESTIMABLE="YES" MEAN_1="2.79" MEAN_2="2.81" ORDER="1160" SD_1="0.81" SD_2="0.77" SE="0.26727243147532775" STUDY_ID="STD-Yoon-1993" TOTAL_1="28" TOTAL_2="28" WEIGHT="5.258204462574744"/>
<CONT_DATA CI_END="0.477594099922918" CI_START="-0.10167040467542485" EFFECT_SIZE="0.1879618476237466" ESTIMABLE="YES" MEAN_1="92.9" MEAN_2="88.7" ORDER="1161" SD_1="22.6" SD_2="21.9" SE="0.1477742726824338" STUDY_ID="STD-Zeiger-1991" TOTAL_1="92" TOTAL_2="92" WEIGHT="17.200779857617434"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-001.10.02" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Self Management and Regular Review</NAME>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.7892727922983626" CI_START="-0.1890655252528246" DF="0.0" EFFECT_SIZE="0.300103633522769" ESTIMABLE="YES" I2="0.0" ID="CMP-001.10.03" NO="3" P_CHI2="1.0" P_Z="0.22919648570160078" STUDIES="1" TAU2="0.0" TOTAL_1="32" TOTAL_2="33" WEIGHT="6.030090709136416" Z="1.202431311913652">
<NAME>Self Monitoring Only</NAME>
<CONT_DATA CI_END="0.7892727922983626" CI_START="-0.1890655252528246" EFFECT_SIZE="0.300103633522769" ESTIMABLE="YES" MEAN_1="78.3" MEAN_2="73.4" ORDER="1162" SD_1="15.3" SD_2="16.9" SE="0.2495806875198205" STUDY_ID="STD-Neri-1996" TOTAL_1="32" TOTAL_2="33" WEIGHT="6.030090709136416"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-001.10.04" NO="4" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Regular Review Only</NAME>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="30.128331474356013" CI_END="0.28673721292260423" CI_START="0.07100813941887463" CI_STUDY="95" CI_TOTAL="95" DF="9.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.17887267617073943" ESTIMABLE="YES" I2="70.12778484709509" I2_Q="0.0" ID="CMP-001.11" NO="11" P_CHI2="4.171986444840847E-4" P_Q="0.6829430681340786" P_Z="0.0011531377549066127" Q="0.7626880454976401" RANDOM="NO" SCALE="1.0" SORT_BY="STUDY" STUDIES="10" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="664" TOTAL_2="682" UNITS="" WEIGHT="100.00000000000001" Z="3.2502248993980336">
<NAME>Peak Expiratory Flow (mean)</NAME>
<GROUP_LABEL_1>Self Management</GROUP_LABEL_1>
<GROUP_LABEL_2>Usual Care</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Usual Care</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Self M'gment</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="28.908787385640032" CI_END="0.31391851292639805" CI_START="0.08148452486698389" DF="5.0" EFFECT_SIZE="0.19770151889669096" ESTIMABLE="YES" I2="82.70422092320734" ID="CMP-001.11.01" NO="1" P_CHI2="2.4162932685922733E-5" P_Z="8.55526530110486E-4" STUDIES="6" TAU2="0.0" TOTAL_1="574" TOTAL_2="585" WEIGHT="86.14262246241647" Z="3.3341755219321083">
<NAME>Optimal Self Management</NAME>
<CONT_DATA CI_END="0.8821129417349663" CI_START="0.39805701548851713" EFFECT_SIZE="0.6400849786117417" ESTIMABLE="YES" MEAN_1="332.0" MEAN_2="290.0" ORDER="1163" SD_1="50.78" SD_2="77.69" SE="0.1234859237375331" STUDY_ID="STD-Ghosh-1998" TOTAL_1="140" TOTAL_2="136" WEIGHT="19.862150740701924"/>
<CONT_DATA CI_END="0.09392489368731341" CI_START="-0.25343555009280216" EFFECT_SIZE="-0.07975532820274436" ESTIMABLE="YES" MEAN_1="335.0" MEAN_2="345.0" ORDER="1164" SD_1="120.0" SD_2="130.0" SE="0.08861398640996732" STUDY_ID="STD-Grampian-1994" TOTAL_1="250" TOTAL_2="260" WEIGHT="38.570621309490384"/>
<CONT_DATA CI_END="1.2815418678020671" CI_START="0.30617397218231485" EFFECT_SIZE="0.793857919992191" ESTIMABLE="YES" MEAN_1="411.0" MEAN_2="332.0" ORDER="1165" SD_1="107.0" SD_2="89.0" SE="0.24882291289873942" STUDY_ID="STD-Ignacio_x002d_Garcia-1995" TOTAL_1="35" TOTAL_2="35" WEIGHT="4.89193235862626"/>
<CONT_DATA CI_END="0.5390896109614952" CI_START="-0.3884166339296854" EFFECT_SIZE="0.07533648851590494" ESTIMABLE="YES" MEAN_1="89.0" MEAN_2="87.7" ORDER="1166" SD_1="17.5" SD_2="16.7" SE="0.23661308376256693" STUDY_ID="STD-Jones-1995" TOTAL_1="33" TOTAL_2="39" WEIGHT="5.409830671164138"/>
<CONT_DATA CI_END="0.8201445854214953" CI_START="-0.23354188254159586" EFFECT_SIZE="0.2933013514399497" ESTIMABLE="YES" MEAN_1="475.0" MEAN_2="447.0" ORDER="1167" SD_1="99.0" SD_2="89.0" SE="0.26880250766708863" STUDY_ID="STD-Yoon-1993" TOTAL_1="28" TOTAL_2="28" WEIGHT="4.191742069413445"/>
<CONT_DATA CI_END="0.43840515136905367" CI_START="-0.1550022921601011" EFFECT_SIZE="0.14170142960447626" ESTIMABLE="YES" MEAN_1="109.2" MEAN_2="104.3" ORDER="1168" SD_1="36.5" SD_2="32.2" SE="0.1513822315639157" STUDY_ID="STD-Zeiger-1991" TOTAL_1="88" TOTAL_2="87" WEIGHT="13.216345313020303"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.7092588941285272" CI_START="-0.7092588941285272" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="YES" I2="0.0" ID="CMP-001.11.02" NO="2" P_CHI2="1.0" P_Z="1.0" STUDIES="1" TAU2="0.0" TOTAL_1="12" TOTAL_2="21" WEIGHT="2.3128516863187967" Z="0.0">
<NAME>Self Monitoring and Regular Review</NAME>
<CONT_DATA CI_END="0.7092588941285272" CI_START="-0.7092588941285272" EFFECT_SIZE="0.0" ESTIMABLE="YES" MEAN_1="396.0" MEAN_2="396.0" ORDER="1169" SD_1="143.0" SD_2="122.0" SE="0.36187343222787294" STUDY_ID="STD-Mulloy-1996" TOTAL_1="12" TOTAL_2="21" WEIGHT="2.3128516863187967"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.45685604321834233" CI_END="0.3916730079742515" CI_START="-0.24324936103579547" DF="2.0" EFFECT_SIZE="0.074211823469228" ESTIMABLE="YES" I2="0.0" ID="CMP-001.11.03" NO="3" P_CHI2="0.7957837366597154" P_Z="0.6468273475724562" STUDIES="3" TAU2="0.0" TOTAL_1="78" TOTAL_2="76" WEIGHT="11.544525851264751" Z="0.4581741275032305">
<NAME>Self Monitoring Only</NAME>
<CONT_DATA CI_END="0.4931730188503277" CI_START="-0.5727319227987543" EFFECT_SIZE="-0.03977945197421331" ESTIMABLE="YES" MEAN_1="359.0" MEAN_2="364.0" ORDER="1170" SD_1="108.0" SD_2="142.0" SE="0.2719195225159248" STUDY_ID="STD-Berg-1997" TOTAL_1="31" TOTAL_2="24" WEIGHT="4.096192945667409"/>
<CONT_DATA CI_END="0.5400267177630077" CI_START="-0.3609888431126984" EFFECT_SIZE="0.08951893732515465" ESTIMABLE="YES" MEAN_1="367.0" MEAN_2="358.0" ORDER="1171" SD_1="68.0" SD_2="121.0" SE="0.22985513202865" STUDY_ID="STD-Kotses-1995" TOTAL_1="36" TOTAL_2="40" WEIGHT="5.732614972837338"/>
<CONT_DATA CI_END="1.1187008743264883" CI_START="-0.5282692947115091" EFFECT_SIZE="0.2952157898074897" ESTIMABLE="YES" MEAN_1="372.0" MEAN_2="340.0" ORDER="1172" SD_1="105.0" SD_2="104.0" SE="0.4201531716983291" STUDY_ID="STD-Kotses-1996" TOTAL_1="11" TOTAL_2="12" WEIGHT="1.7157179327600034"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-001.11.04" NO="4" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Regular Review Only</NAME>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="-2.929713523265622" CI_START="-10.470286476734378" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="MD" EFFECT_SIZE="-6.7" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-001.12" NO="12" P_CHI2="1.0" P_Q="1.0" P_Z="4.959016139190634E-4" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="SUB" TOTAL_1="172" TOTAL_2="175" UNITS="" WEIGHT="100.0" Z="3.4829604533903735">
<NAME>Hospitalisations (mean total days)</NAME>
<GROUP_LABEL_1>Self Management</GROUP_LABEL_1>
<GROUP_LABEL_2>Usual Care</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Self M'gment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Usual Care</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="-2.929713523265622" CI_START="-10.470286476734378" DF="0.0" EFFECT_SIZE="-6.7" ESTIMABLE="YES" I2="0.0" ID="CMP-001.12.01" NO="1" P_CHI2="1.0" P_Z="4.959016139190634E-4" STUDIES="1" TAU2="0.0" TOTAL_1="140" TOTAL_2="136" WEIGHT="100.0" Z="3.4829604533903735">
<NAME>Optimal Self Management</NAME>
<CONT_DATA CI_END="-2.929713523265622" CI_START="-10.470286476734378" EFFECT_SIZE="-6.7" ESTIMABLE="YES" MEAN_1="5.8" MEAN_2="12.5" ORDER="1173" SD_1="10.7" SD_2="19.8" SE="1.9236508968909207" STUDY_ID="STD-Ghosh-1998" TOTAL_1="140" TOTAL_2="136" WEIGHT="100.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-001.12.02" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Self Monitoring &amp; Regular Review</NAME>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-001.12.03" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Self Monitoring Only</NAME>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-001.12.04" NO="4" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Regular Review Only</NAME>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-001.12.05" NO="5" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="32" TOTAL_2="39" WEIGHT="0.0" Z="0.0">
<NAME>Written Action Plan not Optimal</NAME>
<CONT_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" MEAN_1="0.3" MEAN_2="0.0" ORDER="1174" SD_1="1.0" SD_2="0.0" SE="0.0" STUDY_ID="STD-Gallefoss-1999" TOTAL_1="32" TOTAL_2="39" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="3.2451408044092975" CI_END="1.0747121332178806" CI_START="0.9525863045338102" CI_STUDY="95" CI_TOTAL="95" DF="1.0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.0118083115984315" ESTIMABLE="YES" EVENTS_1="114" EVENTS_2="108" I2="69.18469612655137" I2_Q="0.0" ID="CMP-001.13" LOG_CI_END="0.03129215197537734" LOG_CI_START="-0.02109566669189605" LOG_EFFECT_SIZE="0.005098242641740625" METHOD="MH" NO="13" P_CHI2="0.07163559070514802" P_Q="0.0" P_Z="0.7028493917801091" Q="0.0" RANDOM="NO" SCALE="5.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="119" TOTAL_2="114" WEIGHT="100.0" Z="0.3814769240812156">
<NAME>Rescue Medication Use (% subjects)</NAME>
<GROUP_LABEL_1>Self Management</GROUP_LABEL_1>
<GROUP_LABEL_2>Usual Care</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Self M'gment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Usual Care</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.0394274458805979" CI_START="0.9234447756061033" DF="0.0" EFFECT_SIZE="0.9797213096182168" ESTIMABLE="YES" EVENTS_1="92" EVENTS_2="91" I2="0.0" ID="CMP-001.13.01" LOG_CI_END="0.016794180100007872" LOG_CI_START="-0.034589071384176974" LOG_EFFECT_SIZE="-0.008897445642084539" NO="1" P_CHI2="1.0" P_Z="0.49728439376201516" STUDIES="1" TAU2="0.0" TOTAL_1="97" TOTAL_2="94" WEIGHT="83.47663860741878" Z="0.6787687625511969">
<NAME>Optimal Self Management</NAME>
<DICH_DATA CI_END="1.039427445880598" CI_START="0.9234447756061032" EFFECT_SIZE="0.9797213096182168" ESTIMABLE="YES" EVENTS_1="92" EVENTS_2="91" LOG_CI_END="0.016794180100007966" LOG_CI_START="-0.03458907138417703" LOG_EFFECT_SIZE="-0.008897445642084539" ORDER="1175" O_E="0.0" SE="0.030182776273007205" STUDY_ID="STD-Heard-1999" TOTAL_1="97" TOTAL_2="94" VAR="9.109999835464067E-4" WEIGHT="83.47663860741878"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.4348832246318737" CI_START="0.9604069585536791" DF="0.0" EFFECT_SIZE="1.173913043478261" ESTIMABLE="YES" EVENTS_1="22" EVENTS_2="17" I2="0.0" ID="CMP-001.13.02" LOG_CI_END="0.15681655823961846" LOG_CI_START="-0.01754470195682956" LOG_EFFECT_SIZE="0.06963592814139447" NO="2" P_CHI2="1.0" P_Z="0.11745863678285845" STUDIES="1" TAU2="0.0" TOTAL_1="22" TOTAL_2="20" WEIGHT="16.52336139258123" Z="1.565530221947005">
<NAME>Self Monitoring &amp; Regular Review</NAME>
<DICH_DATA CI_END="1.4348832246318737" CI_START="0.9604069585536791" EFFECT_SIZE="1.173913043478261" ESTIMABLE="YES" EVENTS_1="22" EVENTS_2="17" LOG_CI_END="0.15681655823961846" LOG_CI_START="-0.01754470195682956" LOG_EFFECT_SIZE="0.06963592814139447" ORDER="1176" O_E="0.0" SE="0.1024206673415515" STUDY_ID="STD-de-Oliveira-1999" TOTAL_1="22" TOTAL_2="20" VAR="0.010489993098688755" WEIGHT="16.52336139258123"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="25.998177007258793" CI_END="0.46703368391888445" CI_START="0.11319045019460469" CI_STUDY="95" CI_TOTAL="95" DF="5.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.2901120670567446" ESTIMABLE="YES" I2="80.76788230727108" I2_Q="85.30582572996695" ID="CMP-001.14" NO="14" P_CHI2="8.930891105607408E-5" P_Q="1.3915174520418017E-4" P_Z="0.00130943159245867" Q="20.416254393539695" RANDOM="NO" SCALE="4.0" SORT_BY="STUDY" STUDIES="6" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="246" TOTAL_2="269" UNITS="" WEIGHT="99.99999999999999" Z="3.213904626220762">
<NAME>Quality of Life Total Score (mean)</NAME>
<GROUP_LABEL_1>Self Management</GROUP_LABEL_1>
<GROUP_LABEL_2>Usual Care</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Usual care</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Self M'gment</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="5.552185041122987" CI_END="0.3398041870305961" CI_START="-0.10654812284359524" DF="1.0" EFFECT_SIZE="0.11662803209350045" ESTIMABLE="YES" I2="81.98907290385013" ID="CMP-001.14.01" NO="1" P_CHI2="0.018457738892209474" P_Z="0.3057202566294477" STUDIES="2" TAU2="0.0" TOTAL_1="155" TOTAL_2="157" WEIGHT="62.84434693423257" Z="1.0242435736715323">
<NAME>Optimal Self Management</NAME>
<CONT_DATA CI_END="0.8436959252410676" CI_START="0.10187986503834562" EFFECT_SIZE="0.4727878951397066" ESTIMABLE="YES" MEAN_1="16.6" MEAN_2="8.4" ORDER="1177" SD_1="15.9" SD_2="18.4" SE="0.18924226823912896" STUDY_ID="STD-Lahdensuo-1996" TOTAL_1="56" TOTAL_2="59" WEIGHT="22.752510720423757"/>
<CONT_DATA CI_END="0.19392087724791002" CI_START="-0.3649132520162876" EFFECT_SIZE="-0.0854961873841888" ESTIMABLE="YES" MEAN_1="-30.25" MEAN_2="-28.73" ORDER="1178" SD_1="17.51" SD_2="17.91" SE="0.14256234646968258" STUDY_ID="STD-Levy-2000" TOTAL_1="99" TOTAL_2="98" WEIGHT="40.09183621380881"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="2.018724040925611" CI_START="0.665791300762448" DF="0.0" EFFECT_SIZE="1.3422576708440295" ESTIMABLE="YES" I2="0.0" ID="CMP-001.14.02" NO="2" P_CHI2="1.0" P_Z="1.0065874352852367E-4" STUDIES="1" TAU2="0.0" TOTAL_1="22" TOTAL_2="20" WEIGHT="6.840209092912574" Z="3.8889984915431146">
<NAME>Self Monitoring &amp; Regular Review</NAME>
<CONT_DATA CI_END="2.018724040925611" CI_START="0.665791300762448" EFFECT_SIZE="1.3422576708440295" ESTIMABLE="YES" MEAN_1="-28.0" MEAN_2="-50.0" ORDER="1179" SD_1="17.0" SD_2="15.0" SE="0.34514224517259595" STUDY_ID="STD-de-Oliveira-1999" TOTAL_1="22" TOTAL_2="20" WEIGHT="6.840209092912574"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.029737572596111747" CI_END="0.4331293531536858" CI_START="-0.41154284688545967" DF="1.0" EFFECT_SIZE="0.010793253134113083" ESTIMABLE="YES" I2="0.0" ID="CMP-001.14.03" NO="3" P_CHI2="0.8630870597917675" P_Z="0.9600514758305518" STUDIES="2" TAU2="0.0" TOTAL_1="37" TOTAL_2="53" WEIGHT="17.548717751034797" Z="0.05008898698904812">
<NAME>Self Monitoring Only</NAME>
<CONT_DATA CI_END="0.4532188718809784" CI_START="-0.4628213014231617" EFFECT_SIZE="-0.004801214771091645" ESTIMABLE="YES" MEAN_1="-2.73" MEAN_2="-2.72" ORDER="1180" SD_1="2.0" SD_2="2.1" SE="0.2336880117516822" STUDY_ID="STD-Abdulwadud-1999" TOTAL_1="30" TOTAL_2="47" WEIGHT="14.920822026262265"/>
<CONT_DATA CI_END="1.190718569315177" CI_START="-0.9920456756272525" EFFECT_SIZE="0.09933644684396221" ESTIMABLE="YES" MEAN_1="4.59" MEAN_2="4.43" ORDER="1181" SD_1="1.48" SD_2="1.52" SE="0.5568378455318045" STUDY_ID="STD-Blixen-2001" TOTAL_1="7" TOTAL_2="6" WEIGHT="2.6278957247725314"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="1.4594635074971736" CI_START="0.46915360273543133" DF="0.0" EFFECT_SIZE="0.9643085551163024" ESTIMABLE="YES" I2="0.0" ID="CMP-001.14.05" NO="5" P_CHI2="1.0" P_Z="1.35080208001072E-4" STUDIES="1" TAU2="0.0" TOTAL_1="32" TOTAL_2="39" WEIGHT="12.766726221820045" Z="3.817007239701448">
<NAME>Written Action Plan not Optimal</NAME>
<CONT_DATA CI_END="1.4594635074971736" CI_START="0.46915360273543133" EFFECT_SIZE="0.9643085551163024" ESTIMABLE="YES" MEAN_1="-20.2" MEAN_2="-36.5" ORDER="1182" SD_1="15.0" SD_2="18.0" SE="0.2526347199676066" STUDY_ID="STD-Gallefoss-1999" TOTAL_1="32" TOTAL_2="39" WEIGHT="12.766726221820045"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="12.542299562922313" CI_END="0.47036643295518543" CI_START="-0.016793280790466575" CI_STUDY="95" CI_TOTAL="95" DF="1.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.22678657608235941" ESTIMABLE="YES" I2="92.02698041947417" I2_Q="92.02698041947417" ID="CMP-001.15" NO="15" P_CHI2="3.978491368562542E-4" P_Q="3.978491368562542E-4" P_Z="0.06802563919993364" Q="12.542299562922313" RANDOM="NO" SCALE="4.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="131" TOTAL_2="137" UNITS="" WEIGHT="100.0" Z="1.824836942615699">
<NAME>Quality of Life Impact (mean)</NAME>
<GROUP_LABEL_1>Self Management</GROUP_LABEL_1>
<GROUP_LABEL_2>Usual Care</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Usual Care</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Self M'gment</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.25915864782298564" CI_START="-0.29942959906464256" DF="0.0" EFFECT_SIZE="-0.020135475620828437" ESTIMABLE="YES" I2="0.0" ID="CMP-001.15.01" NO="1" P_CHI2="1.0" P_Z="0.8876314014177975" STUDIES="1" TAU2="0.0" TOTAL_1="99" TOTAL_2="98" WEIGHT="76.06049475307651" Z="0.14130195989013425">
<NAME>Optimal Self Management</NAME>
<CONT_DATA CI_END="0.25915864782298564" CI_START="-0.29942959906464256" EFFECT_SIZE="-0.020135475620828437" ESTIMABLE="YES" MEAN_1="-24.27" MEAN_2="-23.88" ORDER="1183" SD_1="20.59" SD_2="17.89" SE="0.14249962022100943" STUDY_ID="STD-Levy-2000" TOTAL_1="99" TOTAL_2="98" WEIGHT="76.06049475307651"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="1.5091393931362438" CI_START="0.5134731543102798" DF="0.0" EFFECT_SIZE="1.0113062737232619" ESTIMABLE="YES" I2="0.0" ID="CMP-001.15.05" NO="5" P_CHI2="1.0" P_Z="6.84809634927565E-5" STUDIES="1" TAU2="0.0" TOTAL_1="32" TOTAL_2="39" WEIGHT="23.93950524692348" Z="3.981502629182672">
<NAME>Written Action Plan not Optimal</NAME>
<CONT_DATA CI_END="1.5091393931362438" CI_START="0.5134731543102798" EFFECT_SIZE="1.0113062737232619" ESTIMABLE="YES" MEAN_1="-13.8" MEAN_2="-32.4" ORDER="1184" SD_1="14.0" SD_2="21.0" SE="0.2540011568272816" STUDY_ID="STD-Gallefoss-1999" TOTAL_1="32" TOTAL_2="39" WEIGHT="23.93950524692348"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="6.059466564946732" CI_END="0.3999411473243074" CI_START="-0.0719010959866615" CI_STUDY="95" CI_TOTAL="95" DF="2.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.16402002566882296" ESTIMABLE="YES" I2="66.99379427935531" I2_Q="66.99379427935531" ID="CMP-001.16" NO="16" P_CHI2="0.04832866779696143" P_Q="0.04832866779696143" P_Z="0.1729989552361006" Q="6.059466564946732" RANDOM="NO" SCALE="4.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="138" TOTAL_2="143" UNITS="" WEIGHT="99.99999999999999" Z="1.3626306148360707">
<NAME>Quality of Life Activity (mean)</NAME>
<GROUP_LABEL_1>Self Management</GROUP_LABEL_1>
<GROUP_LABEL_2>Usual Care</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Usual Care</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Self M'gment</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.2708520673313283" CI_START="-0.28772427224967945" DF="0.0" EFFECT_SIZE="-0.00843610245917561" ESTIMABLE="YES" I2="0.0" ID="CMP-001.16.01" NO="1" P_CHI2="1.0" P_Z="0.9527911061243711" STUDIES="1" TAU2="0.0" TOTAL_1="99" TOTAL_2="98" WEIGHT="71.35568318293531" Z="0.05920213878832246">
<NAME>Optimal Self Management</NAME>
<CONT_DATA CI_END="0.2708520673313283" CI_START="-0.28772427224967945" EFFECT_SIZE="-0.00843610245917561" ESTIMABLE="YES" MEAN_1="-32.29" MEAN_2="-32.07" ORDER="1185" SD_1="25.18" SD_2="26.76" SE="0.14249658258697268" STUDY_ID="STD-Levy-2000" TOTAL_1="99" TOTAL_2="98" WEIGHT="71.35568318293531"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="6.211562490759494E-34" CI_END="1.1895261407751139" CI_START="-0.9931932172846809" DF="0.0" EFFECT_SIZE="0.09816646174521647" ESTIMABLE="YES" I2="100.0" ID="CMP-001.16.03" NO="3" P_CHI2="0.0" P_Z="0.8600611283571689" STUDIES="1" TAU2="0.0" TOTAL_1="7" TOTAL_2="6" WEIGHT="4.673022152076475" Z="0.17629635142960276">
<NAME>Self Monitoring Only</NAME>
<CONT_DATA CI_END="1.1895261407751139" CI_START="-0.9931932172846809" EFFECT_SIZE="0.09816646174521648" ESTIMABLE="YES" MEAN_1="4.9" MEAN_2="4.75" ORDER="1186" SD_1="1.1" SD_2="1.73" SE="0.5568263945860247" STUDY_ID="STD-Blixen-2001" TOTAL_1="7" TOTAL_2="6" WEIGHT="4.673022152076475"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="1.172070436963325" CI_START="0.20834998689447737" DF="0.0" EFFECT_SIZE="0.6902102119289012" ESTIMABLE="YES" I2="0.0" ID="CMP-001.16.05" NO="5" P_CHI2="1.0" P_Z="0.004993907716519577" STUDIES="1" TAU2="0.0" TOTAL_1="32" TOTAL_2="39" WEIGHT="23.971294664988203" Z="2.807426483573659">
<NAME>Written Action Plan not Optimal</NAME>
<CONT_DATA CI_END="1.172070436963325" CI_START="0.2083499868944773" EFFECT_SIZE="0.6902102119289012" ESTIMABLE="YES" MEAN_1="-29.7" MEAN_2="-44.3" ORDER="1187" SD_1="22.0" SD_2="20.0" SE="0.24585157116930506" STUDY_ID="STD-Gallefoss-1999" TOTAL_1="32" TOTAL_2="39" WEIGHT="23.971294664988203"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="10.249545429767306" CI_END="0.1425982856188921" CI_START="-0.33050032836658516" CI_STUDY="95" CI_TOTAL="95" DF="2.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.09395102137384653" ESTIMABLE="YES" I2="80.48693950668789" I2_Q="80.48693950668789" ID="CMP-001.17" NO="17" P_CHI2="0.005947596824460999" P_Q="0.005947596824460999" P_Z="0.4363067430587616" Q="10.249545429767306" RANDOM="NO" SCALE="4.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="138" TOTAL_2="143" UNITS="" WEIGHT="99.99999999999997" Z="0.7784449700761314">
<NAME>Quality of Life Symptoms (mean)</NAME>
<GROUP_LABEL_1>Self Management</GROUP_LABEL_1>
<GROUP_LABEL_2>Usual Care</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Usual Care</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Self M'gment</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="1.496132227901138E-31" CI_END="-0.05407481069499598" CI_START="-0.616640617387448" DF="0.0" EFFECT_SIZE="-0.335357714041222" ESTIMABLE="YES" I2="99.99999999999999" ID="CMP-001.17.01" NO="1" P_CHI2="0.0" P_Z="0.019451961932184587" STUDIES="1" TAU2="0.0" TOTAL_1="99" TOTAL_2="98" WEIGHT="70.72235075871369" Z="2.336754326833126">
<NAME>Optimal Self Management</NAME>
<CONT_DATA CI_END="-0.054074810694996034" CI_START="-0.6166406173874481" EFFECT_SIZE="-0.33535771404122205" ESTIMABLE="YES" MEAN_1="-45.67" MEAN_2="-38.12" ORDER="1188" SD_1="22.86" SD_2="21.98" SE="0.14351432249008128" STUDY_ID="STD-Levy-2000" TOTAL_1="99" TOTAL_2="98" WEIGHT="70.72235075871369"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="1.1902541980694508" CI_START="-0.9924925045050784" DF="0.0" EFFECT_SIZE="0.09888084678218616" ESTIMABLE="YES" I2="0.0" ID="CMP-001.17.03" NO="3" P_CHI2="1.0" P_Z="0.8590551220360679" STUDIES="1" TAU2="0.0" TOTAL_1="7" TOTAL_2="6" WEIGHT="4.697823216173613" Z="0.17757708507846515">
<NAME>Self Monitoring Only</NAME>
<CONT_DATA CI_END="1.1902541980694508" CI_START="-0.9924925045050784" EFFECT_SIZE="0.09888084678218616" ESTIMABLE="YES" MEAN_1="4.44" MEAN_2="4.25" ORDER="1189" SD_1="1.81" SD_2="1.76" SE="0.5568333703557199" STUDY_ID="STD-Blixen-2001" TOTAL_1="7" TOTAL_2="6" WEIGHT="4.697823216173613"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="1.0409069332898382" CI_START="0.08665670307379808" DF="0.0" EFFECT_SIZE="0.5637818181818182" ESTIMABLE="YES" I2="0.0" ID="CMP-001.17.05" NO="5" P_CHI2="1.0" P_Z="0.020561668568494496" STUDIES="1" TAU2="0.0" TOTAL_1="32" TOTAL_2="39" WEIGHT="24.579826025112677" Z="2.315937735796417">
<NAME>Written Action Plan not Optimal</NAME>
<CONT_DATA CI_END="1.0409069332898382" CI_START="0.08665670307379808" EFFECT_SIZE="0.5637818181818182" ESTIMABLE="YES" MEAN_1="-31.1" MEAN_2="-42.5" ORDER="1190" SD_1="20.0" SD_2="20.0" SE="0.24343565436483633" STUDY_ID="STD-Gallefoss-1999" TOTAL_1="32" TOTAL_2="39" WEIGHT="24.579826025112677"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.07229173438351796" CI_END="0.6798111282473244" CI_START="0.09642016158862032" CI_STUDY="95" CI_TOTAL="95" DF="1.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.38811564491797235" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-001.18" NO="18" P_CHI2="0.788028788761762" P_Q="0.788028788761762" P_Z="0.009111778048763237" Q="0.07229173438351796" RANDOM="NO" SCALE="4.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="87" TOTAL_2="98" UNITS="" WEIGHT="100.0" Z="2.607831554994862">
<NAME>Total Direct Costs (mean)</NAME>
<GROUP_LABEL_1>Self Management</GROUP_LABEL_1>
<GROUP_LABEL_2>Usual Care</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Self M'gmnt</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Usual Care</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.7271791634427593" CI_START="-0.01356630516515489" DF="0.0" EFFECT_SIZE="0.35680642913880223" ESTIMABLE="YES" I2="0.0" ID="CMP-001.18.01" NO="1" P_CHI2="1.0" P_Z="0.0590027460375943" STUDIES="1" TAU2="0.0" TOTAL_1="55" TOTAL_2="59" WEIGHT="62.02708809789077" Z="1.8881728750326197">
<NAME>Optimal Self Management</NAME>
<CONT_DATA CI_END="0.7271791634427593" CI_START="-0.01356630516515489" EFFECT_SIZE="0.35680642913880223" ESTIMABLE="YES" MEAN_1="5045.0" MEAN_2="4396.0" ORDER="1191" SD_1="1644.0" SD_2="1946.0" SE="0.18896915311985832" STUDY_ID="STD-Lahdensuo-1996" TOTAL_1="55" TOTAL_2="59" WEIGHT="62.02708809789077"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.912619182371529" CI_START="-0.03410342773515984" DF="0.0" EFFECT_SIZE="0.43925787731818455" ESTIMABLE="YES" I2="0.0" ID="CMP-001.18.05" NO="5" P_CHI2="1.0" P_Z="0.06894837188311402" STUDIES="1" TAU2="0.0" TOTAL_1="32" TOTAL_2="39" WEIGHT="37.972911902109225" Z="1.8187579134127467">
<NAME>Written action Plan not Optimal</NAME>
<CONT_DATA CI_END="0.912619182371529" CI_START="-0.03410342773515984" EFFECT_SIZE="0.43925787731818455" ESTIMABLE="YES" MEAN_1="5900.0" MEAN_2="4000.0" ORDER="1192" SD_1="4800.0" SD_2="3800.0" SE="0.2415153078256325" STUDY_ID="STD-Gallefoss-1999" TOTAL_1="32" TOTAL_2="39" WEIGHT="37.972911902109225"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.5199863051189597" CI_END="-0.10649838364867081" CI_START="-0.6905361978225842" CI_STUDY="95" CI_TOTAL="95" DF="1.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.3985172907356275" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-001.19" NO="19" P_CHI2="0.47084759110951124" P_Q="0.47084759110951124" P_Z="0.007478349340269021" Q="0.5199863051189597" RANDOM="NO" SCALE="4.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="87" TOTAL_2="98" UNITS="" WEIGHT="99.99999999999999" Z="2.67475673013775">
<NAME>Total Indirect Costs (mean)</NAME>
<GROUP_LABEL_1>Self Management</GROUP_LABEL_1>
<GROUP_LABEL_2>Usual Care</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Self M'gmnt</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Usual Care</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="-0.11094646514352252" CI_START="-0.85670621100601" DF="0.0" EFFECT_SIZE="-0.48382633807476627" ESTIMABLE="YES" I2="0.0" ID="CMP-001.19.01" NO="1" P_CHI2="1.0" P_Z="0.01098641712804701" STUDIES="1" TAU2="0.0" TOTAL_1="55" TOTAL_2="59" WEIGHT="61.33156667732961" Z="2.543130552861185">
<NAME>Optimal Self Management</NAME>
<CONT_DATA CI_END="-0.11094646514352252" CI_START="-0.85670621100601" EFFECT_SIZE="-0.48382633807476627" ESTIMABLE="YES" MEAN_1="1149.0" MEAN_2="3561.0" ORDER="1193" SD_1="2794.0" SD_2="6331.0" SE="0.19024832898587554" STUDY_ID="STD-Lahdensuo-1996" TOTAL_1="55" TOTAL_2="59" WEIGHT="61.33156667732961"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.20639539683790764" CI_START="-0.7328145395402805" DF="0.0" EFFECT_SIZE="-0.26320957135118644" ESTIMABLE="YES" I2="0.0" ID="CMP-001.19.05" NO="5" P_CHI2="1.0" P_Z="0.27196744160090325" STUDIES="1" TAU2="0.0" TOTAL_1="32" TOTAL_2="39" WEIGHT="38.668433322670374" Z="1.0985430631705393">
<NAME>Written Action Plan not Optimal</NAME>
<CONT_DATA CI_END="0.20639539683790764" CI_START="-0.7328145395402805" EFFECT_SIZE="-0.26320957135118644" ESTIMABLE="YES" MEAN_1="4600.0" MEAN_2="11900.0" ORDER="1194" SD_1="17300.0" SD_2="33500.0" SE="0.2395987742087498" STUDY_ID="STD-Gallefoss-1999" TOTAL_1="32" TOTAL_2="39" WEIGHT="38.668433322670374"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.16736843810041743" CI_END="0.029911179267220533" CI_START="-0.5504522950302324" CI_STUDY="95" CI_TOTAL="95" DF="1.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.26027055788150594" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-001.20" NO="20" P_CHI2="0.6824614816719261" P_Q="0.6824614816719261" P_Z="0.07875840106978164" Q="0.16736843810041743" RANDOM="NO" SCALE="4.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="87" TOTAL_2="98" UNITS="" WEIGHT="100.0" Z="1.7579359910663421">
<NAME>Total Costs (mean)</NAME>
<GROUP_LABEL_1>Self Management</GROUP_LABEL_1>
<GROUP_LABEL_2>Usual Care</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Self M'gmnt</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Usual Care</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.06155462150698465" CI_START="-0.6776619594666102" DF="0.0" EFFECT_SIZE="-0.3080536689798128" ESTIMABLE="YES" I2="0.0" ID="CMP-001.20.01" NO="1" P_CHI2="1.0" P_Z="0.10235310460718126" STUDIES="1" TAU2="0.0" TOTAL_1="55" TOTAL_2="59" WEIGHT="61.639164636127816" Z="1.6335512813055362">
<NAME>Optimal Self Management</NAME>
<CONT_DATA CI_END="0.06155462150698465" CI_START="-0.6776619594666102" EFFECT_SIZE="-0.3080536689798128" ESTIMABLE="YES" MEAN_1="6194.0" MEAN_2="7956.0" ORDER="1195" SD_1="4039.0" SD_2="6866.0" SE="0.1885791235972806" STUDY_ID="STD-Lahdensuo-1996" TOTAL_1="55" TOTAL_2="59" WEIGHT="61.639164636127816"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.28502630794411576" CI_START="-0.6520091904790376" DF="0.0" EFFECT_SIZE="-0.18349144126746092" ESTIMABLE="YES" I2="0.0" ID="CMP-001.20.05" NO="5" P_CHI2="1.0" P_Z="0.4427218346543764" STUDIES="1" TAU2="0.0" TOTAL_1="32" TOTAL_2="39" WEIGHT="38.360835363872184" Z="0.7676051055926223">
<NAME>Written Action Plan not Optimal</NAME>
<CONT_DATA CI_END="0.28502630794411576" CI_START="-0.6520091904790376" EFFECT_SIZE="-0.18349144126746092" ESTIMABLE="YES" MEAN_1="10500.0" MEAN_2="16000.0" ORDER="1196" SD_1="20500.0" SD_2="35400.0" SE="0.23904406045579657" STUDY_ID="STD-Gallefoss-1999" TOTAL_1="32" TOTAL_2="39" WEIGHT="38.360835363872184"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
</COMPARISON>
</ANALYSES_AND_DATA>
<FIGURES MODIFIED="2008-08-20 18:52:31 +0200" MODIFIED_BY="Toby J Lasserson">
<FIGURE FILENAME="Risk of bias summary.png" FILE_TYPE="PNG" ID="FIG-01" MODIFIED="2008-08-20 18:51:07 +0200" MODIFIED_BY="Toby J Lasserson" NO="1" SHORT_VERSION_FIGURE="YES" TYPE="QUALITY_TABLE_PLOT">
<CAPTION>
<P>Methodological quality summary: review authors' judgements about each methodological quality item for each included study.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAKYAAATXCAIAAADr25lXAAAkr0lEQVR42u2du24UT7CHRyIh2GAD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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-02" MODIFIED="2008-08-20 18:48:51 +0200" MODIFIED_BY="Toby J Lasserson" NO="2" REF_ID="CMP-001.01" SETTINGS="SHOW_WEIGHT_COLUMN:YES;SHOW_RAW_DATA_COLUMNS:YES;SHOW_EFFECT_SIZE_COLUMN:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 1 Self Management versus Usual Care, outcome: 1.1 Hospitalisations (% subjects hospitalised).</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAv4AAAJQCAMAAADBrZAVAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA
AMAAwMD////AwMD/gICA/4CAgP/g4OBAAAAAQAAAAECAgID/gAAAAAALCwsWFhYhISEsLCw3NzdC
QkJNTU1YWFhjY2Nubm55eXmEhISPj4+ampqlpaWwsLC7u7vGxsbR0dHc3Nzn5+cAAAAAADMAAGYA
AJkAAMwAAP8AMwAAMzMAM2YAM5kAM8wAM/8AZgAAZjMAZmYAZpkAZswAZv8AmQAAmTMAmWYAmZkA
mcwAmf8AzAAAzDMAzGYAzJkAzMwAzP8A/wAA/zMA/2YA/5kA/8wA//8zAAAzADMzAGYzAJkzAMwz
AP8zMwAzMzMzM2YzM5kzM8wzM/8zZgAzZjMzZmYzZpkzZswzZv8zmQAzmTMzmWYzmZkzmcwzmf8z
zAAzzDMzzGYzzJkzzMwzzP8z/wAz/zMz/2Yz/5kz/8wz//9mAABmADNmAGZmAJlmAMxmAP9mMwBm
MzNmM2ZmM5lmM8xmM/9mZgBmZjNmZmZmZplmZsxmZv9mmQBmmTNmmWZmmZlmmcxmmf9mzABmzDNm
zGZmzJlmzMxmzP9m/wBm/zNm/2Zm/5lm/8xm//+ZAACZADOZAGaZAJmZAMyZAP+ZMwCZMzOZM2aZ
M5mZM8yZM/+ZZgCZZjOZZmaZZpmZZsyZZv+ZmQCZmTOZmWaZmZmZmcyZmf+ZzACZzDOZzGaZzJmZ
zMyZzP+Z/wCZ/zOZ/2aZ/5mZ/8yZ///MAADMADPMAGbMAJnMAMzMAP/MMwDMMzPMM2bMM5nMM8zM
M//MZgDMZjPMZmbMZpnMZszMZv/MmQDMmTPMmWbMmZnMmczMmf/MzADMzDPMzGbMzJnMzMzMzP/M
/wDM/zPM/2bM/5nM/8zM////AAD/ADP/AGb/AJn/AMz/AP//MwD/MzP/M2b/M5n/M8z/M///ZgD/
ZjP/Zmb/Zpn/Zsz/Zv//mQD/mTP/mWb/mZn/mcz/mf//zAD/zDP/zGb/zJn/zMz/zP///wD//zP/
/2b//5n//8z///80TKWtAAA5M0lEQVR42u19S6xlyZXVycyX2pl22c6ql1VOV/kPTgnJEhI9QUhI
zaAnKCSsbqQWA1oMuuZmgJBoMBMjwQgkhIQwEmqr5RHZIDqYwIxJM7AlLFrYpCl3V1W6vvnsKnfZ
meF8WcW95xf/7z2fOPeuVfXy3ntO/E7Eih074uzYcYUaADhVXEUVAKA/AID+AHBKOKurOGz/D5e/
+P4Kb7R/D0mee/Pl/T++m33h+BoV0lYDN0oj7ylPxxYv4LYLf1YZ+/csVEk6aZWwgwvH2OIt1NUI
D9xTno43daH2wlcm/QeJwOTnUEOMM6WidlzsJXY/LvB+qJD3lPvdFRYQ/43WDGz8a3TBxZUgjRFg
dsEgMzOEQnuDdVXEK+wG9Ra+Nt2fsb6Gxprgpv7S32pHy/5Xx20ZjXVymulXeLxmx/B6Xs4CtB+O
ADOSqM/MJFBbouHpFi3T1gtfl/RvpYCbo/tb7d9QO7xplF8NZ8YAwq0hJXF6wJVIzDU4sYWJM5a+
L5uuQPOmQrZvpfCVSX8+aBeMBecHvrmBHY1l1S7XIzi7onaRsUWqxCgb0++x6nT+rRT+aqUVxrk1
YWJx9juiORKKZc/S2Z+bfOFkiGll48a9etlffeHror8mefPkKptE/rOxNZizHR1pMbZc5fB19K/j
LfzV2kRFW09cqS55b9D2mR6h++DDL24mKK/4a97IWE3PTEu96CrnbBLUnRnv5vny6RYq03EU/spR
mLwx3tStAgB14jjoX+UrHwD0B4CKAZM3APQHANAfAEB/ADgNqDY/g7E9Myzy/Esqtnn+ZDDtwbV7
vCwR5i5qQVaJCSs7Fbh5f9xFoL/FVvc1MCNq0/R2rnZxDMPhIezwBkPemmd9eKvlPjPKwhhnGQ9t
mudPCR4mdVoSaq2x6bJKTTieE8usER5tEcbGcJy5bi2Oest95mjX0fSaK/2YWbbu8tnGkGPQ3gKZ
6/bzzCMEYh1MJibN9rNW+qVNuT9eUVaRhOUeBbsmmiE3o2kj8kfZzCD3Ovilqtwu0fB5X41sstya
7s9ME3um2xErdvhciaGN9kxGchjEszKLD9tsP8swvAvcxeOReFlZpSQszdzlNzZWxgFt26dottHQ
MBUbQddT7qv6EMUcll5+wzwrBo8pEzlNvasJZmbNjVosGIcZmyUrnmP7xv2VoSsKOhv6X5ZhjKtp
umF8OUJts9xntuKTR6bMGKW6v1kVvNRU1il0psjKLc0KtXxNs7SlCxummFZ4pq5GtMsYOZO5Kdtu
E+U+cw3UuR1gIeFiZVzQ8RKIXJaVK2HemYj2Mi9vuYqFJ+TMkyJvVrMn3mK5rxqavyWsQstOSgym
CTgWqJz87sUdxZvBLnb+rBhLHwjUbTRWy4zTjGFr9PiN6XoY0429F9AntlXuq7r22hu0KwbvAfN5
NQaXoxvXC28HyND9nfn2BUxPSpYioPuXZBVN2FV1eqVawydPfSyzbodr3HgI5my7GcbnDZY7zeIz
K3+/8T1M8sP1E4wyRZg1HrXqcp8lkT+rsTiM7yeuH7B/LsDeHwAAYFn8VhWlOIP0B1ZBFcSDwTNw
wgD9gROGvvLjdsSu2G3rxuwhG+61PPUDQCH9WeibYXcdWb2r2lM/ANj0j7J/b77CFUt4acKv+tqX
WNVTPwDk6f48+E1Te7jiuHrwpa9bvK/sqR8A8uifyH6H53zb+6Z784AWYQxvxObO1IMlAoDDpf/B
CrlqyrWyp34AyJz6Tsj+RnHa65m4Rjz1RwYdAJhD+ksha+xjZOp+92hfWNtTPwBMqfwoBuvMeSaT
ofuv5KkfANKRb/HJZnaXgW0BJ4E6Fq5rO9cXmwWAquk/MzdBfaBG3R8AQH8AAP0BAPQHANAfAEB/
ANgW9IVPoe1AFvorse5nH6T7EPsrK+1ZFgU5i2YoNk2blRjqQQQCKvdEV4cUjqDG0eq9j6yUS2uc
sUhjWBlXNHBu4KG/CDWHUIP0HzReX579ceo4QCVRU8KTWkmhCpRf22qMsd8og1IU7YewC0ruNiMB
0rvp39Zc2yC9nBCKgBGeehMrCRMq7DKzZJWSsCggXmocJRzZxcp/6iUMqljzn5uvLUIVnqr89JU1
yAlVwFBTFfuXU5hyEg7RlVxsjVQf5XZQEVBepyHMZOznTQWv+M+Kmjo2zi+n/2TL8TJOJOg+2Qnv
+sDu/zxdnMIduBdYjiajaNxNcG/pIghnmw0fGwPNnHBiDxiCUYCwZdMQ8l7X5w2Al/56DZGnhvMa
vBLhP3tWInEaMK7UzClDQPU4rhojq6PSRJWaT0nrirmy6hMmopQRJjHYlBMTIEH6D9ohjTM5S1/s
L6yvR4qCeWxh4eNZZaQo9LkpibSFJVfR+x/Cf8EfF2gB//4bRWBECg9WlehEdez2gtHDZvkPTWiO
qS+wCVDRLag/kP4AAPoDAOh/4vgG6A+cLG7+Hqa+6rKA02SkRsP/slVsQc0c9v5pCQvS0kuw9xeq
KfVgwtxXP1l3jVYw9wp0JhZaCe+82oD+an25moPMJmnWN/wvs2ARJVFTwqckLPT0Euz9ZYLjN/mO
y76rt4KwUmn7jtpMNw9l/+XG1w5D9v6j6bOgpjrDf1o2Oq1c9FQbKxlAbyd3vPcOlVrXiuPfW6au
s5SfPnOHFDsOw/+BErk7/qLhU2zXXGGyay1RvTLaSXh2I9C3fucwsl0Wk7X6t757Y/T2LzKYi/XI
XBwxz9IyNTwJkVamNhi1/4rUknRJExVtGvNFevlzB0rPs22/N01e+RFGO1HfHGJDdrWCZtJ8hh23
IXKq9dQFo6zNt1RuskZ+afHOtzH1TZGp9Rn+l1k8z1NQkWYVbYaZ2t4/uoxkB3j5pOkfsven1liW
7KWEGjSfEh7PZmifkrAMI8r616HVvfQ2g81Jf9Pe33HLvLCaEbko37eeW+bk8CkBpf19gr2/NOAP
2/vrGXvs/QEbsPffKGDvv+jUF6iN/4tGO5mpL7AJwN4f0h8AQH8AAP0BALo/UBsuqyWb095fxIz+
HRb/zWKLy0X5CfXtdHLUhPMAXFXhLLBmjC9y7f1lbOHy7+8sqONsgDS/Qicq/VMN4V0W/4t5kCzK
T6ifGVGj5wGIeJkcxvip/v11O1uhPonu399VUNvef3ilCbjoL+39BwtZXaaJiMX/Mihz7C9Ke1pS
whQqHmWkV1galyN/65mX9Imq/7zmuHyvijVYp73/uBdJk2mjM+LtjZ5U2A2iWhJZEVION0r27+/Q
stxP4Cgo5T/NXCLq0nG5jre+Z84qcpp3kreXD5voaCnZspSxUbqWJELuyt2dosS/f7SggqZ4mpNd
+SH7rbiPaLqr/wW9xxd7q88NT5ll8kUgywrNGGcPfQKa+GlOlv45UoM2V61iTfmnTUqz/fvLM+wS
D48EEpDr39+t+SxM4eJhI9PiXUwSUBxajHjUpKnEeusVZz0ql/6GmhMx6ddvL6b7H55frv1+PHww
oN8YP8PeP3x3+CZddBh5wL+/G7D33yhg7z+18gNsiv+L644nOvUFKgTs/SH9AQD0BwDQHygA/PsD
pwv495eLAmGrEc1kfi1jf6U4BVkWHkYgouFF0JOgGabPv9C/v8fe326GBHt/+PcvoFCzmrG/3rYl
Nj9FhxFQamFESoH7gCX+/ZWnpuDdJsne/+Y07L/c7ALiWUjoDG8V1UNBRCX7JejgzjNP4LQCi/nP
F0ix9z/Yv3+HawWJ3Ju9jYvp7zT0F0sVaaGhYw49K1U2CJq0ZyVyx+G68lD//oP0z0+kQnt/4a7A
frAVTi1oRV+3JdwRhUxK8d8cz9v0kppj7y/iDnL9Vj3C8xgvf+71VTToKld+aI+2tjpn/sJ/9oLu
3n8jXv4Li0mpCUdSN135l/j3F2FzZ2dqQyO5osC/v7fBBQVkDbk+ahf+sx1GIBdgklwFlG6+LKzo
UCT49w8t8PhG99U1n8LTLYpySg0RNOQ/rI4OqejVj2LYmPSXBuKDdFK+mkFWMiUv8e9fWMxke/+U
MIX2/kn+/V3bA2DvHwLs/TcK2PvPqvwAtfN/0WgnNfUFqgfs/SH9AQD0BwDQHygA7P2B0wXs/eWi
QNaCmW8V2Qjn2R1w+BSs3N4/O/9ke/9IQMPSbXp7f7czRc37P+z9ffTPWmoQEdeHSs3b9ugTLD8c
YO+fnz9NkrCwKmVie399VVMY5Re2idHNE2e/w8Mzdc2iS2tZvarZDMlrclOAFs5p1LLai5dCk594
+LyEZ9syoSWc4kV9Inv/EtwrFTVz0n+w6zcd/Av3MSfUmJsCjHA0md4yKU0y8885DIni5KS5JAF5
fniLNZG9fwnq9O/f2/Wbp4WQt7GNTQHe0Krd1XqO5sVwUkFW/gnhCxIu9O8virqFNP3RMI29/7Gu
/DgN/seL2t6AYDxjd8B6j0sldl80ScJ2v8iz91crslDnc+QFe//IzCs2t3WEsa9t7yiAWVQua/Vs
GXv/EGDvHxpcfbbi6lkAwru44U5FrEjAkvzFJAkf4NX/IM0HVm7p0l+361eOLxo5Twr/qbE2BThS
aWbZHVCkxZTlf6B/f78ONLW9v0vNgr1/CA57fxyQswlVCvb+00v/Sd7HAivzH5pQqfKDGtkIYO8/
z9QXAEB/AAD9AQD0B4Bjn/oKnxPijEWG5Zz/F9r7NzSHyVtKwg7b/XR7f3kmgNPeX693s938/v1B
/6k52Szj/L8sVSqJmhI+nrDLdj/d3l+eCeCy99frXW+MkH9/0D8gcoSUUYpZv+b5P8W8f2THpKDC
LlMQnXISTkiFyju891bCiTXBQs7aKa41T61r99algp/+lgW/cF1UjxGJmPc31Qy4esdeWRMrUisz
CGCfbxEo5KwN5PL/X6u9v2HBb4yXqTJMNQIbt8HMoP9kywlFI8thNyUlHJGiusQotPc/qJOsY/FQ
ry+1s9SB0GXC5q1naSpXlRUFlYq6WHch7blzijOXaHAwHVPedOUnMjpS0mA8b4VXaJqXqnyL/IPS
0p5W6FscYb0YwdWEiZCwroqkkULUxv65/fuLTPbPWifW/gIs+USkf7d84LP5V/V+7QAASxVawvn/
Af7917H37wvcLiWIUfNJtfd3FcW6K7PQegTs/b2Af/+NAvb+8yk/wAb4v2i005n6AlsA7P0h/QEA
9AcA0B8AQH8AKJn6CttFvH6r/yaNbKlZxrbfVZisnCzv+DRRVklPb6ZSYO9v7Shw+vfXTUzM92wO
//6gv9FMsYUx085zCdt+ixJNptG+WToxVVZJT2+mUmLvb+8ocPn31ze7OAuwhL3/ZbOVJcWzgNCR
5vyDlbBqoLWWECnxjk9zZUXpqdBBJRIUiuY6X0D17y8marDEmr+WEPTeuixy0Z/20kg0tjm/kB+r
g5brQTRXgUX+SRtJup5mEjHxY2SkdJkQtFp7f9djC/XDoVxWj0NUXoqcWqGGECll6AbRPHt/qbf5
1bDoXAIWoEX03z7oAIPL+DRDjJ5mQ+MKGSpMjr0/uR5kntHqlEh1yMLnZmWJENPpcfphT7RWDQo6
5gZbiP7kOL3U/tii6qM95RSe9l2VICaYNoZji2AxBNg/xThlmfOrWxdlg3Rney1g25+vkHsfqKR0
gWjOSgimonrjn8y/v14M9+G+RTskjh159v6QH/UMaLD3X3SWAtf/m+H/fDrYSSg/VS8rALHmgL1/
4dQXAEB/AAD9gRPAN0B/4GRx8/cw9e3XBPzm/nqIxQ38Q6XJi1JU5hTvyQkJy6WzEnt/xTNcf8dt
70+OClLv6u8Z7rzagP79mkDMtmU55/3JpMzvMAVlju8QSEuYrNAZ9v6Wqz1y7iDQXnO5Sqe9urxp
sv/yxHx/nMVEmRjfSzrNhFdbR1vQ7D8+0uQZ3NBcj0u5Md4zO/a1xV4M3FuVPS76kyDdjb/uDbyu
FWNatq9NM1xRccKU3euT7Ei/9Tt6uMvFKrbCt77OoZi8eocYldDtQMxlmBRPWNVMVvHv75DsL3/u
9agygJUfvY90OyvEYLy+udOidgrwPGUOJmzzkvI33x4yDI0tpuKdb2PqW6R2bPLtuZjrCCJRZDqY
P4ERKWtzOerQyydN/3zpH9oCcJzsn6iDTFGMyFaF9U6vOx7pHzFeX8vAf5LJp2oWv3DClnV+iX9/
z93hG/z7ZwL+/TcK2Puvo/wAtQxlS0bD1BeoCbD3h/QHANAfAEB/oACw9wdOF7D3NxYFTPtyGy6z
/+XX0/JWsTVr+dwF8JCTC2dlRApcZO9vFD1u72/tFYC9f5D+1CSZ5brM/pdfT8sz2tes5fP3KFCT
VRmRApf59zeLHrP3t/YKpNj7H4BNbhU4c8gyxbt/vwdmsPzvOohwtdPS/M+0sREH9rR4wpRVYJr9
qSnh6S17/wOQuVXg3jwtfRj9LTEllAsBs//KV5PpsG4gYudK5Jp9l/j3L+/BARts097/MOmfk1SN
Xt7s1lArndwaxWrvEQ+Ybohc/kTySvJTfpB//5R+Zlr16EVy2fyY9v7TCtKNrfwMqqIwj7EQwlHV
utn/FjBozWIqzT9v9Bv17sFkPMPeX54pFQgf3sjgvAt7/3hbhvQdWpvMmUK/3WdVT38UmUWfvIJg
7++oLuFcMqlJ8ylhf28tX7DFZIryHjZ7yS863HFnSf/+yBOSOqL07N+QR89czYj8AG/1uWWOh5/f
v7+rKD7v/8Mqv2H8D3t/G1F7f8iQqucx+U0Ge//U+Tpc+m+T//Nrcseo+7sUTrC/UlDcm1xuvEnx
0m99/aXH1dfiNex3ASbH4/9w7cH//uEb//bWw2/6gty9vwndHwByyf/FR+/0X29//OJJzbq/Sn+2
/4fLX9wsJ3PdZF2kLjLbfx+Ddbd2Ydd+VqWM3HzOiRPm7kBdRcj7rPvNQzSQyTGZAO9/cy03ZmWv
hu1bZmygWXH92UcPlZ9/6YOfPamX/lfV2ua8byOr7cyv8so+Vt88uy9a3cpbjqjLsr8tiFHUyRNW
nlcDH7Mbvww9IiFxGVO9oP9iVnjtWbnyMXNVX3/+xusPm/P+1+7zB6//+vNfqHagMlV/Pggm3tUh
kxKeqcJeBteHA6Vft5e4KnvqAJuLAzycpzPfJCGYVmIei89mJ//nHz34oDm/aC52f+PnH1+cnz9T
6b4CbeWHMbNpGJeCpvvKNRGjRWYRLaGeDsDYXAkHGTbmmz3yRyqXJ2U/N7733I8e7D4urL+LN+4/
993a6c/NDsCdIsbXEF23YHOyazIxzWfqjr6Ee1qat9Mrq1N9Yvz2ZL+U8P9bf8N/76NXqld+Ov7y
6ECsVTFn6oxurzvtJrqV0Z9He/UkCScrJ30dJ1eWOl12tE8ds8imefDgKx+82fR6j/b30o0Hv70B
3T8uFW0RwivTbDz8YSsmbFUam5a04eQW0/yb5rXm7i8f7HX+vc4zft68+VqtxLjq1PwzlmsY01Ui
2QzdYFJD12D6kiBbJ+H+NmNyjSylC+zChxKWycn0vbO5+fHqux997Hb39aIrwS3xbrXs13V/1uqW
41o0738NSuf4VR2U+/FY00uZMk/gk2scJTJaLSOfboqYlbDnNouHd6ZvJadd4KvNg2+88/ifPT/8
uH3rXz56UrFacNhb39QaXndF4vgQrM/wkLJIUzz+0i/3732ff+bHN8pKuYL0L1N9Jw4IpKv7Zexf
ZAR48/0vf/rOl95540bl1QibH2Cd/gv//gAA+gMA6A8AoD8AgP4AAPoDwIzQ/Py0sP37x3wKLOw6
o/c/Ma/XGs1tP7y9nAD9aSvNrLq0n7GLNesdXgCsqPy0Hm1bJ2Gab9v+ciNv7MI4Q84r/GnpPCD7
T0H6q629dzzsPy1E9fjvCDm/8jN3TpMcRQFsfOrraPe9R3pyB1iKJaOfbugkwPTS31KBHT+E3SuW
oj+NORL4D8xIf33aRyFJv/y8GSoJMK/yY4n51ts5RUaG+VV/aD7AbNJ/UGTac3eUkwsV/cbQdQQt
qfwsd7AAPOKfFv3J+JeG/1Wl2xVkSZYscqoSaXmgD5yo8gMAoD8AgP4AAPoDAOgPAKA/AGwV6sKn
MGzbs1/jCrLijO8Q+gCOwyLl4voQ2AjSvXwmT6ThaHSrsFq64w4B9ezuQGnEduy/gWnofzDI1SF0
Eznbel4GGW1IbeK5fo9dSuthzqyV5EkN5y1N+z/Yf6LKj2nxr5r0i+70d9XiXw0mww+UpCFav1OA
Qv2GzE6kpVcG4RoYhtRBcUh/p8xW7fjl1/3/jWHxLyUt9ZqIZR836EVCNaQbdZNRj7EGkC47GuI6
lBWyeU1eNagropKfXZqmWPcDtk1/kabWqIbGNkXIqTUY5gPknDHIPkKu7Ei/RnrByV2cQcchlwUP
+R+i3dkAa4dTov+wvVvpB94eIZq0jpMzY5B9JGV3vW/bjS+DrB1p5J7JA6cw9U0gVsZ+QAeHRAJr
SyIVpevTqmBTfborP4H1T+FWu0lRrtWv4bluvLeINBnvDxIV4RDxoH9ja9aaHb+0s2+/GdNJTcWQ
HwkW830QqZzLC413T6NM17s8GUrX3yFIce1D0P2PHUX+/SPidBqFOTWV3NwE3mfVgDr8+2e/9hJR
ZWHpPb95+YH5wAH0pwlCTJRRUX4EZR8YAZM3APQHANAfAEB/ADi5qa9wziSHdfys6aJlLiCsRXRB
Wra+PQCDKb+y4JRk30/uD6z7AB76h9bDD6RNyHombKtPSheQ98JxLBNV+QEbfiCm/AjFhr837jdM
/xuPt3/bz/+QiLFjoNsa4O1c5Ob1IQDtgaD0N+imikvD9L8JePvXqartHFD3B6hW9yEtyDxmKMm+
P9QLIP6BIP0jIlM3xScR2KmVmK4gh8i3TUrVXbpNyfsrMB9IoH8vUtP9uwrnV/u3SGelMVkgaDLA
QvSn+FTYx0brILiM819KthzmKD8Q/kCi8pO60YkEmdwSQdoJ66BQ4XCjLFI7QQajwX4ghf6GA32h
2/s39i99U4Bmnq9FUnYMtOn2+3odq/iayb+eTrZ9/3AdC/+AhSubo8NhBAb9K0Ed9v7bM3ogAfYD
J0v/g5Z9wH5g4/QHANAfAEB/AAD9AQD0BwDQHwBAfwAA/QEA9AcA0B8AQH8AAP0B0B8AQH8AAP0B
APQHANAfAEB/ADhC6J4eWMONb2z3J7+Nt9v7rP2t/mumZexnZk3K/uYuVJudL7ydkDN4Wn4A6K9w
SP3WcpjxgUpM5XOEXFxNrwmROZBAhj8AR3CQH0inv81+k0BcGQ+YdFbBOFOGil236MeGNsRwsWkv
9zeHQGYkj1wfI3QJa/GMQg4Z6QH6oQjDAeDX/XlQbjLWy/yRdLau0d1iSggZfuwru58tk/ufaiR5
3UjUujHG49xZBus3swYjAPSPsr+XmHzsAC61Q+8JMaVI/eRDqtyMzJgurE3FxiiNGrzvMGhe4MCV
n5FFfNB82LRS1EvTcbhgSfF8wcff6A1AeOUnTDJurP64Zg3Tsb/V4Rn30dYRzx2c97ewEgQkSH8p
PZmqQahCdRL5z9KvD7OOxK7GlAnyZMUFTlP5YYwNuvaeUrxhzF4Q4qM6rmvrzBm+UV4J6Dq88aqg
W67ps+WBeGZwfYrAof0ATqzk4ZnxTFUkOwJQN+rw8Hy2TracZUrj7AgAUC3985kM6gMr6P4AAPoD
AOgPAKA/AID+AAD6A8BGoS98itDhb/oJ1sOpv0OM5c5MNHPOi6OdVZwZzR+iT9JTJq3GZHpCP7s4
nHwzxBkvkJadsAs6Jq3WmFjreL9Lm26V0V9QAjOEGnSMIRYrsZlzRhyNS/nRQiFEoP6EVbnD0faC
Iuwf4/R5KInoVSCUhLVszRoj0QBO+nctLUYZs2+ctoF6sSH6w9jXLTGVxxGDoBYl0UoLY2VXOFDG
o2khZLbLiftQvV7TA9ybpGGnVX6GEVb/G8QG+QsptiFUum5NZdGyKB5sVpHSs7LY3+evFpQqE02X
eoA6bX7aCiTlaSjW1VfgfYn4HJSYzLjxaPqdQC+Q3OzS213Y/Z+ti4sw/ZwFFZla34lOfTslx6om
4WzMtj27D7GN09JprmiDOt7VRooe38hJeE7leXIYpwPeJxi7WzVMq5L+sqUi7U+6erzo0g8tEydD
3+6fn7KTF5kl8S9AxYu6DRm1KK4aw/M4PYwMubrmQ0TNBtgvpo/Wy/Pu+RPTP0AEe6KG819PS92W
8jOop8YwOVxWeddfI7G4UBH9/CQn55I4SdGEPtsMpU9CUfrHpU8K6v4yjisH311jAWjFtqoeV1Ah
24SgkltNNfO0OlZ+YPSwWf4vGu0EdH9gQ6DCd3G0jvD//J0XPvnJ8xffB/2B08Ljz9587pM/evX1
D999409vPHP+wveuQ/cHToP6f1FcPrkwLp7/7neuv/K3eW30tz34G3MU5ro5emBuOn8Miqse6bx5
5WfVythM6DJl9D+h+JR2h+P2WQmssY9A8CTeNJo7a2Y6t2ba4xltJB+eO85hmA3Xb/+1//7hhe/u
+Y3rP/xUTcrP3hkyt5yoMedXeUW6UN7HNp3jDumxldmvlXG60kif1sbzuipRu21VVqTU3EiAa7+0
VI3Wki6yl3Pw/vj9zzz3iQ/+7DsD+88b6/PiJ3924xPnd773eFVmmG99+XBwS1/fTEp4pgp7GVwX
NcoYwaQPdL4u/bktDidNOGWMsMYCc0CNdrS8ICyzjNMJ/T/4ezeunO94v/u7CH8+bM6/en7rxrVX
blQx9TVdhndD8yBouq/qCMH0yCyDASsNA4zNwogYibmnIBNnz3R/kUqzLtQHrr948+sffO29t5q9
1E/7u3j71R9fefb2SmtCV/X60lqFOxvS13Bdt2CTt+1kaspYRj59wins19yNZlZWGoFV3Yu7L8+L
Fz965vdL4j1tPnpldeWHqwcWBRpCq0uuCVTennTEWZXs53MlzLhaFaGgjPHyyvKlP2RfFHlSvLr7
+9HPf1NcPmx1nKS/O9evv/PzpvkrFej+cTHBXP7zq3cgPtvor5wzxvh8VSFP2PHOrKOTiKXa6at7
JehPmPjVXsff6zf+z9tnt87/3401iXHVqflnLNcwpqtEshm6wYTVw/7pyzLQslvGYUluePenJrCM
ia923oKdPmNa9sZTyszYkj6Cn/zamz99eP6fXny+6XV8+5O99Mwzf/6zRw9WZX9zTYr/+3d32NXQ
7pPf3f3bHZC4+3X//nij+7q/eb+Ncb+NxbvIbe3uLt3t7g7X9r/urrrwf7fZP9r9sYxNX8CpEu5T
7KvCHfC+Uh2uyrKhVl9f3UP6enKuC/01mdkQeapHj+Kb7//HR+Ly25+4ceOReeszt/7991/8Xx98
uL5gPOytb6pSAc/8Cypz4SFl+aZ4fPP5v/7fHrZf9/oOnbX6Th0Wn9cO2oN2/26aKLkL9k89nN0v
Zf9S0l8OA80vfvCr7//Xj3/5w2dvvvDaP/7g599suoGvAsDmB1hnAIO9PwCA/gAA+gMA6A8AoD8A
gP4AMCOUZX/DR7bQXccHsLDrjBL//gdnBQ85x05/2oavzhL//odlBe6flPIjhOj9l7XfjMuNvLEL
4ww5KxakYr4XcmCz0l+XeWRKWO0sEdX5Py0ki1cccCD/T3Hq62hzEirNaR2xLBbOinAk0OlI/8aa
Dds/hN0rjldAQvKfJv11P/8UYsSSyo84ynEGqE35scS86I++C44MR8d+KD6nJP2lO3/Nz7+q3xi6
Tndc5kKsLPTVX3lWQAX0J+NfUk9CVD/MIAvSg5bTyBfMCqhS+QEA0B8AQH8AAP0BAPQHANAfAI6B
/kL5V/+WCOF4TZaaoogdnQ0AdUt/cpH6kOgAsAL9TYt/1aRfiM7oX7H4V4PJ8C2jhZWiGXdIot9L
oCTXjHcW3E4AnBKcJm+2xb/8uv+/MSz+lW1Roic8+VK04g4fQzg71+bItxMAddBfpOklqvG7zcl9
DyD1lzcxciZBMDYAVqH/aN+YMFkViTq+i/9RRUYcNIcAgEOUn4bi01Eqn7Xq2wiSAmAcAJab+oYH
ABEeAAx579wnKJQYwpW6sO5gAACWkf6axf+oondf+z0Aug288qvnvjBujik2YxLtp/wYwpIVoIHF
PTAPivz7RxZhEtdo7I4CnA7q8O+ffbhL3OMZ+Axse+obAE0QQguHzgLUN/UFANAfAEB/AAD9AeBY
p77CORUdliezpqiqFdsQ3UhBWrk5c5XvEQZbDOW4AeGcMqvvBsR4AgDWoYAk+oesKg8kkQjQkBzJ
SwvP0fhTuxeOM7wzVq1MASBR+RGK0X1v3G+Y/jceb/+2Yf6QiLFjoNsakN65SjgM2gMZ0t8Qo6rw
NEz/m4C3f52q2s4BdX/A/pKt8HhJS56O4I4jNJNsiH8gg/4RAao5etZt+5MlLrlEuzOu29pnfPVc
16ljwDHQXwSI52aZ86v9W+Rz1L3PC1YXwGz0p/hUOKSaCC9RKaET5VHXo/wMSz/oB0CJ8iMSVwxJ
WMe/iaAwFmReEodsbSTPRbAfKKS/NOzXFhi9Fv6NvilA296iRVJ2DHTz025x3rGK34cUDt/63pms
jDP2Qyz8A2Fc2Rw5cukM+leJOuz9t2f0kHnIItgPHBP9M+cIYD9wVPQHANAfAEB/AAD9AQD0BwDQ
HwBAfwAA/QEA9AcA0B8AQH8AAP0B0B8AQH8AAP0BAPQHANAfAEB/ADhC6J4eWMONb2z3J7+Nt9v7
rP2t/mumZexnZo1rfzNT0/WEAYDZ6c+sby2HWxK3tGQqnyNE5Wp64yUX+7meLgCsQX+b/SZhuSKs
mXRWwThT5PiOz/3Y0IYYLjbt5f7mEKjvRJwxrl/BIAAsrftzxzc2EpGxXlgPlHaoO90tpoSQ4ce+
svvZct0aB3jD0CLASvR3sX8gbyeXmU/N0XtCTCnyBOLDB4PwB5aX/kHwQfNhENHAMU59Yx3AWP1x
zRoAYNPSXwr33TftR+P6Xgym9Cld1+HQfYAqlB8+Tn333/ZfuTIZlqG4HljjMXOQWXkl4A4AAAtg
JQ/PLLi2ie5w/KjjTc/ZOtly1ngXiFgD9gNHTf8QwcF9oBLdHwBAfwAA/QEA9AcA0B8AQH8A2CzU
hU/HAbvyHjl+Dif/jh/LHiRXcGijVu4Jw+s1EQyjhqboQyjHFOtF2UdWsxNW/o78xkOVAZv+TeAo
dDJbsg/aH//exlq4XkVpFEGpXSc1vFkTgTBaaEEx9vuLomcnrIJa+XUNRKIe8l2u9trJSf+x4gTJ
E9G7v66tBsnjqsMNHKDbl5syw8dBLhkRFCC5BUgqCgXzm7uB8vrVvd3ftQIRRrPT3yfI+su+Iohl
5b/Il2O0alUX6G+UWpSkypi5gfLS3tv8XK6uiJ2Z/VfTYkj0//meT+izhs0coT55QfuBMahZKzcH
NVw0E+vi2oMN7SbGZq2rgc7qKoGq+6eMtaKrWTFW8JYJfKjo67XrQLnGwbOrsKG6J3iSpJkJprwZ
HZCS2nwhHcEzlBcTZ+W+QwcocOHKcAl/wI+rEV1xLzV81ShcH4tRiMrl2QyqT7wKROEcMacyguwX
YHua7q/oixHlZx9G/9iC4p85CYw/WUoV9DdbedIH675TRnfVcpAp6g82vCEYfmyugZbDFVTINhEY
weIzgQpQx24vGD1slv+LRju1qS9QN6joFtQfSH8AAP0BAPQHQH8AOPWprzSPNa95DfxXnEiV5F5Y
8PXs/V02+057f8fGBNj759Hf1RSaBZBu1i5WNaEqyb2w4OvZ+7viOO39HRsTNmDvXxn9SWjiQhp7
em1T1pMkVB5nervnPHt/mvyRXRsZMu39Z+wV15qn9sV7K/LAQ39T6IwV5jX6wUB6+BiWrIHRgRwI
qmYztqTTrL9GH5/GWBwx8J/GWHcR7pgcyowa7+cp9v7Gxt08e38hbXlS62RIem17/4pfrRpFo2AV
6wb+WxT9hR02Hi3F3t8lcJNFCKktkFdq2Ptn9kyaVnmuRvhPEHWSAsv1NJHdESt8sO3iqi3g/VOh
dSz7p1R9iqKK1BAik/1N8RMkqT7LTW6PR/r32o1TzNRk4C8KFv4HA/lV7P2l/f2Yf9Te39ojkGHv
H44LtIC9/0YBe/85lB9gM/xfNNqJ6P7ARkCFS/i0qvB/fP2lO7ef/cQnbt3+H599H8oPcCp4fPPF
J0+ffHjRNOcX3ZXzi09fffTcf/mrT0B/4Hjxhaf/9B9dXj703r99/V98462zJ6vTXz+zfThdVJmj
MNfN/ozGLjLTjuztbu3CslqOq+vLPfnJqf1plJFDKZXbrDvPm4emgPL0S62Oh4TUwzHt57IiK3ku
hOt/8Pd/dvOF76cFvn3t7Oq//gf3b6ym++9qh/OGOdrA/iqv7GP17bL7otWtvNWwWtg/T2lY96DM
UX92KFkCHuuqfXijjptBqhjJ6W1lRWbxLCcj/kufuf3cb3zwtZ+/92bL/vP+euDz4ds/ef1rP73y
yWdfuHPl+mKEMNf9+SAkOiHDmZTwTBX2Mrg+HChjRHup+84rof+MvYo3DQvTS7nNHANq8tAV69xG
z+JNs5wE+pO/eXn50ZPLC9rp93/cNBfnna6f/vnu7vNxw7579fof/p3/O/9QoK38MGZIq7Z1BkHT
fVVHCKZHZolNsx5NeTblUlPuHj5cB8ptflA2nueKpDqv4H905TMvfP1TX/nRn77+4O0dj3dXDvjj
b73x6q/dv/0bz33rM9+9vhD9udkBuLMOfS3cj/9xEhwjepkQVn7kbWUQyKqscPrcN1go4/BseOWl
5qNXPpo0yYvXdym+spjy0+uv0RFYawHOVJ1yrwLsJrp10n8+4V/YZ1IrS69jr/APsn9ufHX390fN
My8++fBXH73V6zLFf7evnl27/n/oRvPPm99eUPfnUSXFrkpezcQ2SUfvpy/V9IHkjhJ/rjXZ3+PJ
q/t/6blbTy+f/OXvd7rM+UX65/mO91+89vaf71P51MIrP8zQ1JNYzZiuEslm6AaTirpGvzRlrVAt
3AdZTG5b4c06Nm7rD8SYwvl95BWe9bUHb7773g8/+gtf/OyLvzm85WrCn+zT9IXvfeXhz3/67psP
lnsH4Fr3b/Wb/v9xtVj92t/pmk8ueXefytryuO5fjbCdad0/Z+lnXFQzKisU3qjjhsnc1OS0Rbuh
neRsY2zORfH47uXv/punTwOvvc7Orp1de3UVPhz21je1LlmzKV1jA1ocj05xKmuK6/+TPb388O3u
Rz8ivHDt2tlbj26sWJHXDtqIef/u/aRwd8H+SXG38Vd8jP3N/VWK/OG/++AXjx5ffufWR7c/dqP5
1Cfp0y88/CePfvlB8801KxI2P8A6Axjs/QEA9AcA0B8AQH8AAP0BAPQHgBmhLPv3PgB0j/H6NzdW
8pm2hNcah9t84DjpT5vykbfI6QJiuayAWpQfIUTvMaz9Zlxu5I1dGGfIpUALdLEGkv80pL8uV8k8
rUT9oRwA4Ai5mPZDG+9eQNVTX0fz7z3Se84pWZr9tNw5PQK6z8lIf0v3dfwQdq9Ymv60aF7g/+nR
v1VpnHwjBxnBEOColB9LzAv9+Dv/aHBUgFfYU5L+NHqf147SUfUbQ9fp1PBlhf+COcIx/onQn4x/
afhfUXjIFWQFetBymYD7p6r8AADoDwCgPwCA/gAA+gMA6A8Ax0B/ofyrf0uEsOP0lqDjuc/CNg2V
V4bAwnrZ1tixlG9CuAxOrXTNAoZK01u0AseNsykTs9fHDUtQasgilQwy2pDaBhSWQYXQblHjjqKl
20UiNZy3NO3/sOI4UeXHtPhXTfqF6MWxtPhXg8nwAyVJE6cB40lydSItPX93yOuZQqYOikP6O2W2
ascvv+7/bwyLfylfd3GERbdeNg8CWBrSJVCvy45G4a29dbY7gidd0ZdhEP+kaGve0qBnnBj9RZrw
VO3sbYqQU2ugkIQ3KadvZBmzo9Ckw+wWZh+i5PGmz3O/swHmDqdEfxonmvEeIZq0jlM2h8iUvJRy
OytNCvUa4LinvhQnFqXzz8Ehn5JCkYWlaFahIMKXgTOWICz8nO7KT8DPiXCr3dIamhr1q4tyFFJ9
yDPOJEhiCt/zdC+IeNDf0LZHi/9RQe6+9nsAdBt45ZfQNI0EU/k+SDvHbb/KC6MSHoxOsXT1QoR3
5Y9hu3joGMeNIv/+EY14GoU5NZXc3OC1pwrU4d8/+7WXiCoLYultXzRHrwJOWvcv0a4n1aRp8oAy
NLoA0AImbwDoDwCgPwCA/gBwclNf4ZxJDuv4WdNFy1xAWIvogrRs7VddxjkD6ms44Zy+Ku8e5No9
VnqANPqHuHIgiULWM2FbfblRRr2XZt/f9RLwH8hSftRNV71xv2H633i8/Tt2avWJGDsGuq0BCZ1L
UHH3A++BDOlviFFp9N+JUMXCvwl4+9dpp+0cUPcHqFb3IS3IMklOsu/XoqIbABn0txnkvabb9lPy
+yRyiekMlkbs+7FLFyinfy9S0x27Cj/vEvxAF0jncIyomRwA+OlP8amwj43C3Dyecf5L8gbIaBxo
O8BByk/qRicSZIpwEZTutkm/oANIS5jzAtPSXxr2awuMXgv/Rt8UoOkdWiRlx0Cbbr9/3bGKr5n8
ezqcp9hO+34AcOLK5shRYt8PVIc67P23Z/SQOasF+4Fjon9DM4YGQH8AAP0BAPQHANAfAEB/AAD9
AQD0BwDQHwBAfwAA/QEA9AcA0B8AQH8AAP0BAPQHANAfOHa8f/7s52su3xVsBwHmwvVPPb5ompc+
9prjHjY7AsdN/pu//pMd+5uf/PRb1zcg/Vn7L7e7J+sv7q6wLkQblLP99zFYd2sXto5+rRVeKbb8
mDBh81cwe6Wu1Ppz5TAmx9Rs+p96ctqFxs5MzXMJPP7ix34w/jh/+rMbtUt/zrs/tTMYrcH2AbrK
bkPr7dzfckRdk/2ybPrHhAmbv4LZKwF5rH+NNapm0wxkV3Lj3LhgZdZ/LEW6F59/dcf+8+Hney/c
eVyj9D/zCB2mCvuxyo3hQOnE7aXuO2eVsX+ONtcTZsFQwXR4YmY8Mg7FsKiwfekXf7rj/kVzsfvr
Pt9tnn/plRsbWPnpxATvBmZNnqiBGItyowrwZRLmM2ff1be3r4SbY2l8/us/fnv3caH/Pfzxne9u
gP5a4/mqtesWrLqa99Jv6mFfT5jL6uIZ7E+vv4i6FrotS7WU6vP0993XP/zBtuhvVVjfH/oZwm5s
2Mkj3mwAs7W8mnDupCK3/nzCn/OkKcRiiv9PfvYl1un96t/zt975u9uiv11hnG+C7auwf4HHYAco
lksW9Y0/+sLti/Ne72k/z289elSf6p+57s+YrhJJedQpQwzsT6vDjImvDG+ttvW3GfOlr/xYtqPe
eOvxrYv++/7z2+LRk22s/HDWLsntPjhXq7Jd5u/UyD6INs9Vr/EKO8CePeOTTTgnVR7Xl7CVr6v+
vNF8CVu3tVCOyGzRlnny5Jn2nW+7EPTxlytVCzKMHlLlB2s2qSAdjTLHeC2t8/lfvLH79x/+4VEY
PfDJAwIHjTpl7F8Qr1185c6nv/yvXqu3GmHyBqzTf2HyBgCgPwCA/gAA+gMA6A8AoD8AzAjlrW9/
YuKwEqocVB1ZHF348MThvOFmznPr+uO3x6ywPnzs9KdtnAIqhnLSvF1MZiUI56OekPIjhOhPW2+/
GZcbeWMXxhlyqV4wd+Kg/AlJf128kin21B/D9zYMrSMg59RIwPvTpX+QBTuuKzSnFThDPe8X6XCi
fyoBppwe/fVWF74bCieX0/2Xya0d13YPR+D/6dG/ZZpTupNjoDje2SF0oVOa+nrlf6tvj/p/ExgN
FlH9l8oDkv+UpP+gyOwntcqor+o3hq7ThlxY918ixwWzAiqgPxn/0vC/ogKQK8iS9KAlNBJaLiug
XuUHAEB/AAD9AQD0B4DjALa6nzKSXtXkvs9JC19H1pD+wAnjzOoV6Xb+rm5lxhnfIfQBHFb6wtxj
YC6zdy+fydmF1dK2ryisMo+pDbdFb8ugR/SUu4Gx86nQ/2CQc5zRTOTIeomqBBGuOO6eaL2QFaR1
NEfy/cYVadCqlttdqPZ/sP/U6N8JyLb1e3Oe8eteIIpBhraSU+6H2v8SY/iBi933QY4K/0sk4TIs
6+KZrO6DikxTNCsVNZOTVP4nC5QdfsWsI/S3Lf7l164fGDfkDqyBkKZ93KAXCdWQjmKDRzP0wCFu
o711bshDbOFOT5P4itVoqFDHrfqc5tTXQ3+RVk2qyLXzI6e6QPon6akFSz1mRynPRamtahfO9SzN
MKABR6/8DBNPVaVOG2YOMIqccKPY9Cwl94QeOGrdn+KMonTiOcgjSuiaHqlMjXHGEtjpcoorP4H1
T+HWt0nRqtWvLtZRNuuzIpUJ69MT8TRHtdCGsj7zadujxf+oGY/G7+03TWNXfunr8Qmm8iSMvWLa
hdSNht7lyVDy/uFgLHe/1/GYl37IOzgqrZpELS18JILISi9dUFIwPzPFIqMHcfiTTT7rL1kkgEqv
vXQh7820ylIToyhTafomCgQW40shLVC20YPYYQn2Z4/jYtbechIdYTIlJM7+lBQnzNV3K/utL01e
6kX1Pi00usBcE5/oYvbcmlxifmdoeGD64XIqzXLuXGHxCdQ+lMyYK+gP1DtXmj1X0B+YnodiK7kq
C5/COYR4l8Ui5TZt0MzVc8Xa0pWruYKsrU9HDPsNt/zqBxZ8nJUmqPGv+/dGjikrlfKNSjS4oDQ6
U/bDhPILr/sL8kXLXoTXYrj2wVAgX2sFWb8gwob9lomq8QEAAeWn99Uv3fyrLvzFsCnF5e3f9vM/
JKLeHNIV3l5H02t/oD1gw+vfX9sVZZj+NwFv/zpjtZ0D6v4Asp00e+zUmiYwQGWbzmHvFhCmf0Rk
kk4m3dt/Irecm67MycIYdFTbNNZnv7iC2T6QQv9epKYbHAn/7DvBD7RwdzKhbesSkU02SX0Okh+I
09+UuxnCXJi7xjPOfwkqMlQQB4iD7f/heeFlcMb3V3j3pf2XRdPSQmRmP2YTTJmlJ3mWtnQTVaWV
7QFB6W4vJAmyGW5tNhCZthyJYwyQQ/2BYTqBudIR5s4+uYwsMd2rLkq3Np39x0hn0kw91V/KdzLM
QbVIMmFqxiUk0dqQCmcRhFWYgGWnL47+gV7g4QxjHX9Z/338Ia9Y4Zv+tnmrj9dGlIH7K85ekpu9
HkgL0DKfMzVbZwoO6e/waq958m/ce9ZJ++o4FEA/BIDUeTIFpLoZJyzzfXHgpD9PYhrSs9dolCtc
CcP767tPxlutYx9+iNf/lBEY5y7BnJW9HcgRQCmjO4WUlZ8acdDSJYS/Q5nngw7SctijngwhUhSW
MRSPKjp52XuS40G9iufr/lXzf6W4R637sxidFRpm6/lssuw9l1gsW3Y89AdmUn6CJDUWXXhBFzs8
e88lR/RB44mUABafgBSQhvLBUoWrEZVlDQAZ2XczWo3szBvGyJVB+gN+/YIzXbFQLklVY9DquX9t
XU3Kranw4uzHr3ogPUsljCMFHTjeAphHl9oEIP2BGZSorRQW0h84YWDqC4D+AAD6AwDoDwCgPwCA
/gAA+gMA6A8Ax4P/D5uDu9WMTD0LAAAAAElFTkSuQmCC
</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-03" MODIFIED="2008-08-20 18:52:31 +0200" MODIFIED_BY="Toby J Lasserson" NO="3" REF_ID="CMP-001.03" SETTINGS="SHOW_WEIGHT_COLUMN:YES;SHOW_RAW_DATA_COLUMNS:YES;SHOW_EFFECT_SIZE_COLUMN:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 1 Self Management versus Usual Care, outcome: 1.3 ER Visits (% subjects).</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAv4AAALACAMAAADcy4ZWAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
</FIGURES>
<FEEDBACK/>
<APPENDICES/>
<EXTENSIONS/>
</COCHRANE_REVIEW>